	data source	chemical_type	chemical name	pubchem id	smile	disease name	gene symbol	variant	label
0	pharmgkb	Drug	meloxicam	5281106.0	CC1=CN=C(S1)N/C(=C\2/C(=O)C3=CC=CC=C3S(=O)(=O)N2C)/O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	Metabolism/PK
1	pharmgkb	Drug	lornoxicam	5282204.0	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=C(S1(=O)=O)C=C(S3)Cl		CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13	Metabolism/PK
2	pharmgkb	Drug	siponimod	44599207.0			CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
3	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs17376848	Toxicity
4	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs2297595	Toxicity
5	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs1801265	Toxicity
6	pharmgkb	Drug	dexlansoprazole	9578005.0	CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
7	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	Toxicity
8	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs1801160	Toxicity
9	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs1801159	Toxicity
10	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	dose reduction	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	Dosage
11	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs17376848	Toxicity
12	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs1801158	Toxicity
13	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs1801159	Toxicity
14	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs1801158	Toxicity
15	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs1801265	Toxicity
16	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs1801160	Toxicity
17	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	rs2108622	Dosage
18	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	rs121434568	Efficacy
19	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs3745274	Metabolism/PK
20	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	Dosage
21	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		NUDT15	rs116855232	Dosage
22	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41	Metabolism/PK
23	pharmgkb	Drug	tropisetron	656665.0		Vomiting	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	Efficacy
24	pharmgkb	Drug	ibuprofen	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
25	pharmgkb	Drug, Metabolite	desipramine	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10	Metabolism/PK
26	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs74503330	Efficacy
27	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs267606723	Efficacy
28	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993958	Efficacy
29	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121908752	Efficacy
30	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508759	Efficacy
31	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs77834169	Efficacy
32	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508537	Efficacy
33	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs115545701	Efficacy
34	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs368505753	Efficacy
35	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs202179988	Efficacy
36	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs78769542	Efficacy
37	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs141033578	Efficacy
38	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs78060119	Toxicity
39	pharmgkb	Drug	rasburicase			Hemolysis,Methemoglobinemia	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
40	pharmgkb	Drug	flurbiprofen	3394.0	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29	Metabolism/PK
41	pharmgkb	Drug	trimipramine	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Metabolism/PK
42	pharmgkb	Drug	tenoxicam	5312154.0	CN1/C(=C(/NC2=CC=CC=N2)\O)/C(=O)C3=C(S1(=O)=O)C=CS3		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
43	pharmgkb	Drug	tropisetron	656665.0			CYP2D6	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	Metabolism/PK
44	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs59086055	Other
45	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs115232898	Toxicity
46	pharmgkb	Drug	celecoxib	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	Metabolism/PK
47	pharmgkb	Drug	piroxicam	5280452.0	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
48	pharmgkb	Drug	ivacaftor / lumacaftor	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	Efficacy
49	pharmgkb	Drug	ivacaftor / tezacaftor	72722243.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F	Cystic Fibrosis	CFTR	rs113993960	Efficacy
50	pharmgkb	Drug	flucloxacillin	21319.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	drug-induced liver injury	HLA-B	HLA-B*57:01	Toxicity
51	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1801160	Other
52	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72549306	Other
53	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72549303	Other
54	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs115232898	Other
55	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs78060119	Other
56	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1801268	Other
57	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1801266	Other
58	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72549309	Other
59	pharmgkb	Drug Class	hormonal contraceptives for systemic use			Thrombosis	F5	rs6025	Toxicity
60	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Toxicity
61	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		UGT1A1	UGT1A1*1, UGT1A1*28	Dosage
62	pharmgkb	Drug	desflurane	42113.0	C(C(F)(F)F)(OC(F)F)F	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
63	pharmgkb	Drug	desflurane	42113.0	C(C(F)(F)F)(OC(F)F)F	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
64	pharmgkb	Drug	trimipramine	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C		CYP2C19	CYP2C19*1, CYP2C19*2	Metabolism/PK
65	pharmgkb	Drug, Metabolite	desipramine	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Toxicity
66	pharmgkb	Drug	enflurane	3226.0	C(C(OC(F)F)(F)F)(F)Cl	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
67	pharmgkb	Drug	enflurane	3226.0	C(C(OC(F)F)(F)F)(F)Cl	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
68	pharmgkb	Drug	halothane	3562.0	C(C(F)(F)F)(Cl)Br	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
69	pharmgkb	Drug	isoflurane	3763.0	C(C(F)(F)F)(OC(F)F)Cl	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
70	pharmgkb	Drug	halothane	3562.0	C(C(F)(F)F)(Cl)Br	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
71	pharmgkb	Drug	isoflurane	3763.0	C(C(F)(F)F)(OC(F)F)Cl	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
72	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
73	pharmgkb	Drug	methoxyflurane	4116.0	COC(C(Cl)Cl)(F)F		CACNA1S	rs1800559	Toxicity
74	pharmgkb	Drug	methoxyflurane	4116.0	COC(C(Cl)Cl)(F)F	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
75	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
76	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Malignant Hyperthermia	CACNA1S	rs1800559	Toxicity
77	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Malignant Hyperthermia	CACNA1S	rs772226819	Toxicity
78	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs59086055	Toxicity
79	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases,Myelosuppression	NUDT15	rs116855232	Toxicity
80	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38	Toxicity
81	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	Toxicity
82	pharmgkb	Drug	abacavir	441300.0	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N	Drug Hypersensitivity,HIV Infections	HLA-B	HLA-B*57:01	Toxicity
83	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	Dosage
84	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs3745274	Toxicity
85	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01	Toxicity
86	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909041	Efficacy
87	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs80282562	Efficacy
88	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909013	Efficacy
89	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508256	Efficacy
90	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121908755	Efficacy
91	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs193922525	Efficacy
92	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121908753	Efficacy
93	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs74551128	Efficacy
94	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508288	Efficacy
95	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508442	Efficacy
96	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs150212784	Efficacy
97	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508513	Efficacy
98	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909020	Efficacy
99	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs75527207	Efficacy
100	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs77932196	Efficacy
101	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs186045772	Efficacy
102	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909005	Efficacy
103	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs75541969	Efficacy
104	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs11971167	Efficacy
105	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121908757	Efficacy
106	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28	Metabolism/PK
107	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs78655421	Efficacy
108	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*6, CYP2B6*26	Dosage
109	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs2297595	Toxicity
110	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O			rs12777823	Dosage
111	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	Metabolism/PK
112	pharmgkb	Drug	amitriptyline	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	Toxicity
113	pharmgkb	Drug	amitriptyline	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	Metabolism/PK
114	pharmgkb	Drug	clomipramine	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Toxicity
115	pharmgkb	Drug	clomipramine	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	Metabolism/PK
116	pharmgkb	Drug	imipramine	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Toxicity
117	pharmgkb	Drug	imipramine	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	Dosage
118	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	Toxicity
119	pharmgkb	Drug	doxepin	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	Metabolism/PK
120	pharmgkb	Drug	imipramine	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	Metabolism/PK
121	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	Toxicity
122	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	Metabolism/PK
123	pharmgkb	Drug	voriconazole	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
124	pharmgkb	Drug	lansoprazole	3883.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	Gastroesophageal Reflux	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17	Metabolism/PK
125	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Cardiovascular Diseases	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Efficacy
126	pharmgkb	Drug	pantoprazole	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
127	pharmgkb	Drug	atomoxetine	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6	Toxicity
128	pharmgkb	Drug	atomoxetine	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96	Metabolism/PK
129	pharmgkb	Drug	flecainide	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Arrhythmias, Cardiac	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	Metabolism/PK
130	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41	Metabolism/PK
131	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41	Efficacy
132	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	cardiotoxicity,Respiratory Insufficiency	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	Toxicity
133	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Heart Failure	CYP2D6	CYP2D6*1, CYP2D6*4	Dosage
134	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41	Metabolism/PK
135	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17	Metabolism/PK
136	pharmgkb	Drug	propafenone	4932.0	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O	Arrhythmias, Cardiac,Tachycardia	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	Metabolism/PK
137	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Psychotic Disorders,Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	Metabolism/PK
138	pharmgkb	Drug	clomipramine	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
139	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
140	pharmgkb	Drug	imipramine	3696.0	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Depressive Disorder, Major	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
141	pharmgkb	Drug	omeprazole	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Esophagitis,Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
142	pharmgkb	Drug	omeprazole	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26	Metabolism/PK
143	pharmgkb	Drug	lansoprazole	3883.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	Gastroesophageal Reflux,Helicobacter Infections	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
144	pharmgkb	Drug	pantoprazole	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	Helicobacter Infections,Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
145	pharmgkb	Drug	zuclopenthixol	5311507.0	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Metabolism/PK
146	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26	Metabolism/PK
147	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs67376798	Other
148	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs67376798	Toxicity
149	pharmgkb	Prodrug	tegafur	5386.0		Neoplasms	DPYD	rs67376798	Toxicity
150	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs67376798	Toxicity
151	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs3918290	Toxicity
152	pharmgkb	Prodrug	tegafur	5386.0		Neoplasms	DPYD	rs3918290	Toxicity
153	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs3918290	Toxicity
154	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs3918290	Other
155	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs55886062	Other
156	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs55886062	Toxicity
157	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs55886062	Toxicity
158	pharmgkb	Prodrug	tegafur	5386.0		Neoplasms	DPYD	rs55886062	Toxicity
159	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs148994843	Other
160	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs56005131	Other
161	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Leukopenia,Neutropenia	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3	Toxicity
162	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3	Dosage
163	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	dose reduction	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9	Dosage
164	pharmgkb	Drug	tobramycin	36294.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N	Ototoxicity	MT-RNR1	rs267606617	Toxicity
165	pharmgkb	Drug	amikacin	37768.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N	Ototoxicity	MT-RNR1	rs267606617	Toxicity
166	pharmgkb	Drug	gentamicin	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-ND1,MT-RNR1	rs267606617	Toxicity
167	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606617	Toxicity
168	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606617	Toxicity
169	pharmgkb	Drug	kanamycin	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606617	Toxicity
170	pharmgkb	Drug	kanamycin	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606619	Toxicity
171	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606619	Toxicity
172	pharmgkb	Drug	gentamicin	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs267606619	Toxicity
173	pharmgkb	Drug	tobramycin	36294.0	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N	Ototoxicity	MT-RNR1	rs267606619	Toxicity
174	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606619	Toxicity
175	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606618	Toxicity
176	pharmgkb	Drug	gentamicin	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs267606618	Toxicity
177	pharmgkb	Drug	kanamycin	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606618	Toxicity
178	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606618	Toxicity
179	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Vomiting	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN	Efficacy
180	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Cardiovascular Diseases	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11	Dosage
181	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55	Metabolism/PK
182	pharmgkb	Drug	aripiprazole	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Psychotic Disorders,schizoaffective disorder,Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	Metabolism/PK
183	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	heart transplantation,hemopoietic stem cell transplant,Kidney Transplantation,liver transplantation,lung transplantation	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	Dosage
184	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	Metabolism/PK
185	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41	Metabolism/PK
186	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	Dosage
187	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40	Efficacy
188	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Pain	CYP2D6	CYP2D6*5, CYP2D6*17	Efficacy
189	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain,Pain, Postoperative	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	Efficacy
190	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Cardiovascular Diseases,Ischemic Attack, Transient,Stroke	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17	Efficacy,Toxicity
191	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
192	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
193	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
194	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
195	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
196	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia	SLCO1B1	rs4149056	Metabolism/PK
197	pharmgkb	Drug	pitavastatin	5282452.0			SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	Metabolism/PK
198	pharmgkb	Drug	pitavastatin	5282452.0			SLCO1B1	rs4149056	Metabolism/PK
199	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
200	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	rs4149056	Metabolism/PK
201	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
202	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
203	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Toxicity
204	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	Metabolism/PK
205	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
206	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCG2	rs2231142	Metabolism/PK
207	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	statin-related myopathy	SLCO1B1	rs4149056	Toxicity
208	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
209	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SLCO1B1	rs4149056	Metabolism/PK
210	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	Metabolism/PK
211	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Metabolism/PK
212	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Metabolism/PK
213	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
214	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02	Toxicity
215	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-A	HLA-A*31:01	Toxicity
216	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	heart transplantation,hematopoietic stem cell transplantation,Kidney Transplantation,lung transplantation	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	Metabolism/PK
217	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder,Depressive Disorder, Major	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
218	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	Toxicity
219	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A4	CYP3A4*1, CYP3A4*20, CYP3A4*22	Metabolism/PK
220	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12	Toxicity
221	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02	Toxicity
222	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02, HLA-B*15:11	Toxicity
223	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epidermal Necrolysis, Toxic,Epilepsy,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02	Toxicity
224	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	Toxicity
225	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs56038477	Toxicity
226	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs56038477	Toxicity
227	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs75017182	Other
228	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs75017182	Toxicity
229	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs75017182	Toxicity
230	pharmgkb	Drug	vortioxetine	9966051.0	CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10	Metabolism/PK
231	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
232	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl		CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9	Metabolism/PK
233	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder,Obsessive-Compulsive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	Metabolism/PK
234	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	agitation,Alcohol-Related Disorders,cardiotoxicity,Depression,Depressive Disorder,Depressive Disorder, Major,Drug Toxicity,dysphoria,Edema,Nausea,Obsessive-Compulsive Disorder,Tachycardia,Vomiting	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81	Toxicity
235	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	Metabolism/PK
236	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Leukopenia,Myelosuppression	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6	Toxicity
237	pharmgkb	Drug	doxepin	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2C19	CYP2C19*1, CYP2C19*2	Metabolism/PK
238	pharmgkb	Drug	amitriptyline	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Metabolism/PK
239	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	rs4149056	Metabolism/PK
240	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	VKORC1	rs9923231	Toxicity
241	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
242	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
243	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Toxicity
244	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Dosage
245	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs8050894	Dosage
246	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	Dosage
247	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs2359612	Dosage
248	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7294	Dosage
249	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46	Metabolism/PK
250	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	time to therapeutic inr	VKORC1	rs9923231	Efficacy
251	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	time in therapeutic range	VKORC1	rs9923231	Efficacy
252	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC19A1	rs1051266	Efficacy
253	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Leprosy,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01	Toxicity
254	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs3745274	Metabolism/PK
255	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28	Metabolism/PK
256	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia,Myocardial Infarction	ABCG2	rs2231142	Efficacy
257	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neutropenia	UGT1A1	rs10929302	Toxicity
258	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation,Proteinuria	CYP3A4	rs4646437	Metabolism/PK
259	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
260	pharmgkb	Drug	methazolamide	4100.0	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01	Toxicity
261	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation,heart valve replacement	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14	Efficacy
262	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	Dosage
263	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	VKORC1	rs9923231	Toxicity
264	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	Dosage
265	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	Dosage
266	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs2884737	Dosage
267	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	CYP4F2	rs2108622	Dosage
268	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
269	pharmgkb	Drug	salmeterol	5152.0	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O	Asthma	ADRB2	rs1042713	Efficacy
270	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	CYP2B6	rs28399499	Toxicity
271	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage,over-anticoagulation,time above therapeutic range	VKORC1	rs9923231	Toxicity
272	pharmgkb	Drug Class	hmg coa reductase inhibitors			statin-related myopathy	SLCO1B1	rs4149056	Toxicity
273	pharmgkb	Drug	captopril	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Diabetes Mellitus, Type 2,Heart Failure,Pulmonary Disease, Chronic Obstructive	ACE	rs1799752	Efficacy
274	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C		CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30	Metabolism/PK
275	pharmgkb	Drug	mirtazapine	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Metabolism/PK
276	pharmgkb	Drug	rabeprazole	5029.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
277	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18	Metabolism/PK
278	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Toxicity
279	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,Organ Transplantation	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	Dosage
280	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs61742245	Dosage
281	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*40:01	Toxicity
282	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	Metabolism/PK
283	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,hematotoxicity,Leukopenia,Lymphoma,mucositis,Neoplasms,Neutropenia,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,primary central nervous system lymphoma,Thrombocytopenia,Toxic liver disease	MTHFR	rs1801133	Toxicity
284	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Arthritis, Rheumatoid,Drug Toxicity	MTHFR	rs1801133	Toxicity
285	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01, HLA-B*15:02, HLA-B*38:02	Toxicity
286	pharmgkb	Drug	isoniazid	3767.0	C1=CN=CC=C1C(=O)NN	Tuberculosis	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A	Metabolism/PK
287	pharmgkb	Drug Class	antiepileptics			Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02	Toxicity
288	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	rs2242480	Dosage
289	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,laparoscopic sleeve gastrectomy,liver transplantation,lung transplantation	CYP3A4	CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22	Metabolism/PK
290	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A4	rs2242480	Metabolism/PK
291	pharmgkb	Drug	methazolamide	4100.0	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*01:02	Toxicity
292	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	rs71647871	Efficacy
293	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	rs71647871	Metabolism/PK
294	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN1A	rs3812718	Dosage
295	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-C	HLA-C*03:02	Toxicity
296	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs4673993	Efficacy
297	pharmgkb	Drug	etanercept			Arthritis, Psoriatic,Arthritis, Rheumatoid,Crohn Disease,Inflammation,Psoriasis,Spondylitis, Ankylosing	TNF	rs1800629	Efficacy
298	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4		HLA-DRB1	HLA-DRB1*01:01	Toxicity
299	pharmgkb	Drug Class	Platinum compounds			Neoplasms	XRCC1	rs25487	Efficacy
300	pharmgkb	Drug	erlotinib	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Resistance,Lung Neoplasms	EGFR	rs121434569	Efficacy
301	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs16969968	Toxicity
302	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Exanthema,Hypersensitivity,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:01	Toxicity
303	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ALDH2	rs671	Toxicity
304	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	HLA-DPB1	HLA-DPB1*03:01	Toxicity
305	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease,Hyperlipidemias	APOE	rs7412	Efficacy
306	pharmgkb	Drug Class	Ace Inhibitors, Plain			Angioedema	XPNPEP2	rs3788853	Toxicity
307	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension,Hypertension	ADD1	rs4961	Efficacy
308	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Drug Resistance	EGFR	rs121434569	Efficacy
309	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid,Neuromyelitis Optica	FCGR3A	rs396991	Efficacy
310	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease,Myocardial Infarction	KIF6	rs20455	Efficacy
311	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*06:02, HLA-C*07:27, HLA-C*08:01	Toxicity
312	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,Stevens-Johnson Syndrome	HLA-A	HLA-A*33:03	Toxicity
313	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs7557402	Toxicity
314	pharmgkb	Drug	etoposide	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O			rs6539870	Toxicity
315	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CSRP3	rs983332	Efficacy
316	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	ARAP2	rs437943	Efficacy
317	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CST5	rs6138150	Efficacy
318	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MAFB	rs6028945	Efficacy
319	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MAFB	rs6071980	Efficacy
320	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs11188072	Dosage
321	pharmgkb	Drug Class	diuretics			Hypertension,Myocardial Infarction	ADD1	rs4961	Efficacy
322	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DRD3	rs6280	Efficacy
323	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9	rs6759892	Dosage
324	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC19A1	rs9977268	Efficacy
325	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease	PTGS2	rs20417	Efficacy
326	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		ABCB1	rs1045642	Dosage
327	pharmgkb	Drug	dicloxacillin	18381.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O		ABCB1	rs1045642	Other
328	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	ABCB1	rs1045642	Toxicity
329	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs17222723	Toxicity
330	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		ABCB1	rs1128503	Other
331	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	ABCB1	rs2032582	Other
332	pharmgkb	Drug	digoxin	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	rs2032582	Other
333	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	PTGER3	rs11209716	Toxicity
334	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Neoplasms	SLCO1B3	rs11045585	Toxicity
335	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	MME	rs2016848	Toxicity
336	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		DRD2	rs1799978	Toxicity
337	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		ESR2	rs4986938	Toxicity
338	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	BDKRB2	rs8012552	Toxicity
339	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX4	rs10871454	Dosage
340	pharmgkb	Drug	trastuzumab			Breast Neoplasms,Drug Toxicity	ERBB2	rs1136201	Toxicity
341	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs104894539	Dosage
342	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs104894540	Dosage
343	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs104894541	Dosage
344	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs104894542	Dosage
345	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	rs2229109	Other
346	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	HLA-C	rs9461684	Toxicity
347	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	SLCO1B1	rs11045819	Efficacy
348	pharmgkb	Drug	troglitazone	5591.0	CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O	Diabetes Mellitus, Type 2		rs10811661	Efficacy
349	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		ESR1	rs9340799	Toxicity
350	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasm, Residual,Precursor Cell Lymphoblastic Leukemia-Lymphoma		rs9345389	Toxicity
351	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasm, Residual,Precursor Cell Lymphoblastic Leukemia-Lymphoma		rs4888024	Toxicity
352	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A,SPECC1L	rs5760410	Toxicity
353	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs868856	Efficacy
354	pharmgkb	Drug Class	topoisomerase I inhibitors			Neoplasms	EGFR	rs712829	Efficacy
355	pharmgkb	Drug	geldanamycin	46936377.0	C[C@@H]1C[C@H]([C@@H]([C@@H](/C=C(\[C@H]([C@@H](/C=C\C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)/C)C)O)OC	Neoplasms	EGFR	rs712829	Efficacy
356	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DTNBP1	rs2619538	Toxicity
357	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ALOX5	rs2115819	Efficacy
358	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	LTA4H	rs2660845	Efficacy
359	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	ADRB3	rs4994	Toxicity
360	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs2842030	Efficacy
361	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	LEP	rs4731426	Toxicity
362	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	CCND1	rs9344	Efficacy
363	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DTNBP1	rs742105	Efficacy
364	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Colitis, Ulcerative	ABCB1	rs2032582	Efficacy
365	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	ABCB1	rs1128503	Efficacy
366	pharmgkb	Drug	amiodarone	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Torsades de Pointes	KCNH2	rs12720441	Toxicity
367	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs11545078	Toxicity
368	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	C9orf72	rs774359	Efficacy
369	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms,Neutropenia	CBR3	rs8133052	Efficacy,Toxicity
370	pharmgkb	Drug	daunorubicin	30323.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	Drug Toxicity	NRP2	rs10932125	Other
371	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Carcinoma, Non-Small-Cell Lung,Neoplasms	CYP3A,CYP3A4	rs12721627	Dosage
372	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs951439	Efficacy
373	pharmgkb	Drug	propofol	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O		UGT1A9	rs58597806	Toxicity
374	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N		BAG6,PRRC2A	rs750332	Toxicity
375	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	C9orf72	rs3849942	Efficacy
376	pharmgkb	Drug	erlotinib	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Neoplasms	EGFR	rs712829	Efficacy
377	pharmgkb	Drug	rofecoxib	5090.0	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3		PTGS2	rs20417	Efficacy
378	pharmgkb	Drug	sildenafil	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	ACE	rs4343	Efficacy
379	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4086116	Dosage
380	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Disease	PPARA	rs4253778	Efficacy
381	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs2814707	Efficacy
382	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	GBP6	rs928655	Efficacy
383	pharmgkb	Drug Class	anthracyclines and related substances			Precursor Cell Lymphoblastic Leukemia-Lymphoma	CAT	rs10836235	Toxicity
384	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	rs2306283	Other
385	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	rs11572080	Other
386	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	rs10509681	Other
387	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	DTNBP1	rs909706	Efficacy
388	pharmgkb	Drug	iloperidone	71360.0		Acquired Long QT Syndrome (aLQTS)	NRG3	rs4933824	Toxicity
389	pharmgkb	Drug	iloperidone	71360.0		Acquired Long QT Syndrome (aLQTS)	NUBPL	rs7142881	Toxicity
390	pharmgkb	Drug	iloperidone	71360.0		Acquired Long QT Syndrome (aLQTS)	CELF4	rs4799915	Toxicity
391	pharmgkb	Drug	iloperidone	71360.0		Acquired Long QT Syndrome (aLQTS)	CERKL	rs993648	Toxicity
392	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Acquired Long QT Syndrome (aLQTS)	NOS1AP	rs10918594	Toxicity
393	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Acquired Long QT Syndrome (aLQTS)	NOS1AP	rs10494366	Toxicity
394	pharmgkb	Drug Class	Measles vaccines				TLR3	rs3775291	Efficacy
395	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders,Substance-Related Disorders	PICK1	rs2076369	Toxicity
396	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DTNBP1	rs3213207	Toxicity
397	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	PIK3CA	rs870995	Dosage
398	pharmgkb	Drug Class	antipsychotics			Schizophrenia	CLCN6,MTHFR	rs1801133	Toxicity
399	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Transplantation	CYP2B6	rs2279343	Toxicity
400	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	DRD3	rs6280	Efficacy
401	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	HTR2A	rs6311	Efficacy
402	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	TYMS	rs2853539	Efficacy
403	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Schizophrenia	DRD3	rs167771	Toxicity
404	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Rectal Neoplasms	GSTP1	rs1695	Toxicity
405	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Lymphoma, Non-Hodgkin	ABCC2	rs8187710	Toxicity
406	pharmgkb	Drug Class	Platinum compounds			Ovarian Neoplasms	CD3EAP,ERCC1,PPP1R13L	rs3212986	Efficacy
407	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms	CYP3A4	rs2740574	Toxicity
408	pharmgkb	Drug	pramipexole	59868.0	CCCN[C@@H]1CCC2=C(C1)SC(=N2)N	Parkinson Disease	DRD3	rs6280	Efficacy
409	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		NR1I2	rs2472677	Other
410	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs165599	Efficacy
411	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	GRM3	rs724226	Efficacy
412	pharmgkb	Drug	ritonavir	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs5128	Toxicity
413	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	LPIN1	rs10192566	Efficacy
414	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	TCF7L2	rs12255372	Efficacy
415	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ABCC1	rs119774	Efficacy
416	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCC1	rs28364006	Efficacy
417	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCC1	rs2238476	Efficacy,Toxicity
418	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCG2	rs17731538	Efficacy
419	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,Psoriasis	ABCC1	rs246240	Toxicity
420	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCG2	rs13120400	Efficacy
421	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension	APOB	rs1367117	Efficacy
422	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Myocardial Infarction	CYP1A2	rs762551	Toxicity
423	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs12248560	Dosage
424	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	FPGS	rs1544105	Efficacy
425	pharmgkb	Drug	nitrous oxide				MTHFR	rs1801133	Toxicity
426	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	rs1113129	Toxicity
427	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NALCN	rs7992226	Other
428	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs10821936	Other
429	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity	MTHFR	rs4846051	Toxicity
430	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	rs1800909	Efficacy
431	pharmgkb	Drug Class	Antihypertensives And Diuretics In Combination				NOS3	rs2070744	Efficacy
432	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	TCF7L2	rs290487	Efficacy
433	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	ABCC2	rs17222723	Toxicity
434	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	ABCC1	rs45511401	Toxicity
435	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Congenital Abnormalities,Craniofacial Abnormalities	EPHX1	rs1051740	Toxicity
436	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Congenital Abnormalities,Craniofacial Abnormalities	EPHX1	rs2234922	Toxicity
437	pharmgkb	Drug	etoposide	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O		SLIT1	rs2784917	Toxicity
438	pharmgkb	Drug	fexofenadine	3348.0	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O		ABCB1	rs1045642	Dosage
439	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	PRDX4	rs518329	Dosage
440	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	EPHX1	rs2234922	Dosage
441	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	XRCC4	rs1382368	Dosage
442	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	ADM	rs11042725	Efficacy
443	pharmgkb	Drug	clodronate	25419.0	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl	Osteitis Deformans	VDR	rs731236	Efficacy
444	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs3761422	Toxicity
445	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs2267076	Toxicity
446	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Cystitis,Transplantation	CYP2B6	rs8192709	Toxicity
447	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	DDRGK1,ITPA	rs1127354	Efficacy
448	pharmgkb	Drug	erlotinib	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Neoplasms	EGFR	rs712829	Toxicity
449	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Hypertension	KCNIP1,KCNMB1	rs11739136	Efficacy
450	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs963468	Efficacy
451	pharmgkb	Drug	leflunomide	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	ESR1	rs9340799	Efficacy
452	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension,Kidney Diseases,Nephrosclerosis	GRK4	rs1024323	Efficacy
453	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O		ABCC10	rs9349256	Toxicity
454	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	AGT	rs943580	Toxicity
455	pharmgkb	Drug	coumarin				CYP2A6	rs1801272	Other
456	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs28399433	Other
457	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9	rs2070959	Dosage
458	pharmgkb	Drug Class	antipsychotics			tardive dyskinesia	COMT	rs4680	Toxicity
459	pharmgkb	Drug	coumarin				CYP2A6	rs28399433	Other
460	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs28399468	Other
461	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Hepatic Veno-Occlusive Disease,Transplantation	CYP2B6	rs3745274	Toxicity
462	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	rs3758149	Efficacy
463	pharmgkb	Drug Class	antipsychotics			Schizophrenia	COMT	rs4680	Other
464	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP3A,CYP3A4	rs2740574	Other
465	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		CYP2C8	rs10509681	Other
466	pharmgkb	Drug	cerivastatin	446156.0	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	Rhabdomyolysis	RYR2	rs2819742	Toxicity
467	pharmgkb	Drug	amiodarone	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Long QT Syndrome	NOS1AP	rs10919035	Toxicity
468	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SHMT1	rs1979277	Toxicity
469	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		CYP2C8	rs11572080	Dosage
470	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	GABRQ	rs3810651	Efficacy
471	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		CYP2D6	rs5030655	Efficacy
472	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	CACNG2	rs2284017	Efficacy
473	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		CYP2D6	rs3892097	Efficacy
474	pharmgkb	Drug Class	antidepressants			Depression	FKBP5	rs3800373	Efficacy
475	pharmgkb	Drug	zoledronate	68740.0	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	Neoplasms,Osteonecrosis	FDPS	rs2297480	Toxicity
476	pharmgkb	Drug	cangrelor	9854012.0	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F		P2RY12	rs9859552	Efficacy
477	pharmgkb	Drug	hydroxyurea	3657.0	C(=O)(N)NO	Thalassemia	MAP3K5	rs9376230	Efficacy
478	pharmgkb	Drug	hydroxyurea	3657.0	C(=O)(N)NO	Thalassemia	MAP3K5	rs9483947	Efficacy
479	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	CRY1	rs8192440	Efficacy
480	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	DRD1	rs4532	Efficacy
481	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	GSK3B	rs334558	Efficacy
482	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs2826494	Efficacy
483	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	OR52J2P,OR52J3	rs2499984	Efficacy
484	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	CACNG2	rs2284018	Efficacy
485	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	IL12A	rs568408	Toxicity
486	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs8832	Efficacy
487	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs7934165	Dosage
488	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs1491850	Dosage
489	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	NR1D1,THRA	rs2314339	Efficacy
490	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation,Organ Transplantation	IMPDH1	rs2278294	Efficacy
491	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2120266	Dosage
492	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2289658	Dosage
493	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Leukopenia	IMPDH1	rs2278294	Toxicity
494	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs4358872	Dosage
495	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs1948308	Dosage
496	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2378676	Dosage
497	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs4877900	Dosage
498	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ANKK1	rs7118900	Dosage
499	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	DRD2	rs2283265	Dosage
500	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NGF	rs2239622	Dosage
501	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs10835210	Dosage
502	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	GSK3B	rs6438552	Efficacy
503	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	TPH1	rs1800532	Efficacy
504	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute,Neoplasms	CDA	rs532545	Efficacy
505	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid	CDA	rs532545	Toxicity
506	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	rs602950	Toxicity
507	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	rs3215400	Toxicity
508	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2236196	Other
509	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	ADRB1	rs1801253	Toxicity
510	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	GNB3	rs5443	Toxicity
511	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	HTR2A	rs6313	Toxicity
512	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depression,Depressive Disorder,Depressive Disorder, Major,Hypotension	ABCB1	rs1045642	Toxicity
513	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Coronary Artery Disease,Hypertension	KCNIP1,KCNMB1	rs2301149	Efficacy
514	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	DRD3	rs6280	Efficacy
515	pharmgkb	Drug	oxaliplatin	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	ABCB1	rs1045642	Efficacy
516	pharmgkb	Drug	oxaliplatin	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	ABCB1	rs1128503	Efficacy
517	pharmgkb	Drug	nitroprusside	11963622.0	[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4]		ACE	rs1799752	Efficacy
518	pharmgkb	Drug	acetylcholine	187.0	CC(=O)OCC[N+](C)(C)C		ACE	rs1799752	Efficacy
519	pharmgkb	Drug	nifedipine	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	SLC14A2	rs1123617	Efficacy
520	pharmgkb	Drug	nifedipine	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	SLC14A2	rs3745009	Efficacy
521	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs1044396	Other
522	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		CYP1A2	rs762551	Efficacy
523	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		HTR2A	rs7997012	Toxicity
524	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		CYP3A4	rs12721627	Other
525	pharmgkb	Drug	nemonapride			Schizophrenia	ANKK1	rs1800497	Toxicity
526	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17880887	Dosage
527	pharmgkb	Drug	nitrous oxide				MTHFR	rs1801131	Toxicity
528	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC		ABCB1	rs1045642	Other
529	pharmgkb	Drug	spironolactone	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	Heart Failure	ACE	rs1799752	Efficacy
530	pharmgkb	Drug	spironolactone	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C		ACE	rs4343	Efficacy
531	pharmgkb	Drug	sumatriptan	5358.0	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	Cluster Headache	GNB3	rs5443	Efficacy
532	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs762551	Dosage,Toxicity
533	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	BDNF	rs6265	Efficacy
534	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	Acute coronary syndrome	CYP2C19	rs4244285	Efficacy
535	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	WNT5B	rs2010851	Other
536	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus	NEUROD1	rs1801262	Efficacy
537	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus	PAX4	rs114202595	Efficacy
538	pharmgkb	Drug	bucindolol	51045.0	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	Heart Failure	ADRA2C	rs61767072	Efficacy
539	pharmgkb	Drug	sulfamethoxazole	5329.0	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	HIV Infections	GCLC	rs761142	Toxicity
540	pharmgkb	Drug Class	Alkylating Agents			Neoplasms	EGFR	rs712829	Efficacy
541	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	rs9282564	Other
542	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	rs72552784	Other
543	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	LDLR	rs688	Efficacy
544	pharmgkb	Drug	tolbutamide	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	rs9332239	Other
545	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC		ABCB1	rs2032582	Other
546	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	rs1057910	Efficacy
547	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	REN	rs2368564	Toxicity
548	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	EDN1	rs5370	Toxicity
549	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	P2RY1	rs1065776	Efficacy
550	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	NR1D1,THRA	rs2071427	Efficacy
551	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	FSIP1	rs7179742	Toxicity
552	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	CEP68	rs7572857	Toxicity
553	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PPARG	rs3856806	Toxicity
554	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	IL4	rs2243250	Toxicity
555	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ADORA1	rs2228079	Toxicity
556	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease	GP6	rs1613662	Efficacy
557	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	FCER1G	rs11587213	Toxicity
558	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		IL1B	rs1143627	Toxicity
559	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TBXA2R	rs1131882	Toxicity
560	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	ITGA2	rs1062535	Efficacy
561	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		NTRK1	rs2768759	Efficacy
562	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		HNMT	rs1050891	Toxicity
563	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs9332096	Dosage
564	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C		VEGFA	rs833061	Toxicity
565	pharmgkb	Drug	erythromycin	12560.0	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O		ABCC2	rs717620	Other
566	pharmgkb	Drug, Ion	calcium	271.0	[Ca+2]		VDR	rs731236	Efficacy
567	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		F13A1	rs5985	Efficacy
568	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2B6	CYP2B6*1, CYP2B6*5	Efficacy
569	pharmgkb	Drug, Metabolite	desipramine	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	MC1R	rs2228479	Efficacy
570	pharmgkb	Drug, Metabolite	desipramine	2995.0	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	MC1R	rs2228478	Efficacy
571	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs72551330	Toxicity
572	pharmgkb	Drug	doxepin	667477.0	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2C9	CYP2C9*1, CYP2C9*3	Efficacy
573	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs135543	Efficacy
574	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs135550	Efficacy
575	pharmgkb	Drug Class	antidepressants			Depressive Disorder	GRIK4	rs12800734	Efficacy
576	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Diabetes Mellitus,Hypertension	KCNJ1	rs12795437	Toxicity
577	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	rs12782374	Dosage
578	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Anxiety Disorders,Depressive Disorder, Major	CRHR1	rs242941	Efficacy
579	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	COMT	rs4680	Efficacy
580	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B3	rs7311358	Other
581	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CETP	rs708272	Efficacy
582	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ACE	rs1799752	Efficacy
583	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Coronary Artery Disease	ACE	rs1799752	Efficacy
584	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO1	rs12720462	Other
585	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO3	rs2266780	Other
586	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO1	rs7877	Other
587	pharmgkb	Drug	thalidomide	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	ERCC1	rs735482	Efficacy
588	pharmgkb	Drug	thalidomide	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	XRCC5	rs1051685	Efficacy
589	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs10509680	Dosage
590	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PRSS53,VKORC1	rs17886199	Dosage
591	pharmgkb	Drug	thalidomide	5426.0	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	GSTT1	rs4630	Toxicity
592	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4918758	Dosage
593	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs61162043	Dosage
594	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SREBF1	rs60282872	Efficacy
595	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	SCAP	rs12487736	Efficacy
596	pharmgkb	Drug	ABT-751			Neoplasms	UGT1A4	rs6755571	Other
597	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough	BDKRB2	rs8016905	Toxicity
598	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	TLR4	rs4986790	Efficacy
599	pharmgkb	Drug Class	Ace Inhibitors, Plain			Coronary Artery Disease	AGTR1	rs5186	Efficacy,Toxicity
600	pharmgkb	Drug	pitavastatin	5282452.0			SLCO1B1	rs2306283	Other
601	pharmgkb	Drug Class	Ace Inhibitors, Plain				ABO	rs495828	Toxicity
602	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough		rs4459610	Toxicity
603	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough		rs4267385	Toxicity
604	pharmgkb	Drug	amphetamine	3007.0	C[C@@H](CC1=CC=CC=C1)N		OPRM1	rs510769	Efficacy
605	pharmgkb	Drug	amphetamine	3007.0	C[C@@H](CC1=CC=CC=C1)N		OPRM1	rs2281617	Other
606	pharmgkb	Drug Class	antipsychotics				CYP2D6	rs5030655	Toxicity
607	pharmgkb	Drug Class	antipsychotics			Schizophrenia	RGS2	rs4606	Toxicity
608	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		UGT1A3	UGT1A3*1, UGT1A3*2	Efficacy
609	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	AOX1	rs55754655	Efficacy
610	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	MTTP	rs1800591	Efficacy
611	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hyperlipoproteinemia Type II	MTTP	rs1800591	Efficacy
612	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	UST	rs2500535	Efficacy
613	pharmgkb	Prodrug	zidovudine	35370.0	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]		UGT2B7	rs28365062	Other
614	pharmgkb	Prodrug	zidovudine	35370.0	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]	HIV Infections	ABCC4	rs11568695	Other
615	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	ABCB1	rs1045642	Toxicity
616	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease,Myalgia unspecified	ABCB1	rs1045642	Toxicity
617	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		AGTR1	rs12721226	Efficacy
618	pharmgkb	Drug Class	corticosteroids			Asthma	DCAF4	rs7160796	Efficacy
619	pharmgkb	Drug Class	corticosteroids			Crohn Disease	FKBP5	rs4713916	Efficacy
620	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	ABCB1	rs2032582	Toxicity
621	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		CYP1A2	rs72547517	Other
622	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		CYP1A2	rs72547516	Other
623	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs1150226	Efficacy
624	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Coronary Disease	SLCO1B1	rs4149081	Efficacy
625	pharmgkb	Drug	dexmedetomidine	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C		PRKCB	rs9922316	Other
626	pharmgkb	Drug	dexmedetomidine	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C		ADRA2A	rs1800544	Other
627	pharmgkb	Drug	disulfiram	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	DRD2	rs2283265	Efficacy
628	pharmgkb	Drug	disulfiram	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	ANKK1	rs1800497	Efficacy
629	pharmgkb	Drug Class	diuretics			Nephrosclerosis	PDE4D	rs702553	Efficacy
630	pharmgkb	Drug	lopinavir	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	ABCC2	rs8187710	Efficacy
631	pharmgkb	Drug	mitotane	4211.0	C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl	Adrenocortical Carcinoma	CYP2B6	rs3745274	Other
632	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease,Hypercholesterolemia	ABCG8	rs11887534	Efficacy
633	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		POR	rs1057868	Other
634	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Myalgia unspecified	CYP3A5	CYP3A5*1, CYP3A5*3	Efficacy,Toxicity
635	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hyperlipidemias	CYP3A4	CYP3A4*1, CYP3A4*4	Efficacy
636	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CYBA	rs4673	Other
637	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	SLC6A5	rs2298826	Toxicity
638	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	CETP	rs4783961	Efficacy
639	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	ABCB1	rs1922242	Efficacy
640	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	CETP	rs5882	Efficacy
641	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CETP	rs5882	Efficacy
642	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		HMGCR	rs17238540	Efficacy
643	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17238540	Efficacy
644	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17244841	Efficacy
645	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		HMGCR	rs17244841	Efficacy
646	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease,Myocardial Infarction	MTHFR	rs1801133	Efficacy
647	pharmgkb	Drug Class	hmg coa reductase inhibitors			Acute coronary syndrome	CXCL5	rs352046	Efficacy
648	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Acute coronary syndrome	TNF	rs1800629	Other
649	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Myocardial Ischemia	F3	rs3917643	Efficacy
650	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease	ABCA1	rs2230806	Efficacy
651	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Diabetes Mellitus,Hypertension,Vascular Diseases	NPC1L1	rs17655652	Efficacy
652	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	SCARB1	rs5888	Efficacy
653	pharmgkb	Drug Class	hmg coa reductase inhibitors			Colonic Neoplasms	HMGCR	rs12654264	Other
654	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		LPL	rs328	Efficacy
655	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA1	rs964184	Efficacy
656	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ABCB1	rs7787082	Efficacy
657	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Heart Failure	AGTR1	rs5186	Efficacy
658	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	AGT	rs5051	Efficacy
659	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	SCARB1	rs4238001	Efficacy
660	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	SLCO1B1	rs4149015	Toxicity
661	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	ABCC2	rs3740066	Toxicity
662	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Metabolic Syndrome	CRP	rs3091244	Efficacy
663	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742435	Toxicity
664	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742423	Toxicity
665	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742421	Toxicity
666	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742417	Toxicity
667	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742390	Toxicity
668	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders	DRD2	rs2440390	Toxicity
669	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	GABRA1	rs2290732	Efficacy
670	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2251954	Toxicity
671	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2245705	Toxicity
672	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNQ1	rs2237895	Efficacy
673	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNQ1	rs2237892	Efficacy
674	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	ABCG2	rs2231137	Toxicity
675	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	ABCA1	rs2230808	Efficacy
676	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	ABCA1	rs2230806	Efficacy
677	pharmgkb	Drug	captopril	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Hypertension	ACE2	rs2106809	Efficacy
678	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs1969624	Toxicity
679	pharmgkb	Drug	benazepril	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Essential hypertension	MTR	rs1805087	Efficacy
680	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertrophy, Left Ventricular	APOB	rs1801701	Efficacy
681	pharmgkb	Drug	dobutamine	36811.0	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O		ADRB1	rs1801253	Efficacy
682	pharmgkb	Drug	disulfiram	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	MTHFR	rs1801133	Efficacy
683	pharmgkb	Drug Class	Enzymes			Stroke	F12	rs1801020	Efficacy
684	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertrophy, Left Ventricular	ADRA2A	rs1800545	Efficacy
685	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	COL26A1	rs17135437	Toxicity
686	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Metabolic Syndrome	CRP	rs1417938	Efficacy
687	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	HTR2A	rs6313	Toxicity
688	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCG2	rs2231142	Toxicity
689	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	ABCB1	rs1128503	Toxicity
690	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs10929303	Other
691	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A	rs10929303	Toxicity
692	pharmgkb	Drug	iloperidone	71360.0		Schizophrenia	CYP2D6	rs1065852	Toxicity
693	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	ABCB1	rs1045642	Toxicity
694	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs1042640	Other
695	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A	rs1042640	Toxicity
696	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs8330	Other
697	pharmgkb	Drug	mirtazapine	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depression	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7	Other
698	pharmgkb	Drug	mirtazapine	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depression	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7	Efficacy
699	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders	HTR2C	rs1414334	Toxicity
700	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	SLCO1B1	rs4149056	Toxicity
701	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	ABCC2	rs2273697	Other
702	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCC4	rs9561765	Efficacy
703	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	NOD2	rs2066844	Efficacy
704	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C19	CYP2C19*1, CYP2C19*2	Efficacy
705	pharmgkb	Drug	digoxin	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	rs1128503	Other
706	pharmgkb	Drug Class	Enzymes			Stroke	A2M	rs669	Efficacy
707	pharmgkb	Drug	benazepril	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	PRCP	rs2229437	Efficacy
708	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs12407843	Efficacy
709	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs77235035	Efficacy
710	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	HTR1B	rs130058	Other
711	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs2470890	Efficacy
712	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs2472304	Efficacy
713	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs4646425	Efficacy
714	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs4646427	Efficacy
715	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	rs34130495	Other
716	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	rs35167514	Other
717	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	DRD3	rs6280	Efficacy
718	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major		rs13432159	Toxicity
719	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C19	CYP2C19*1, CYP2C19*2	Dosage
720	pharmgkb	Drug	trimipramine	5584.0	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C		CYP2C9	CYP2C9*1, CYP2C9*3	Other
721	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs3737224	Efficacy
722	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs41273215	Efficacy
723	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs822441	Efficacy
724	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs822442	Efficacy
725	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major		rs2069521	Toxicity
726	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs2069526	Toxicity
727	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs4646425	Toxicity
728	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs4646427	Toxicity
729	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs324026	Efficacy
730	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs324023	Efficacy
731	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs167770	Efficacy
732	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Drug Toxicity	GRIN2B	rs1806201	Toxicity
733	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	GRIN2B	rs1806201	Toxicity
734	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	HTR2A	rs6313	Toxicity
735	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Deafness,Ototoxicity,Testicular Neoplasms	GSTM1	GSTM1 non-null, GSTM1 null	Toxicity
736	pharmgkb	Drug	dobutamine	36811.0	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O		GNAS	rs62205366	Efficacy
737	pharmgkb	Drug	captopril	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Diabetes Mellitus, Type 2	AGTR1	rs5186	Efficacy
738	pharmgkb	Drug Class	antidepressants			Depression	TGFBR3	rs12082710	Efficacy
739	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ZNF804A	rs1344706	Efficacy
740	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertrophy, Left Ventricular	ADRB2	rs1042714	Efficacy
741	pharmgkb	Drug	benazepril	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	AGT	rs7079	Efficacy
742	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	CYP11B2	rs1799998	Efficacy
743	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major		rs16965962	Toxicity
744	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	rs60369023	Other
745	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ABCB1	rs10248420	Efficacy
746	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs1062613	Efficacy
747	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs2276302	Efficacy
748	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Diabetes Mellitus	PPARA	rs4253778	Efficacy
749	pharmgkb	Drug	flunisolide	82153.0	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O	Asthma	TBXT	rs2305089	Efficacy
750	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		DCK	rs66878317	Other
751	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs1110470	Efficacy
752	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs3024530	Efficacy
753	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs1805010	Efficacy
754	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs2239347	Efficacy
755	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs1029489	Efficacy
756	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	TGFB1	rs1800471	Efficacy
757	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Carcinoma, Non-Small-Cell Lung	SLCO1B1	rs4149056	Dosage
758	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	SV2C	rs11960832	Efficacy
759	pharmgkb	Drug, Biological Intermediate	l-tryptophan	6305.0	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N		SLC22A2	rs316019	Other
760	pharmgkb	Drug	memantine	4054.0	CC12CC3CC(C1)(CC(C3)(C2)N)C	Dementia	NR1I2	rs1523130	Other
761	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		PPARA	rs4823613	Efficacy
762	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		PPARA	rs4253728	Efficacy
763	pharmgkb	Drug	talinolol				ABCB1	rs1045642	Other
764	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs9552679	Efficacy
765	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	WNK1	rs880054	Efficacy
766	pharmgkb	Drug Class	antipsychotics			Schizophrenia	HSPG2	rs878949	Toxicity
767	pharmgkb	Drug Class	antipsychotics			Schizophrenia	HSPG2	rs2445142	Toxicity
768	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GABRG3	rs2061051	Toxicity
769	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ADRB2	rs1042713	Toxicity
770	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs238	Efficacy
771	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKCA	rs4791040	Efficacy
772	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs4815273	Efficacy
773	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs2776546	Efficacy
774	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Neoplasms	UGT1A9	rs17868320	Toxicity
775	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	MEX3C	rs17751934	Toxicity
776	pharmgkb	Drug Class	antineoplastic agents			Pancreatic Neoplasms	DPYD	rs1760217	Efficacy
777	pharmgkb	Drug Class	antineoplastic agents			Pancreatic Neoplasms	SERPINA3	rs17091162	Efficacy
778	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depression	SLC39A14	rs17060812	Efficacy
779	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	RBMS3	rs17024608	Efficacy
780	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	ABCC4	rs1678387	Toxicity
781	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	CSRNP3	rs7588295	Toxicity
782	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	ALDH1A2	rs12903202	Efficacy
783	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	CLOCK	rs1522113	Efficacy
784	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs1423515	Efficacy
785	pharmgkb	Drug Class	Thiazides, plain			Essential hypertension	SLC12A3	rs13306673	Efficacy
786	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	SLC30A8	rs13266634	Efficacy
787	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Transplantation	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	Toxicity
788	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	PEAR1	rs12041331	Toxicity
789	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs11252394	Efficacy
790	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	CYP3A4	rs2740574	Other
791	pharmgkb	Drug	timolol	33624.0	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	Other
792	pharmgkb	Drug	didanosine	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	XDH	rs1594160	Toxicity
793	pharmgkb	Drug	didanosine	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	XDH	rs1429376	Toxicity
794	pharmgkb	Drug	didanosine	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	NT5C2	rs11191561	Toxicity
795	pharmgkb	Drug	didanosine	50599.0	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	NT5C2	rs11598702	Toxicity
796	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs1124493	Other
797	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10	Other
798	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	SLC19A1	rs1051266	Efficacy
799	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	SLCO1B1	rs2306283	Efficacy
800	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	CDA	rs602950	Toxicity
801	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCB1	rs1045642	Efficacy
802	pharmgkb	Drug	nifedipine	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Pregnancy	CYP3A5	rs776746	Other
803	pharmgkb	Drug	methacholine	1993.0	CC(C[N+](C)(C)C)OC(=O)C	Asthma	ADRB2	rs1042713	Efficacy
804	pharmgkb	Drug	sipoglitazar	9825652.0	CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4		UGT2B15	UGT2B15*1, UGT2B15*2	Efficacy
805	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	rs28371759	Other
806	pharmgkb	Drug	indinavir	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	UGT1A1	rs4148323	Toxicity
807	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Cardiovascular Diseases	IL6	rs1800795	Efficacy
808	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs2631372	Efficacy
809	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Angina Pectoris,Heart Failure	UGT1A1	rs4148323	Other
810	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Leukopenia,Neoplasms	ABCC11	rs7194667	Toxicity
811	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs9626730	Efficacy
812	pharmgkb	Drug Class	Drugs used in alcohol dependence			Alcoholism	GATA4	rs13273672	Efficacy
813	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	KCNJ1	rs11600347	Toxicity
814	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	SFRP5	rs11189381	Toxicity
815	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs1105525	Efficacy
816	pharmgkb	Drug	amiodarone	2157.0	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Long QT Syndrome	NOS1AP	rs10800397	Toxicity
817	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	CDKN2B-AS1	rs10757274	Toxicity
818	pharmgkb	Drug	debrisoquine	2966.0	C1CN(CC2=CC=CC=C21)C(=N)N		CYP2D6	rs1080985	Other
819	pharmgkb	Drug	zonisamide	5734.0	C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:07	Toxicity
820	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF-AS	rs10501087	Efficacy
821	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	rs6265	Efficacy
822	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	rs11030104	Efficacy
823	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Prostatic Neoplasms	VEGFA	rs2010963	Efficacy
824	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	SLCO2B1	rs12422149	Efficacy
825	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs7046653	Efficacy
826	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	SLC29A1	rs9394992	Toxicity
827	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	TBC1D32	rs7740004	Toxicity
828	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O		SLCO1B3	rs7311358	Other
829	pharmgkb	Drug	sildenafil	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	VEGFA	rs699947	Efficacy
830	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C		VEGFA	rs699947	Toxicity
831	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				AGT	rs699	Toxicity
832	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O		TNFAIP3	rs6920220	Efficacy
833	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		STK39	rs6749447	Efficacy
834	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Diabetes Mellitus,Hypertension	KCNJ1	rs658903	Toxicity
835	pharmgkb	Drug Class	antipsychotics			tardive dyskinesia	HTR2A	rs6311	Efficacy
836	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		TOP1	rs6072262	Toxicity
837	pharmgkb	Drug	eculizumab				C5	rs56040400	Efficacy
838	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms		rs934635	Toxicity
839	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms		rs16964189	Toxicity
840	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms		rs9936750	Toxicity
841	pharmgkb	Drug	glyburide	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Anemia, Hemolytic	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
842	pharmgkb	Drug	glyburide	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2	G6PD	rs5030868	Toxicity
843	pharmgkb	Drug	chloramphenicol	298.0	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	Anemia, Hemolytic,Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
844	pharmgkb	Drug	phenazopyridine	4756.0	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N	Anemia, Hemolytic,Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype	Toxicity
845	pharmgkb	Drug	nitrofurantoin	5353830.0	C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-]	Anemia, Hemolytic,Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
846	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	rs1045642	Efficacy
847	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms,Neutropenia	CDA	rs60369023	Toxicity
848	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Alcoholism	SLC6A4	rs1042173	Efficacy
849	pharmgkb	Drug	clomipramine	2801.0	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl		SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
850	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Alcoholism	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
851	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	NR3C2	rs5522	Efficacy
852	pharmgkb	Drug Class	opioids			Pain	COMT	rs4633	Other
853	pharmgkb	Drug Class	opioids			Pain	COMT	rs6269	Other
854	pharmgkb	Drug Class	opioids			Pain	COMT	rs4818	Other
855	pharmgkb	Drug	platinum			Ovarian Neoplasms	ERCC5	rs17655	Efficacy
856	pharmgkb	Drug	rhodamine 123				ABCB1	rs1045642	Other
857	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	DCK	rs4694362	Toxicity
858	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC28A3	rs7867504	Other
859	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		FPGS	rs7856096	Dosage
860	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BMP5	rs41271330	Efficacy
861	pharmgkb	Drug	diltiazem	39186.0	CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC	Hypertension	PLCD3	rs12946454	Efficacy
862	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264663	Toxicity
863	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs274618	Other
864	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs1990040	Other
865	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs13242038	Other
866	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs724226	Other
867	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs2189814	Other
868	pharmgkb	Drug	dimercaprol	3080.0	C(C(CS)S)O	Hemolysis,Lead Poisoning, Nervous System, Childhood	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
869	pharmgkb	Drug	ciprofloxacin	2764.0	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	Anemia, Hemolytic	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
870	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
871	pharmgkb	Drug	sulfadoxine	17134.0	COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
872	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
873	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*14:01	Toxicity
874	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*09:01	Toxicity
875	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	MYLIP	rs9370867	Efficacy
876	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs1476413	Efficacy
877	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs17421511	Efficacy
878	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs16853826	Toxicity
879	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs10197559	Toxicity
880	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	DHFR	rs1643650	Efficacy
881	pharmgkb	Drug	vincristine	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Drug Toxicity,Neurotoxicity Syndromes	CAPG	rs3770102	Toxicity
882	pharmgkb	Drug	vincristine	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs4728709	Toxicity
883	pharmgkb	Drug	vincristine	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1045642	Efficacy
884	pharmgkb	Drug	vincristine	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Neurotoxicity Syndromes	ACTG1	rs1135989	Toxicity
885	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*03:01	Toxicity
886	pharmgkb	Drug	debrisoquine	2966.0	C1CN(CC2=CC=CC=C21)C(=N)N		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*38	Other
887	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Exanthema	HLA-C	HLA-C*03:02	Toxicity
888	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*15:02	Toxicity
889	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*13:02	Toxicity
890	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome		rs2844665	Toxicity
891	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	PSORS1C3	rs3094188	Toxicity
892	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	POU5F1	rs3130501	Toxicity
893	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	POU5F1	rs3130931	Toxicity
894	pharmgkb	Drug	sparteine				CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*7, CYP2D6*8, CYP2D6*11, CYP2D6*12, CYP2D6*41, CYP2D6*59, CYP2D6*62	Other
895	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	KCNQ5	rs9351963	Toxicity
896	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Neoplasms	BCL2L11	rs724710	Efficacy
897	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	PPARA	rs4823613	Other
898	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	ATP7B	rs9535828	Efficacy
899	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	ATP7B	rs9535826	Efficacy
900	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		NR1I2	rs2276706	Other
901	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		NR1I2	rs3814058	Other
902	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRD1	rs2236861	Other
903	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	GAL	rs948854	Other
904	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs9479757	Other
905	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PTGS2	rs4648287	Toxicity
906	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PLA2G4A	rs10157410	Toxicity
907	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	GALNT2	rs2144297	Toxicity
908	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	GALNT2	rs2144300	Other
909	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ABCB1	rs3213619	Toxicity
910	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ABCB1	rs10267099	Toxicity
911	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	FTO	rs12595985	Toxicity
912	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	FTO	rs9940629	Toxicity
913	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-A	HLA-A*02:01	Toxicity
914	pharmgkb	Drug	itopride				FMO3	rs2266782	Other
915	pharmgkb	Drug	itopride				FMO3	rs2266780	Other
916	pharmgkb	Drug Class	hmg coa reductase inhibitors			Asthma	HLA-G	rs1063320	Efficacy
917	pharmgkb	Drug	dextromethorphan	5360696.0	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*13, CYP2D6*31, CYP2D6*69, CYP2D6*100, CYP2D6*101	Other
918	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-B	HLA-B*48:01	Toxicity
919	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01	Toxicity
920	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease,Myocardial Infarction	ITGB3	rs5918	Efficacy
921	pharmgkb	Drug	trichloroethylene	6575.0	C(=C(Cl)Cl)Cl	Drug Hypersensitivity	HLA-B	HLA-B*13:01	Toxicity
922	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*13:02	Toxicity
923	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:18	Toxicity
924	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:19	Toxicity
925	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:27	Toxicity
926	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*27:09	Toxicity
927	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*38:02	Toxicity
928	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*48:04	Toxicity
929	pharmgkb	Drug Class	antiepileptics			Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01	Toxicity
930	pharmgkb	Drug	acetazolamide	1986.0	CC(=O)NC1=NN=C(S1)S(=O)(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01	Toxicity
931	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01	Toxicity
932	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	rs1045642	Other
933	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	rs2273697	Toxicity
934	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7200749	Dosage
935	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7200749	Dosage
936	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs61742245	Dosage
937	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs55894764	Dosage
938	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17878544	Dosage
939	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*39:01	Toxicity
940	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*13:01	Toxicity
941	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*15:05	Toxicity
942	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PPARA	rs4253728	Dosage
943	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		UGT1A9	rs2003569	Efficacy
944	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CNR1	rs6454674	Other
945	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CNR1	rs806368	Other
946	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Psychotic Disorders	NR1I2	rs7643645	Metabolism/PK
947	pharmgkb	Drug	bevacizumab			Macular Degeneration	CFH	rs1061170	Dosage
948	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3			rs478437	Efficacy
949	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		E2F7	rs310786	Efficacy
950	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	E2F7	rs310786	Toxicity
951	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CREB1	rs889895	Efficacy
952	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		GSTM3	rs1799735	Metabolism/PK
953	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		ANKK1	rs1800497	Metabolism/PK
954	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Hypotension	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	Toxicity
955	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Fatigue	TPMT	TPMT*1, TPMT*3A, TPMT*3C	Toxicity
956	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Fatigue	UGT1A1	UGT1A1*1, UGT1A1*28	Toxicity
957	pharmgkb	Drug	galantamine	9651.0	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	Dementia	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	Metabolism/PK
958	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	rs628031	Efficacy
959	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XBP1	rs2269577	Efficacy,Toxicity
960	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs58425034	Other
961	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR1A	rs6295	Efficacy
962	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O		ABCC2	rs12762549	Toxicity,Metabolism/PK
963	pharmgkb	Drug	deferiprone	2972.0	CC1=C(C(=O)C=CN1C)O	beta-Thalassemia	UGT1A6	rs6759892	Efficacy,Toxicity
964	pharmgkb	Drug	ethanol	702.0	CCO		ADH1B	rs1229984	Metabolism/PK
965	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC22A1	rs72552763	Metabolism/PK
966	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung	DHFR	rs442767	Toxicity
967	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B1	rs4149056	Toxicity
968	pharmgkb	Drug	atomoxetine	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs3785143	Efficacy
969	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	ABCB1	rs1045642	Other
970	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		TBXA2R	rs4523	Efficacy
971	pharmgkb	Drug	bevacizumab			Macular Degeneration	CXCL8	rs4073	Efficacy
972	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	CYP2C8	rs11572076	Toxicity
973	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	DAPK1	rs11141915	Toxicity
974	pharmgkb	Drug	rituximab			Lupus Erythematosus, Systemic	IL2	rs6822844	Efficacy
975	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Leukemia, Lymphocytic, Chronic, B-Cell	CYP2B6	CYP2B6*1, CYP2B6*6	Efficacy,Toxicity
976	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BDNF	rs7124442	Efficacy
977	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Sarcoma	GSTA1	rs3957357	Efficacy
978	pharmgkb	Drug	ustekinumab			Psoriasis	HLA-C	HLA-C*06:02	Efficacy
979	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs76387818	Toxicity
980	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs12022243	Toxicity
981	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ENOSF1	rs2741171	Toxicity
982	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	GRIN1	rs1126442	Toxicity
983	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	IL11	rs1126757	Efficacy
984	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Stomach Neoplasms	EGFR	rs2293347	Efficacy
985	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Autism Spectrum Disorder	DRD3	rs6280	Efficacy
986	pharmgkb	Drug Class	egfr inhibitors			Carcinoma, Non-Small-Cell Lung,Colorectal Neoplasms,Neoplasms,Pancreatic Neoplasms	EGFR	rs2227983	Toxicity
987	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	UGT1A1	UGT1A1*60	Efficacy
988	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	CYP3A5	rs776746	Dosage,Toxicity
989	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	HLA-DPB1	HLA-DPB1*04:01	Toxicity
990	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			anaphylactoid reaction	HLA-DRB1	HLA-DRB1*11:01	Toxicity
991	pharmgkb	Drug	tiotropium	5487426.0	C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	Asthma	ADRB2	rs1042713	Efficacy
992	pharmgkb	Drug	topiramate	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	Alcohol-Related Disorders	GRIK1	rs2832407	Efficacy,Metabolism/PK
993	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Prostatic Neoplasms	ORM2	rs2250242	Metabolism/PK
994	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	KCNJ11	rs5219	Efficacy
995	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	rs2273697	Metabolism/PK
996	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC3	rs3738948	Efficacy
997	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XPA	rs1800975	Efficacy
998	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC4	rs1799801	Efficacy
999	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	APLF	rs3213239	Efficacy
1000	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs13181	Toxicity
1001	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	CXXC4	rs4413407	Efficacy
1002	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	WNT5B	rs12819505	Efficacy
1003	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	WIF1	rs10878232	Efficacy
1004	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	AXIN2	rs11868547	Efficacy
1005	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	AXIN2	rs4541111	Efficacy
1006	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Agranulocytosis	MTR	rs3768142	Toxicity
1007	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CRHR1	rs28364032	Efficacy
1008	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	NEDD4L	rs520210	Efficacy
1009	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	PAX4	rs6467136	Efficacy
1010	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	DHFR	rs1650697	Toxicity
1011	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung	GGH	rs11545078	Toxicity
1012	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	FOLR3	rs61734430	Efficacy
1013	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs3788189	Efficacy
1014	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs914232	Efficacy
1015	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ABCB1	rs1045642	Toxicity
1016	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs1052555	Efficacy
1017	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity	HLA-B	HLA-B*51:01	Toxicity
1018	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		CYP2D6	rs28360521	Toxicity
1019	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	ADRB2	rs1042714	Efficacy
1020	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	CHIA	rs3818822	Toxicity
1021	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A,UGT1A9	rs8330	Toxicity
1022	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	SLC30A9	rs1047626	Toxicity
1023	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	HLA-DPB1	rs3097671	Toxicity
1024	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB1	rs1042136	Toxicity
1025	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB1	rs1042151	Toxicity
1026	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB2	rs3129294	Toxicity
1027	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma		rs1074373	Toxicity
1028	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	TSC1	rs7862221	Toxicity
1029	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	THRA	rs11819745	Toxicity
1030	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	CAPN10	rs3792269	Efficacy
1031	pharmgkb	Drug	latanoprost	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGS1	rs10306114	Efficacy
1032	pharmgkb	Drug	latanoprost	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	ABCC4	rs11568658	Efficacy
1033	pharmgkb	Drug	pioglitazone	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus	ADIPOQ	rs2241766	Efficacy
1034	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	SOD2	rs4880	Toxicity
1035	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLC22A4	rs1050152	Efficacy
1036	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus		rs10747673	Efficacy
1037	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SP1	rs2683511	Efficacy,Metabolism/PK
1038	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	PPARA	rs149711321	Efficacy,Metabolism/PK
1039	pharmgkb	Drug Class	hmg coa reductase inhibitors				CELSR2	rs646776	Efficacy
1040	pharmgkb	Drug Class	hmg coa reductase inhibitors				SLCO1B1	rs2900478	Efficacy
1041	pharmgkb	Drug Class	hmg coa reductase inhibitors					rs445925	Efficacy
1042	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Abortion, Spontaneous	CYP1A2	CYP1A2*1A, CYP1A2*1F	Toxicity
1043	pharmgkb	Drug	clonidine	2803.0	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	Liver Cirrhosis	GNB3	rs5443	Efficacy
1044	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	GSTT1	GSTT1 non-null, GSTT1 null	Efficacy
1045	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs2054675	Toxicity
1046	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs3786547	Toxicity
1047	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH3	rs3787430	Efficacy
1048	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	TGFB1	rs1800470	Efficacy
1049	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis	TNFRSF10A	rs20575	Efficacy
1050	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs2631367	Efficacy
1051	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A6	rs2070959	Toxicity
1052	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	COMT	rs4680	Toxicity
1053	pharmgkb	Drug	eculizumab			paroxysmal nocturnal hemoglobinuria	CR1	rs2274567	Efficacy
1054	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs35864111	Efficacy
1055	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs13207351	Efficacy
1056	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs12505410	Efficacy
1057	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs13120400	Efficacy
1058	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs2725252	Efficacy
1059	pharmgkb	Drug, Biological Intermediate	levodopa	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	HOMER1	rs4704559	Toxicity
1060	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	GGCX	rs2592551	Dosage
1061	pharmgkb	Drug	busulfan	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	hemopoietic stem cell transplant	CYP2C19	rs12248560	Metabolism/PK
1062	pharmgkb	Drug	busulfan	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	hemopoietic stem cell transplant	CYP2C9	rs1799853	Metabolism/PK
1063	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	CYP2B6	rs3745274	Efficacy,Toxicity
1064	pharmgkb	Drug Class	corticosteroids			Asthma	HDAC1	rs1741981	Efficacy
1065	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation		rs11265572	Metabolism/PK
1066	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	Arthritis, Rheumatoid	ABCG2	rs2231142	Efficacy
1067	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLC22A1	rs683369	Efficacy,Metabolism/PK
1068	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs3806598	Metabolism/PK
1069	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs2741049	Metabolism/PK
1070	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	rs4646437	Efficacy,Metabolism/PK
1071	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL1B	rs4848306	Efficacy
1072	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	IL1RN	rs4251961	Efficacy
1073	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	TLR9	rs352139	Efficacy
1074	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	TLR2	rs4696480	Efficacy
1075	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease	TLR2	rs1816702	Efficacy
1076	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	TLR2	rs3804099	Efficacy
1077	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	CD14	rs2569190	Efficacy
1078	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL17A	rs2275913	Efficacy
1079	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	TNFAIP3	rs6927172	Efficacy
1080	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL6	rs10499563	Efficacy
1081	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	TLR4	rs5030728	Efficacy
1082	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	CNPY4	rs1554973	Efficacy
1083	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	TNFRSF1A	rs4149570	Efficacy
1084	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	IFNG	rs2430561	Efficacy
1085	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	KCNQ1	rs2237895	Toxicity
1086	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800896	Dosage
1087	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800872	Dosage
1088	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800871	Dosage
1089	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	rs1045642	Toxicity
1090	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CMPK1	rs11211524	Efficacy
1091	pharmgkb	Drug Class	hmg coa reductase inhibitors				ABCB1	rs1045642	Other
1092	pharmgkb	Drug	methylphenobarbital	8271.0	CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*16	Metabolism/PK
1093	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CDA	rs1048977	Other
1094	pharmgkb	Drug	vitamin e	14985.0	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O		CYP4F2	rs2108622	Metabolism/PK
1095	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C		BCHE	rs28933389	Toxicity
1096	pharmgkb	Drug	isoproterenol	3779.0	CC(C)NCC(C1=CC(=C(C=C1)O)O)O		ADRB2	rs1042713	Other
1097	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NTRK2	rs10465180	Efficacy
1098	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NTRK2	rs1778929	Efficacy
1099	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	FKBP5	rs1360780	Efficacy
1100	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	TRAF3IP2	rs76228616	Toxicity
1101	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TAPBP	rs1059288	Toxicity
1102	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TAPBP	rs2071888	Toxicity
1103	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5		ABCG2	rs2231142	Metabolism/PK
1104	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs10792367	Efficacy
1105	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX4	rs10871454	Dosage
1106	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4086116	Dosage
1107	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		FMO1	rs10912675	Other
1108	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		FMO1	rs7877	Other
1109	pharmgkb	Drug	XK469	148183.0	CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl		AOX1	rs10931910	Metabolism/PK
1110	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	RRAS2	rs11023197	Efficacy
1111	pharmgkb	Drug	celecoxib	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	ALOX12	rs11078659	Efficacy,Toxicity
1112	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		UGT2B10	rs112561475	Metabolism/PK
1113	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGIR	rs1126510	Toxicity
1114	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	OCRL	rs113165732	Other
1115	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F			rs1155463	Toxicity
1116	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders	HTR1B	rs11568817	Toxicity
1117	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	PAPLN	rs11628713	Toxicity
1118	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms		rs11719165	Toxicity
1119	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Hypertension	NR1H3	rs12221497	Toxicity
1120	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2C19	rs12768009	Metabolism/PK
1121	pharmgkb	Drug Class	hmg coa reductase inhibitors				CFAP44	rs13064411	Efficacy
1122	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER2	rs1353411	Toxicity
1123	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs376817657	Metabolism/PK
1124	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs140471703	Metabolism/PK
1125	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs143690364	Metabolism/PK
1126	pharmgkb	Drug, Biological Intermediate	levodopa	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Cocaine-Related Disorders	DBH	rs1611115	Efficacy
1127	pharmgkb	Drug	timolol	33624.0	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O	Bradycardia		rs16947	Toxicity
1128	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, B-Cell, Acute	ABCC4	rs9516519	Toxicity
1129	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A5	rs776746	Metabolism/PK
1130	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	PTGS1	rs10306135	Toxicity
1131	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		THBD	rs1042580	Toxicity
1132	pharmgkb	Drug Class	radiotherapy			pneumonitis	CDK1	rs10711	Toxicity
1133	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		FGD4	rs10771973	Toxicity
1134	pharmgkb	Drug Class	radiotherapy				PRKCE	rs11125035	Toxicity
1135	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O		BDKRB2	rs1799722	Efficacy
1136	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	KCNT2	rs1886629	Toxicity
1137	pharmgkb	Drug	sildenafil	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	NOS3	rs2070744	Efficacy
1138	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Spondylitis, Ankylosing	TNF	rs1799964	Efficacy
1139	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ALDH5A1	rs2760118	Efficacy
1140	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs2857657	Efficacy
1141	pharmgkb	Drug	phenobarbital	4763.0	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	Epilepsy	ABCB1	rs1045642	Efficacy
1142	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depression	CYP2C19	rs4244285	Toxicity
1143	pharmgkb	Drug	etravirine	193962.0	CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N	HIV Infections	CYP2C19	rs4244285	Metabolism/PK
1144	pharmgkb	Drug	atomoxetine	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs12708954	Efficacy
1145	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		ALG10	rs1705772	Toxicity
1146	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		FMO3	rs1736557	Efficacy
1147	pharmgkb	Drug Class	Ace Inhibitors, Plain				ACE	rs1799752	Toxicity
1148	pharmgkb	Drug	timolol	33624.0	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O		ADRB1	rs1801252	Efficacy
1149	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease		rs342293	Efficacy
1150	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	rs1877724	Dosage
1151	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms		rs1901440	Toxicity
1152	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder	ABCB1	rs2032582	Efficacy
1153	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER2	rs2075797	Toxicity
1154	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	GDNF	rs2216711	Efficacy
1155	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs8187707	Toxicity
1156	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia		rs7912580	Efficacy
1157	pharmgkb	Drug	vardenafil	110634.0	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C		CYP3A5	rs776746	Metabolism/PK
1158	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER3	rs7551789	Toxicity
1159	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ACE	rs4292	Toxicity
1160	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ACE	rs4291	Toxicity
1161	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TLR3	rs3775291	Toxicity
1162	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		AGT	rs5050	Toxicity
1163	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	EIF2AK4	rs2412459	Efficacy
1164	pharmgkb	Drug	celecoxib	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	IL23R	rs7518660	Toxicity
1165	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT2B7	rs7438135	Toxicity
1166	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid	SLC16A7	rs3763980	Efficacy
1167	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F			rs642990	Toxicity
1168	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N			rs578427	Metabolism/PK
1169	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC47A2	rs34834489	Metabolism/PK
1170	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	rs36056065	Toxicity
1171	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	FLT4	rs307826	Efficacy
1172	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	FLT4	rs307821	Efficacy
1173	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Coronary Disease	SLCO1B1	rs4149081	Efficacy
1174	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension		rs495828	Toxicity
1175	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	DRD2	rs2734833	Efficacy
1176	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major		rs2433320	Efficacy
1177	pharmgkb	Drug	verapamil	2520.0	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Coronary Artery Disease,Hypertension	NR1H3	rs2279238	Toxicity
1178	pharmgkb	Drug	celecoxib	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	PTGES	rs2302821	Toxicity
1179	pharmgkb	Drug	fexofenadine	3348.0	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O		SLCO2B1	rs2306168	Metabolism/PK
1180	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	GDNF	rs2973049	Efficacy
1181	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		HNF4A	rs3212198	Dosage
1182	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	AHR	rs4410790	Metabolism/PK
1183	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	TPH2	rs4570625	Efficacy
1184	pharmgkb	Drug Class	thiazolidinediones			Diabetes Mellitus, Type 2	AQP2	rs296766	Toxicity
1185	pharmgkb	Drug Class	hmg coa reductase inhibitors				ADAMTS1	rs402007	Efficacy
1186	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs4132670	Toxicity
1187	pharmgkb	Drug	celecoxib	2662.0	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	PTGER4	rs4133101	Toxicity
1188	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1B	rs3397	Efficacy
1189	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1B	rs1061631	Efficacy
1190	pharmgkb	Drug	etoposide	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O			rs446112	Efficacy
1191	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs4506565	Toxicity
1192	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	OPRD1	rs4654327	Efficacy
1193	pharmgkb	Drug	entacapone	5281081.0	CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N	Parkinson Disease	COMT	rs4680	Efficacy
1194	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CACNA1C	rs1006737	Toxicity
1195	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GRIN3A	rs10121600	Other
1196	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		COL26A1	rs10279545	Toxicity
1197	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs1045280	Other
1198	pharmgkb	Drug, Biological Intermediate	estradiol	5757.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O			rs11849538	Other
1199	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs1044397	Other
1200	pharmgkb	Drug	etoposide	36462.0	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1045642	Metabolism/PK
1201	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	rs3740066	Metabolism/PK
1202	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLCO1A2	rs3764043	Metabolism/PK
1203	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	GPR83	rs3758785	Efficacy
1204	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Essential hypertension	GPR83	rs3758785	Efficacy
1205	pharmgkb	Drug Class	Ace Inhibitors, Plain			Hypertension	AGTR1	rs5182	Toxicity
1206	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	RORA	rs809736	Efficacy
1207	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	DTNBP1	rs760761	Efficacy
1208	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CACNA1C	rs10848635	Toxicity
1209	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CRHR2	rs2270007	Efficacy
1210	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder		rs585719	Efficacy
1211	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major		rs6127921	Efficacy
1212	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major		rs6966038	Efficacy
1213	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		IL1B	rs16944	Efficacy
1214	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Hyperlipidemias	CYP3A5	rs776746	Toxicity
1215	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Toxic liver disease	CYP3A5	rs776746	Toxicity
1216	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms	ABCB1	rs2032582	Efficacy
1217	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Coronary Disease	LEPR	rs1137101	Efficacy
1218	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hyperlipidemias	LEPR	rs1137101	Efficacy
1219	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Transplantation	ABCB1	rs1045642	Metabolism/PK
1220	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045872	Metabolism/PK
1221	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045821	Metabolism/PK
1222	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		SLCO1B1	rs2291073	Efficacy
1223	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	SLCO1B1	rs4149032	Metabolism/PK
1224	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	rs4149036	Efficacy
1225	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	COMT	rs4680	Efficacy
1226	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major		rs4675690	Toxicity
1227	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs301434	Efficacy
1228	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs301435	Efficacy
1229	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs3087879	Efficacy
1230	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CHAT	rs1880676	Efficacy
1231	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs2734841	Toxicity
1232	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs2734842	Toxicity
1233	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CHAT	rs3810950	Efficacy
1234	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CYP3A43	rs472660	Metabolism/PK
1235	pharmgkb	Drug Class	Influenza vaccines			Narcolepsy	HLA-DQB1	HLA-DQB1*06:02	Toxicity
1236	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HLA-DRB3	HLA-DRB3*02:02	Toxicity
1237	pharmgkb	Drug	ticlopidine	5472.0	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl		HLA-B	HLA-B*44:03	Toxicity
1238	pharmgkb	Drug	methylene blue	6099.0		Anemia, Hemolytic,Hemolysis,Protein Deficiency	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Efficacy,Toxicity
1239	pharmgkb	Drug	ticlopidine	5472.0	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl	Toxic liver disease	HLA-C	HLA-C*14:03	Toxicity
1240	pharmgkb	Drug	pazopanib	11525740.0		Carcinoma, Renal Cell	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37	Toxicity
1241	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC22A11	rs11231809	Efficacy
1242	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC1	rs246240	Efficacy
1243	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC1	rs3784864	Efficacy
1244	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC29A1	rs760370	Efficacy
1245	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs7917983	Toxicity
1246	pharmgkb	Drug	propofol	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O		CYP2B6	rs3745274	Dosage
1247	pharmgkb	Drug	antithymocyte globulin			Kidney Transplantation	FCGR3A	rs396991	Other
1248	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*59	Dosage
1249	pharmgkb	Drug Class	Pertussis vaccines				TLR4	rs2770150	Efficacy
1250	pharmgkb	Drug Class	Pertussis vaccines				TLR4	rs4986790	Efficacy
1251	pharmgkb	Drug	daunorubicin	30323.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	NOS3	rs1799983	Efficacy
1252	pharmgkb	Drug	melphalan	4053.0	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl	Multiple Myeloma	SLC7A5	rs4240803	Toxicity
1253	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	DBH	rs1611115	Efficacy
1254	pharmgkb	Drug	salvianolic acid b	6441188.0	C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O	Coronary Disease	NOS3	rs1799983	Efficacy
1255	pharmgkb	Drug Class	antipsychotics				COMT	rs4680	Toxicity
1256	pharmgkb	Drug Class	antipsychotics				COMT	rs4680	Toxicity
1257	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2		NAT1	rs13253389	Metabolism/PK
1258	pharmgkb	Drug	rocuronium	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1B1	rs2306283	Efficacy
1259	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		ABCB1	rs9282564	Toxicity
1260	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC4	rs7317112	Toxicity
1261	pharmgkb	Drug	adalimumab			Crohn Disease	ATG16L1	rs10210302	Efficacy
1262	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	LEPR	rs1137101	Toxicity
1263	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	ANKK1	rs1800497	Toxicity
1264	pharmgkb	Biological Intermediate	bilirubin	5280352.0	CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C	Colorectal Neoplasms	UGT1A	rs11563250	Metabolism/PK
1265	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A	rs11563250	Toxicity
1266	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	rs1934969	Metabolism/PK
1267	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	SOD2	rs4880	Toxicity
1268	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	CYP2C8	rs1113129	Toxicity
1269	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	ERCC1	rs3212986	Toxicity
1270	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC1	rs11615	Toxicity
1271	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	familial hypercholesterolemia	POR	rs1057868	Efficacy
1272	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR1A	rs6295	Efficacy
1273	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	COMT	rs4680	Efficacy
1274	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs846908	Metabolism/PK
1275	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs4844880	Metabolism/PK
1276	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs846910	Metabolism/PK
1277	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Psychotic Disorders	ABCB5	rs17143212	Toxicity
1278	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	GSTP1	rs1138272	Efficacy
1279	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N		UGT1A4	rs3732219	Other
1280	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N		UGT1A4	rs3732218	Other
1281	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C		CYP2C19	CYP2C19*1, CYP2C19*2	Other
1282	pharmgkb	Drug	benazepril	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	MTHFR	rs1801133	Efficacy
1283	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs1570360	Efficacy
1284	pharmgkb	Drug	daptomycin	16129629.0	CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C		ABCB1	rs1045642	Metabolism/PK
1285	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1A	rs767455	Efficacy
1286	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ILKAP	rs113095083	Efficacy
1287	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	TET2	rs12505746	Efficacy
1288	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	FBXL17	rs7706429	Efficacy
1289	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	FBXL17	rs4431329	Efficacy
1290	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension		rs9285669	Efficacy
1291	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	CSMD1	rs11993031	Efficacy
1292	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	CSMD1	rs7387065	Efficacy
1293	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	SLIT1	rs11189015	Efficacy
1294	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	DIAPH3	rs77876672	Efficacy
1295	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	UGGT2	rs9590353	Efficacy
1296	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ANKFN1	rs9915451	Efficacy
1297	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC22A3	rs2076828	Efficacy
1298	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative		rs11959113	Dosage
1299	pharmgkb	Drug	erlotinib	176870.0	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC		CYP1A2	rs2472304	Metabolism/PK
1300	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	BDNF	rs6265	Efficacy
1301	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs16944	Toxicity
1302	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs1143634	Toxicity
1303	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	rs6265	Toxicity
1304	pharmgkb	Drug	dextromethorphan	5360696.0	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*36, CYP2D6*40, CYP2D6*42, CYP2D6*56	Other
1305	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	KCNJ6	rs2835859	Dosage
1306	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Toxic liver disease	POLG	rs3087374	Toxicity
1307	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma		rs1364805	Efficacy
1308	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	GALNT17	rs7794356	Efficacy
1309	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	MLLT3	rs6475448	Efficacy
1310	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma		rs953977	Efficacy
1311	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute	ABCB1	rs1128503	Efficacy
1312	pharmgkb	Drug	liraglutide	44147092.0	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	Obesity,Polycystic Ovary Syndrome	GLP1R	rs10305420	Efficacy
1313	pharmgkb	Drug	liraglutide	44147092.0	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	Obesity,Polycystic Ovary Syndrome	GLP1R	rs6923761	Efficacy
1314	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC22A2	rs316019	Other
1315	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	rs3211371	Efficacy
1316	pharmgkb	Drug	ketamine	3821.0	CNC1(CCCCC1=O)C2=CC=CC=C2Cl	Neoplasms,Pain	CYP2B6	CYP2B6*1, CYP2B6*6	Metabolism/PK
1317	pharmgkb	Drug Class	anthracyclines and related substances			Breast Neoplasms	ECT2L	rs11155012	Efficacy
1318	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	HLA-DRB1	rs17885382	Toxicity
1319	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	NFATC2	rs6021191	Toxicity
1320	pharmgkb	Drug	vancomycin	14969.0	C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O			rs2789047	Metabolism/PK
1321	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs6838116	Toxicity
1322	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	CXCL8	rs1126647	Toxicity
1323	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	IL13	rs1800925	Toxicity
1324	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs12346562	Efficacy
1325	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension		rs1104514	Efficacy
1326	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension		rs10739150	Efficacy
1327	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		UGT2B7	rs7439366	Dosage
1328	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Neoplasms	NR1I2	rs6785049	Toxicity
1329	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	LGR5	rs17109924	Efficacy
1330	pharmgkb	Drug Class	adrenergics, inhalants			Asthma		rs34548976	Efficacy
1331	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder		rs12461964	Dosage
1332	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder		rs113288603	Metabolism/PK
1333	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	FMO5	rs7541245	Efficacy
1334	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	rs8187710	Toxicity
1335	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	rs717620	Toxicity
1336	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease	FDPS	rs2297480	Other
1337	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs4688040	Metabolism/PK
1338	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,suicide	GRIA3	rs4825476	Toxicity
1339	pharmgkb	Drug Class	Beta Blocking Agents				GNB3	rs5443	Other
1340	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	rs8192709	Metabolism/PK
1341	pharmgkb	Drug Class	calcium channel blockers			Hypertension	TANC2	rs2429427	Efficacy
1342	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs2242480	Toxicity
1343	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms,hand-foot syndrome	ABCB1	rs2032582	Toxicity
1344	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	IL10	rs1800896	Toxicity
1345	pharmgkb	Drug	cilostazol	2754.0	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
1346	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus Erythematosus, Systemic	CYP2C19	rs4244285	Toxicity
1347	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus erythematosus	CYP2B6	rs4802101	Toxicity,Metabolism/PK
1348	pharmgkb	Drug	varenicline	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	CHRNA4	rs1044396	Efficacy
1349	pharmgkb	Drug Class	Opium alkaloids and derivatives			Pain	CHRNA3	rs1051730	Toxicity
1350	pharmgkb	Drug	amodiaquine	2165.0	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O		CYP2C8	rs11572080	Toxicity
1351	pharmgkb	Drug	amodiaquine	2165.0	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O		CYP2C8	rs10509681	Toxicity
1352	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP1A2	rs762551	Efficacy
1353	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	P2RY12	rs6809699	Efficacy
1354	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		P2RY12	rs6787801	Efficacy
1355	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease	CES1P1	rs3785161	Efficacy
1356	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	Efficacy
1357	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	Neoplasms	CYP3A4	rs35599367	Other
1358	pharmgkb	Drug Class	antipsychotics			Schizophrenia		rs9346455	Toxicity
1359	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs3759811	Other
1360	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs4775936	Other
1361	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs749292	Other
1362	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs700518	Other
1363	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	rs1800566	Dosage
1364	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	rs1059751	Toxicity
1365	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell	VEGFA	rs1570360	Efficacy
1366	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell	KDR	rs2239702	Efficacy
1367	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell,hand-foot syndrome	VEGFA	rs2010963	Toxicity
1368	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell,Hypertension	ABCB1	rs1045642	Toxicity
1369	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCC2	rs717620	Metabolism/PK
1370	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	ESR1	rs4870061	Toxicity
1371	pharmgkb	Drug	agomelatine	82148.0	CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC	Depressive Disorder	ABCB1	rs1045642	Efficacy
1372	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder,Narcolepsy	ABCB1	rs1045642	Efficacy
1373	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder	ABCB1	rs1045642	Efficacy
1374	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	LRRC15	rs11313667	Efficacy
1375	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	LRRC15	rs11313667	Efficacy
1376	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	LRRC15	rs11313667	Efficacy
1377	pharmgkb	Drug	rivastigmine	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease	CHAT	rs2177370	Efficacy
1378	pharmgkb	Drug	galantamine	9651.0	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	Alzheimer Disease	CHAT	rs2177370	Efficacy
1379	pharmgkb	Drug	donepezil	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease	CHAT	rs2177370	Efficacy
1380	pharmgkb	Drug	telmisartan	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C	Essential hypertension	GNB3	rs5443	Efficacy
1381	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		DRD3	rs6280	Metabolism/PK
1382	pharmgkb	Drug	modafinil	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	rs1045642	Efficacy
1383	pharmgkb	Drug	silibinin	31553.0	COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O		ABCB1	rs1045642	Metabolism/PK
1384	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	DRD2	rs1076560	Efficacy
1385	pharmgkb	Drug	modafinil	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	rs1128503	Efficacy
1386	pharmgkb	Drug	amisulpride	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Schizophrenia	DRD2	rs1079597	Efficacy
1387	pharmgkb	Drug Class	corticosteroids			Asthma	ST13	rs138335	Efficacy
1388	pharmgkb	Drug Class	corticosteroids			Asthma	ST13	rs138337	Efficacy
1389	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder	FGF2	rs1449683	Efficacy
1390	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ADCY2	rs1544938	Efficacy
1391	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRG1	rs17716295	Efficacy
1392	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Lymphoma, B-Cell	CYP2B6	CYP2B6*1, CYP2B6*6	Metabolism/PK
1393	pharmgkb	Drug	infliximab			Arthritis, Rheumatoid	FCGR3A	rs396991	Efficacy
1394	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	rs1045642	Toxicity
1395	pharmgkb	Drug Class	Antihypertensives			Coronary Artery Disease,Hypertension	ATP2B1	rs12817819	Efficacy
1396	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GRM3	rs6465084	Efficacy
1397	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GRM3	rs1468412	Toxicity
1398	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRXN1	rs12467557	Efficacy
1399	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRXN1	rs10490162	Efficacy
1400	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	HMGCR	rs17671591	Efficacy
1401	pharmgkb	Drug	bevacizumab			Macular Degeneration	ARMS2	rs10490924	Efficacy
1402	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	CYP2E1	CYP2E1*1A, CYP2E1*5B	Toxicity
1403	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CAT	rs1001179	Other
1404	pharmgkb	Drug Class	Hepatitis vaccines				IL13	rs1295686	Efficacy
1405	pharmgkb	Drug Class	Hepatitis vaccines				IL4R	rs1805015	Efficacy
1406	pharmgkb	Drug	imiquimod	57469.0	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	Carcinoma, Basal Cell	TLR7	rs179008	Efficacy
1407	pharmgkb	Drug	infliximab				TNF	rs361525	Efficacy
1408	pharmgkb	Drug	voriconazole	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	Mycoses	CYP3A4	rs4646437	Metabolism/PK
1409	pharmgkb	Drug	regadenoson	219024.0	CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O		AMPD1	rs17602729	Toxicity
1410	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs2231135	Toxicity
1411	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	DHFR	rs1650723	Toxicity
1412	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	DHFR	rs1053129	Efficacy
1413	pharmgkb	Drug	pegloticase			Hemolysis,Methemoglobinemia	G6PD	G6PD A- 202A_376G	Toxicity
1414	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Failure	CYP3A5	rs776746	Toxicity
1415	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP3A5	rs776746	Efficacy
1416	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Arteriosclerosis	CYP3A5	rs776746	Efficacy
1417	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease,Myocardial Infarction	ADAMTS1	rs428785	Efficacy
1418	pharmgkb	Drug	peginterferon alfa-2b	71306834.0		Hepatitis B, Chronic	HLA-DPA1	rs3077	Efficacy
1419	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:13	Toxicity
1420	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	rs1045642	Toxicity
1421	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	VDR	rs1540339	Efficacy
1422	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	VDR	rs2239179	Efficacy
1423	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	GRIN2B	rs1072388	Efficacy
1424	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	PLCB1	rs6108160	Efficacy
1425	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	GIPR	rs10423928	Toxicity
1426	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs4586	Efficacy
1427	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression		rs10514475	Efficacy
1428	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	HTR2A	rs6314	Efficacy
1429	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	HOTAIR	rs7958904	Efficacy
1430	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Essential hypertension	SLCO1B1	rs4149056	Toxicity
1431	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	SLCO1B1	rs2306283	Efficacy
1432	pharmgkb	Drug Class	antipsychotics			Schizophrenia		rs2513265	Efficacy
1433	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	MALAT1	rs619586	Efficacy
1434	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	H19	rs2839698	Efficacy
1435	pharmgkb	Drug	milnacipran	65833.0	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	Depressive Disorder	ADRA2A	rs1800544	Efficacy
1436	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP7A1	rs3808607	Efficacy
1437	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms		rs6983267	Efficacy
1438	pharmgkb	Drug	modafinil	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	rs2032582	Efficacy
1439	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	ESR1	rs2813543	Toxicity
1440	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Osteosarcoma	REV3L	rs462779	Efficacy
1441	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus Nephritis	GSTA1	rs3957356	Efficacy
1442	pharmgkb	Drug	milnacipran	65833.0	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	Depressive Disorder	HTR1A	rs6295	Efficacy
1443	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		GRID2	rs1875705	Efficacy
1444	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		GRM7	rs2069062	Efficacy
1445	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Osteosarcoma	REV1	rs3087403	Efficacy
1446	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease,Diabetes Mellitus, Type 2	IRS1	rs13431554	Efficacy
1447	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	SOD2	rs4880	Toxicity
1448	pharmgkb	Drug	terbutaline	5403.0	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O		ADRB2	rs1042714	Efficacy
1449	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ABCB1	rs1045642	Efficacy
1450	pharmgkb	Drug	voriconazole	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		ABCB1	rs1045642	Metabolism/PK
1451	pharmgkb	Drug	nifedipine	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	ADRA1A	rs1048101	Efficacy
1452	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	rs1051740	Efficacy
1453	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC28A2	rs1060896	Efficacy,Toxicity
1454	pharmgkb	Drug	infliximab			Crohn Disease	IL1B	rs1143634	Efficacy
1455	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PROC	rs1799808	Dosage
1456	pharmgkb	Drug Class	catecholamines			Coronary Artery Disease	ADRB1	rs1801253	Dosage
1457	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia		rs1805054	Toxicity
1458	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	RRM1	rs183484	Efficacy
1459	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	NOS3	rs2070744	Efficacy
1460	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC28A1	rs2242046	Toxicity
1461	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCC2	rs3740065	Efficacy
1462	pharmgkb	Drug	ramipril	5362129.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	Hypertension	ACE	rs4344	Efficacy
1463	pharmgkb	Drug	ramipril	5362129.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	Hypertension	ACE	rs4359	Efficacy
1464	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	rs719235	Toxicity
1465	pharmgkb	Drug	nitrendipine	4507.0	CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C	Hypertension	AGTR1	rs5186	Efficacy
1466	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		AGTR1	rs5186	Efficacy
1467	pharmgkb	Biological Intermediate	angiotensin II	65143.0	CC[C@H](C)C(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N		AGTR1	rs5186	Efficacy
1468	pharmgkb	Drug	perindopril	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Hypertension	AGTR1	rs5186	Efficacy
1469	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Liver Cirrhosis	AGTR1	rs5186	Efficacy
1470	pharmgkb	Drug	quinapril	54892.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O	Coronary Artery Disease	AGT	rs699	Efficacy
1471	pharmgkb	Drug	icotinib	22024915.0	C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Other
1472	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	ABCC10	rs2125739	Metabolism/PK
1473	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	rs1265112	Toxicity
1474	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	rs130072	Toxicity
1475	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	TCF19	rs2073724	Toxicity
1476	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	POLR3G	rs2562519	Toxicity
1477	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections		rs6545803	Toxicity
1478	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs1051298	Efficacy
1479	pharmgkb	Drug	tipifarnib			Neoplasms	ABCB1	rs1128503	Metabolism/PK
1480	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	DRD2	rs1799732	Efficacy
1481	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD2	rs1799732	Efficacy
1482	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	GRIN2B	rs1019385	Dosage
1483	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs17701271	Efficacy
1484	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs17495520	Efficacy
1485	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs1419555	Efficacy
1486	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs1663330	Efficacy
1487	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs1663332	Efficacy
1488	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs518350	Efficacy
1489	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs6002674	Efficacy
1490	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	rs2293347	Efficacy
1491	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs8192719	Metabolism/PK
1492	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Neoplasms	EGFR	rs712829	Efficacy
1493	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DAOA	rs778293	Toxicity
1494	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	DUSP1	rs881152	Efficacy
1495	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	HTR1A	rs878567	Toxicity
1496	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	TAS2R16	rs846664	Toxicity
1497	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder		rs2056527	Efficacy
1498	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		POR	rs1057868	Metabolism/PK
1499	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PROX1	rs340874	Toxicity
1500	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A9	rs11692021	Toxicity
1501	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs72551344	Metabolism/PK
1502	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs34993780	Metabolism/PK
1503	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs35350960	Metabolism/PK
1504	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP3A4	rs4986910	Efficacy
1505	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		LIPC	rs1800588	Efficacy
1506	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ACE	rs4341	Efficacy
1507	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		LDLR	rs688	Efficacy
1508	pharmgkb	Drug	lovastatin	53232.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		LDLR	rs5925	Efficacy
1509	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	rs1128503	Efficacy
1510	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	rs1128503	Toxicity
1511	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ABCC2	rs113646094	Metabolism/PK
1512	pharmgkb	Drug	nelfinavir	64143.0	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	HIV Infections,Pancreatic Neoplasms	CYP2C19	rs4244285	Metabolism/PK
1513	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	CYP2B6*27, CYP2B6*28	Other
1514	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Acute coronary syndrome	LEPR	rs1805094	Efficacy
1515	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		FKBP5	rs73748206	Other
1516	pharmgkb	Drug	cefotaxime	456256.0	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O		SLC22A8	rs11568482	Metabolism/PK
1517	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl		NEDD4L	rs292449	Efficacy
1518	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs2283265	Toxicity
1519	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8	Metabolism/PK
1520	pharmgkb	Drug Class	Ace Inhibitors, Plain			Hypertension	AGT	rs699	Efficacy
1521	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ULK3	rs2290573	Efficacy
1522	pharmgkb	Drug Class	corticosteroids			Asthma	TBX21	rs2240017	Efficacy
1523	pharmgkb	Drug	flupirtine	53276.0	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N	drug-induced liver injury	HLA-DRB1	HLA-DRB1*16:01	Toxicity
1524	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-DQB1	HLA-DQB1*05:02	Toxicity
1525	pharmgkb	Drug	flupirtine	53276.0	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N	drug-induced liver injury	HLA-DQB1	HLA-DQB1*05:02	Toxicity
1526	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DDC	rs12718541	Toxicity
1527	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DRD1	rs265976	Efficacy
1528	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs2036657	Toxicity
1529	pharmgkb	Drug Class	cannabinoids			Substance-Related Disorders	FAAH	rs324420	Toxicity
1530	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP3A4	rs2740574	Toxicity
1531	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	RRM1	rs9937	Efficacy,Toxicity
1532	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C		ABCB1	rs2032582	Dosage
1533	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation,Myasthenia Gravis	ABCB1	rs1128503	Dosage
1534	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	hypertensive nephrosclerosis	GRK4	rs1801058	Efficacy
1535	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA1	rs2727786	Efficacy
1536	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	LPL	rs320	Efficacy
1537	pharmgkb	Drug Class	Thiazides, plain			Diabetes Mellitus	ACE	rs4341	Toxicity
1538	pharmgkb	Drug Class	Thiazides, plain				AGTR1	rs5186	Toxicity
1539	pharmgkb	Drug Class	Thiazides, plain			Diabetes Mellitus	GNB3	rs5443	Toxicity
1540	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	rs3789243	Efficacy
1541	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	PPARG	rs1801282	Toxicity
1542	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs36118214	Metabolism/PK
1543	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	PON1	rs705379	Efficacy
1544	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs1947275	Efficacy
1545	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs6813183	Efficacy
1546	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs1355368	Efficacy
1547	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs734644	Efficacy
1548	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	NAT2	rs4271002	Toxicity
1549	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Stomach Neoplasms	IGFBP3	rs2854744	Efficacy
1550	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Stomach Neoplasms		rs2960436	Efficacy
1551	pharmgkb	Drug	perindopril	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	AGTR1	rs275651	Efficacy
1552	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17	Efficacy,Metabolism/PK
1553	pharmgkb	Drug	perindopril	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	BDKRB1	rs12050217	Efficacy
1554	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ABCB1	rs1128503	Toxicity
1555	pharmgkb	Drug	leflunomide	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	ESR1	rs2234693	Efficacy
1556	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TBXAS1	rs6962291	Toxicity
1557	pharmgkb	Drug Class	antipsychotics				LEPR	rs1137101	Toxicity
1558	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	VEGFA	rs2010963	Efficacy
1559	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular		rs4604006	Efficacy
1560	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	NOS3	rs2070744	Efficacy
1561	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	NOS3	rs1799983	Efficacy
1562	pharmgkb	Prodrug	tegafur	5386.0			CYP2A6	rs8192725	Other
1563	pharmgkb	Prodrug	tegafur	5386.0			CYP2A6	rs28399433	Other
1564	pharmgkb	Prodrug	tegafur	5386.0			CYP2A6	rs8192720	Other
1565	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD2	rs1799978	Dosage
1566	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs3735451	Toxicity
1567	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs4646440	Toxicity
1568	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs4646437	Toxicity
1569	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs2246709	Toxicity
1570	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	OR52E2	rs16909440	Efficacy
1571	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	ASIC2	rs11869731	Efficacy
1572	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs16973410	Efficacy
1573	pharmgkb	Drug	somatropin recombinant				COL1A1	rs1800012	Dosage
1574	pharmgkb	Drug, Biological Intermediate	testosterone	6013.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C		UGT1A4	UGT1A4*1a, UGT1A4*3a	Metabolism/PK
1575	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2D6	rs28371706	Metabolism/PK
1576	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	rs594709	Efficacy
1577	pharmgkb	Drug	bevacizumab				CFH	rs800292	Efficacy
1578	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600879	Efficacy,Toxicity
1579	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600880	Efficacy,Toxicity
1580	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs4554144	Efficacy,Toxicity
1581	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs11940316	Efficacy,Toxicity
1582	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7438135	Efficacy,Toxicity
1583	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7662029	Efficacy,Toxicity
1584	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7439366	Efficacy,Toxicity
1585	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs4292394	Efficacy,Toxicity
1586	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600893	Efficacy,Toxicity
1587	pharmgkb	Drug	topotecan	60700.0	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O	Brain Neoplasms	ABCG2	rs4148157	Metabolism/PK
1588	pharmgkb	Metabolite	difluorodeoxyuridine			Neoplasms	CDA	rs4655226	Metabolism/PK
1589	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CMPK1	rs1044457	Efficacy
1590	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	NT5C3A	rs3750117	Metabolism/PK
1591	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	SH2D5	rs10916852	Efficacy
1592	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CMPK1	rs7543016	Efficacy
1593	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	TENT4A	rs274713	Efficacy
1594	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CMPK1	rs35687416	Efficacy
1595	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	DCTD	rs12507552	Efficacy
1596	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	TENT4A	rs274717	Efficacy
1597	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CDC5L	rs992160	Efficacy
1598	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C		AKR1C3	rs62621365	Metabolism/PK
1599	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C		AKR1C4	rs11253043	Metabolism/PK
1600	pharmgkb	Drug Class	corticosteroids			Asthma	TAAR6	rs7772821	Efficacy
1601	pharmgkb	Drug	dimethyl fumarate	637568.0	COC(=O)/C=C/C(=O)OC	Psoriasis	GSTP1	rs1695	Efficacy
1602	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	COL1A1	rs1800012	Toxicity
1603	pharmgkb	Drug	ranibizumab			Macular Degeneration	NRP1	rs2070296	Efficacy
1604	pharmgkb	Drug	topiramate	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C		INSR	rs2396185	Efficacy
1605	pharmgkb	Drug	asparaginase			Pancreatitis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	CPA2	rs199695765	Toxicity
1606	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ABCB1	rs1045642	Dosage
1607	pharmgkb	Drug	tolperisone	5511.0	CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5	Metabolism/PK
1608	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP1A2	rs762551	Metabolism/PK
1609	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder		rs77107237	Metabolism/PK
1610	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ABCB1	rs2032582	Dosage
1611	pharmgkb	Drug	phenobarbital	4763.0	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	Stevens-Johnson Syndrome	HLA-B	HLA-B*51:01	Toxicity
1612	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	PSMA4	rs57064725	Metabolism/PK
1613	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs7170068	Metabolism/PK
1614	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hyperglycemia	PRKCB	rs11649514	Toxicity
1615	pharmgkb	Drug	sulfinpyrazone	5342.0	C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4		UGT1A9	rs72551330	Metabolism/PK
1616	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	NR1I3	rs2307424	Metabolism/PK
1617	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	NR1I3	rs3003596	Metabolism/PK
1618	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs3814055	Metabolism/PK
1619	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs2461817	Metabolism/PK
1620	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs7643645	Metabolism/PK
1621	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	UGT2B7	rs28365063	Metabolism/PK
1622	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs4148740	Metabolism/PK
1623	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs4148739	Metabolism/PK
1624	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A4	rs2740574	Metabolism/PK
1625	pharmgkb	Drug Class	Dipeptidyl peptidase 4 (DPP-4) inhibitors			Diabetes Mellitus	CDKAL1	rs7756992	Efficacy
1626	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Prostatic Neoplasms	VAC14	rs875858	Toxicity
1627	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs12132152	Toxicity
1628	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs115632870	Other
1629	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72728438	Other
1630	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Pancreatic Neoplasms	TYMS	rs2847153	Efficacy
1631	pharmgkb	Drug	rivastigmine	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease,Lewy Body Disease	BCHE	rs1803274	Efficacy
1632	pharmgkb	Drug	donepezil	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	Other
1633	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Essential hypertension	CYP2C9	rs1057910	Efficacy,Metabolism/PK
1634	pharmgkb	Drug	rivastigmine	77991.0	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease	ACHE	rs2571598	Efficacy
1635	pharmgkb	Drug	ritonavir	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections	ABCB1	rs2032582	Metabolism/PK
1636	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5		CYP2C9	rs72558187	Metabolism/PK
1637	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs274622	Other
1638	pharmgkb	Drug, Metabolite	endoxifen	10090750.0	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3			rs4386686	Other
1639	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs3832043	Other
1640	pharmgkb	Drug Class	antineoplastic agents			Breast Neoplasms	RBFOX1	rs6500843	Efficacy
1641	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	VEGFA	rs699947	Efficacy
1642	pharmgkb	Drug	brivaracetam	9837243.0	CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
1643	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCC2	rs717620	Efficacy
1644	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colonic Neoplasms	NR1I2	rs10934498	Metabolism/PK
1645	pharmgkb	Drug	vitamin e	14985.0	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O		CYP4F2	rs3093105	Metabolism/PK
1646	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Kidney Transplantation	UGT1A9	rs3832043	Metabolism/PK
1647	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3732360	Toxicity
1648	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms		rs11185648	Toxicity
1649	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms	RXRA	rs62576288	Toxicity
1650	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms	RXRA	rs1536475	Toxicity
1651	pharmgkb	Drug Class	antiepileptics			Psychotic Disorders,Schizophrenia		rs16935279	Metabolism/PK
1652	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	rs4148386	Metabolism/PK
1653	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	LRP2	rs2228171	Toxicity
1654	pharmgkb	Drug	busulfan	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	Transplantation	GSTA1	rs3957357	Metabolism/PK
1655	pharmgkb	Drug Class	calcium channel blockers			Hypertension	NUMA1	rs10898815	Efficacy
1656	pharmgkb	Drug Class	calcium channel blockers			Hypertension	PICALM	rs588076	Efficacy
1657	pharmgkb	Drug Class	hmg coa reductase inhibitors			Schizophrenia	SREBF1	rs11868035	Toxicity
1658	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		SLCO1B1	rs11045819	Metabolism/PK
1659	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		SLCO1B1	rs2306283	Metabolism/PK
1660	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs2273618	Toxicity
1661	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs3746574	Toxicity
1662	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	RXRA	rs6413517	Toxicity
1663	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs6130615	Toxicity
1664	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs9725457	Toxicity
1665	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs2502815	Toxicity
1666	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs2501873	Toxicity
1667	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs10538494	Toxicity
1668	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms,Neutropenia	NR1I3	rs75114882	Toxicity
1669	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3732359	Toxicity
1670	pharmgkb	Drug	indinavir	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	CYP3A4	rs2740574	Other
1671	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neurotoxicity Syndromes	CYP2C8	rs11572080	Toxicity
1672	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC22A1	rs622342	Efficacy
1673	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3814058	Toxicity
1674	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs2661319	Efficacy
1675	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	RXRA	rs2234753	Toxicity
1676	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O		ABCG2	rs72552713	Metabolism/PK
1677	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia,Lymphoma	CDA	rs2072671	Toxicity
1678	pharmgkb	Drug Class	opioids			Pain	COMT	rs4680	Other
1679	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	DRD2	rs1799732	Toxicity
1680	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	HTR2A	rs6314	Efficacy
1681	pharmgkb	Drug Class	Photodynamic therapy			Choroidal Neovascularization	F13A1	rs5985	Efficacy
1682	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B3	rs4149117	Dosage,Toxicity
1683	pharmgkb	Drug Class	interferons			Carcinoma, Renal Cell	STAT3	rs4796793	Efficacy
1684	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	PICK1	rs713729	Other
1685	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major		rs521093	Efficacy
1686	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CTLA4	rs231775	Toxicity
1687	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	FHIT	rs49411	Efficacy
1688	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	MTRF1L	rs766127	Efficacy
1689	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	RGS17	rs672170	Efficacy
1690	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	PON2	rs2299267	Efficacy
1691	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CTNNA3	rs10997242	Efficacy
1692	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CACNA1A	rs2112460	Efficacy
1693	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major		rs2831440	Efficacy
1694	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD1	rs4532	Other
1695	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD1	rs686	Other
1696	pharmgkb	Drug	adalimumab			Crohn Disease	HFE	rs2071303	Efficacy
1697	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Vascular Diseases	LDLR	rs1433099	Efficacy
1698	pharmgkb	Drug	adalimumab			Crohn Disease	TF	rs1799852	Efficacy
1699	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Vascular Diseases	LDLR	rs2738466	Efficacy
1700	pharmgkb	Drug	dexamethasone	5743.0	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SERPINE1	rs6092	Toxicity
1701	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	UGT2B7	rs61361928	Metabolism/PK
1702	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	CYP3A4	rs56324128	Metabolism/PK
1703	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	SLCO1B1	rs4149056	Metabolism/PK
1704	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs12201199	Other
1705	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs17839843	Other
1706	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs3931660	Other
1707	pharmgkb	Drug	adalimumab				CRP	rs1130864	Efficacy
1708	pharmgkb	Drug	adalimumab			Inflammatory Bowel Diseases	ATG5	rs510432	Efficacy
1709	pharmgkb	Drug	rasagiline	3052776.0	C#CCN[C@@H]1CCC2=CC=CC=C12	Parkinson Disease	DRD2	rs1076560	Efficacy
1710	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid		rs10945919	Efficacy
1711	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CERS6	rs13393173	Efficacy
1712	pharmgkb	Drug	rasagiline	3052776.0	C#CCN[C@@H]1CCC2=CC=CC=C12	Parkinson Disease	DRD2	rs2283265	Efficacy
1713	pharmgkb	Drug	telaprevir	3010818.0	CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5	Hepatitis C	CYP24A1	rs2585428	Metabolism/PK
1714	pharmgkb	Drug	bisoprolol	2405.0	CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O	Hypertension	ACY3	rs2514036	Efficacy
1715	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Hypertension	NPHS1	rs3814995	Efficacy
1716	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Organ Transplantation	ABCC2	rs3740066	Metabolism/PK
1717	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Kidney Transplantation	SLCO1B1	rs2306283	Metabolism/PK
1718	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	NCOA1	rs1804645	Toxicity
1719	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	LRMDA	rs10509373	Efficacy
1720	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	GALR1	rs2717162	Efficacy
1721	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GALR1	rs2717162	Efficacy
1722	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	rs1128503	Toxicity
1723	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	DOT1L	rs2269879	Efficacy
1724	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs1544410	Metabolism/PK
1725	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs4516035	Metabolism/PK
1726	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRM2	rs324650	Other
1727	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs10994982	Metabolism/PK
1728	pharmgkb	Drug	dabigatran			Atrial Fibrillation	ABCB1	rs4148738	Metabolism/PK
1729	pharmgkb	Drug	dabigatran			Atrial Fibrillation	CES1	rs2244613	Toxicity
1730	pharmgkb	Drug	dabigatran			Atrial Fibrillation	CES1	rs8192935	Metabolism/PK
1731	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	SLC6A12	rs557881	Toxicity
1732	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Organ Transplantation	IMPDH1	rs2228075	Toxicity
1733	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOB	rs676210	Efficacy
1734	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs16969968	Metabolism/PK
1735	pharmgkb	Drug Class	Opium alkaloids and derivatives			Pain	CHRNA5	rs16969968	Toxicity
1736	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072660	Toxicity
1737	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072658	Other
1738	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2229959	Other
1739	pharmgkb	Drug	stavudine	18283.0	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	HIV Infections	TNF	rs1799964	Toxicity
1740	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs3813567	Toxicity
1741	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs3743078	Toxicity
1742	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs637137	Toxicity
1743	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs684513	Toxicity
1744	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A2	rs2470890	Metabolism/PK
1745	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A1	rs2606345	Metabolism/PK
1746	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A2	rs762551	Metabolism/PK
1747	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	HIV Infections	DRD3	rs6280	Toxicity
1748	pharmgkb	Drug Class	Dihydropyridine derivatives				NOS1AP	rs10494366	Toxicity
1749	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CHRNA3	rs1051730	Other
1750	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	GNB3	rs5443	Toxicity
1751	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	ESR1	rs2234693	Toxicity
1752	pharmgkb	Drug	amphetamine	3007.0	C[C@@H](CC1=CC=CC=C1)N		DRD2	rs12364283	Other
1753	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GRIN3A	rs11788456	Other
1754	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	KCNJ6	rs2070995	Other
1755	pharmgkb	Drug Class	Analgesics			Pain	KCNJ6	rs2070995	Efficacy
1756	pharmgkb	Drug	flucloxacillin	21319.0	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Toxic liver disease	NR1I2	rs3814055	Toxicity
1757	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	NOS1AP	rs10494366	Efficacy
1758	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CHRNA3	rs578776	Other
1759	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CHRNA5	rs615470	Other
1760	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA5	rs684513	Other
1761	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	IGF2BP2	rs4402960	Efficacy
1762	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	IGF2BP2	rs1470579	Efficacy
1763	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	SLC6A3	rs2975226	Efficacy
1764	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Coronary Disease	CRP	rs1205	Efficacy
1765	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Coronary Disease		rs2808630	Efficacy
1766	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs1125394	Other
1767	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Bipolar Disorder,Depression	DRD2	rs6279	Other
1768	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Bipolar Disorder,Depression	DRD2	rs6275	Other
1769	pharmgkb	Drug	ritonavir	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs2854116	Toxicity
1770	pharmgkb	Drug	ritonavir	392622.0	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs2854117	Toxicity
1771	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCB1	rs2032582	Toxicity
1772	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	CBR1	rs9024	Dosage,Metabolism/PK
1773	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N		HSPA1A,HSPA1L	rs1043620	Toxicity
1774	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	rs71486745	Dosage
1775	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	ESR2	rs944050	Efficacy
1776	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCG2	rs2199939	Efficacy
1777	pharmgkb	Drug	perindopril	107807.0	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	AGTR1	rs5182	Efficacy
1778	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNJ11	rs5219	Efficacy
1779	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CAPN10	rs5030952	Toxicity
1780	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs4795893	Efficacy
1781	pharmgkb	Drug	alendronate	2088.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	Bone Diseases	MVK	rs10161126	Efficacy
1782	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC1	rs3212986	Toxicity
1783	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs4849127	Toxicity
1784	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	ZBTB22	rs3130100	Toxicity
1785	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus erythematosus	CYP2B6	rs7254579	Metabolism/PK
1786	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs10851907	Metabolism/PK
1787	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms,Neutropenia	RXRA	rs11185647	Toxicity
1788	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	ESR2	rs10140457	Toxicity
1789	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	HNF4A	rs1884613	Metabolism/PK
1790	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs7091672	Toxicity
1791	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs4752219	Toxicity
1792	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs4752220	Toxicity
1793	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs1409314	Toxicity
1794	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs10510050	Toxicity
1795	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	RAPGEF5	rs16873129	Efficacy
1796	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CRH	rs4737771	Efficacy
1797	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	PARP11	rs2532560	Efficacy
1798	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	NBEA	rs9315310	Efficacy
1799	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	CYP3A43	rs62471956	Metabolism/PK
1800	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	SLCO1B1	rs113681054	Metabolism/PK
1801	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs2869950	Toxicity
1802	pharmgkb	Drug	busulfan	2478.0	CS(=O)(=O)OCCCCOS(=O)(=O)C	Leukemia, Myeloid, Acute	GSTM1	rs3754446	Metabolism/PK
1803	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs4790694	Toxicity
1804	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	PMCH	rs7973796	Toxicity
1805	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	CYP19A1	rs7176005	Toxicity
1806	pharmgkb	Drug Class	antipsychotics			Schizophrenia	INSIG2	rs17587100	Toxicity
1807	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs11568820	Metabolism/PK
1808	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	GRIA1	rs4958381	Toxicity
1809	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Prostatic Neoplasms	PTGS2	rs12042763	Efficacy
1810	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CHRNA5	rs16969968	Other
1811	pharmgkb	Drug	aripiprazole	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Schizophrenia	TAAR6	rs4305746	Efficacy
1812	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ADORA1	rs16851030	Toxicity
1813	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs12721646	Other
1814	pharmgkb	Drug	triamcinolone	31307.0	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	Retinal Diseases	HCG22	rs3873352	Toxicity
1815	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	DRD2	rs4460839	Efficacy
1816	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		TGFB1	rs1800469	Toxicity
1817	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs7917432	Toxicity
1818	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	OCRL	rs757639	Toxicity
1819	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	CYP1A1	rs2472297	Metabolism/PK
1820	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	IL1A	rs11677416	Efficacy
1821	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	LTC4S	rs730012	Efficacy
1822	pharmgkb	Drug	triamcinolone	31307.0	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	Retinal Diseases	HCG22	rs2523864	Toxicity
1823	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT1A6	rs1105879	Dosage
1824	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Myocardial Infarction	CYP3A5	rs776746	Efficacy
1825	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Hypersensitivity	LTA,TNF	rs1800629	Toxicity
1826	pharmgkb	Drug	leflunomide	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	DHODH	rs3213422	Efficacy
1827	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854547	Efficacy
1828	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854548	Efficacy
1829	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854555	Efficacy
1830	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	Efficacy
1831	pharmgkb	Drug	erythromycin	12560.0	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	Neoplasms	CYP3A4	rs35599367	Other
1832	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs1801131	Efficacy
1833	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	HSPA1L	rs2227956	Toxicity
1834	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	ARG1	rs2781659	Efficacy
1835	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	COMT	rs165599	Efficacy
1836	pharmgkb	Drug	abacavir	441300.0	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N	Drug Hypersensitivity	LST1,LTA,LTB	rs3093726	Toxicity
1837	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders,Depressive Disorder, Major	HTR1B	rs6296	Toxicity
1838	pharmgkb	Drug	latanoprost	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGFR	rs3766355	Efficacy
1839	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	UGT1A4	rs2011425	Metabolism/PK
1840	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	CD69	rs11052877	Efficacy
1841	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	GALNT18	rs4910008	Efficacy
1842	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	CSNK2A3,GALNT18	rs7937567	Efficacy
1843	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	MLLT3	rs10964552	Efficacy
1844	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	RARS	rs244898	Efficacy
1845	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	CYCSP5	rs9469003	Toxicity
1846	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Dosage
1847	pharmgkb	Drug	zafirlukast	5717.0	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC		CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13	Metabolism/PK
1848	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ITIH3	rs2535629	Efficacy
1849	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Hematologic Neoplasms	ADORA2A,ADORA2A-AS1	rs2298383	Toxicity
1850	pharmgkb	Drug	valganciclovir	64147.0	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	Kidney Transplantation	ABCC4	rs11568658	Toxicity
1851	pharmgkb	Drug	valganciclovir	64147.0	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	Kidney Transplantation	ABCB1	rs2229109	Toxicity
1852	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	CYP3A5	rs776746	Metabolism/PK
1853	pharmgkb	Drug	dalcetrapib	6918540.0	CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C	Acute coronary syndrome	ADCY9	rs1967309	Efficacy,Toxicity
1854	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	KDR	rs1870377	Efficacy
1855	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Infection	CYP3A5	rs776746	Toxicity
1856	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GNMT	rs10948059	Toxicity
1857	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC2A2	rs8192675	Efficacy
1858	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	UGT1A9	rs7574296	Toxicity
1859	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	VEGFA	rs3025040	Toxicity
1860	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders		rs17180299	Metabolism/PK
1861	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs1799793	Toxicity
1862	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs50872	Toxicity
1863	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL16	rs7170924	Toxicity
1864	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ABCB1	rs1128503	Toxicity
1865	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL1B	rs12621220	Toxicity
1866	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL1B	rs1143623	Toxicity
1867	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		POR	rs41301394	Dosage
1868	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		DDHD1	rs17126068	Dosage
1869	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NEDD4	rs2288344	Dosage
1870	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		ASPH	rs4379440	Efficacy
1871	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	SLCO1B1	rs2306283	Toxicity
1872	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Thrombocytopenia	SLCO1B1	rs4149056	Toxicity
1873	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Exanthema	ABCC2	rs717620	Toxicity
1874	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	hand-foot syndrome,Hypertension	KDR	rs1870377	Toxicity
1875	pharmgkb	Drug	captopril	44093.0	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Alzheimer Disease	ACE	rs4291	Efficacy
1876	pharmgkb	Drug	raloxifene	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Menopause,Schizophrenia	ESR1	rs11543791	Efficacy
1877	pharmgkb	Drug	raloxifene	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Menopause,Schizophrenia	UGT1A8	rs1042597	Efficacy
1878	pharmgkb	Drug	clindamycin	29029.0	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl		HLA-B	HLA-B*51:01	Toxicity
1879	pharmgkb	Drug	clindamycin	29029.0	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl		HLA-B	HLA-B*15:27	Toxicity
1880	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		B4GALT2	rs1061781	Efficacy
1881	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	rs2108622	Efficacy
1882	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	Efficacy
1883	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs699664	Efficacy
1884	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	Efficacy
1885	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Neoplasms	CYP3A4	rs2740574	Toxicity,Metabolism/PK
1886	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-B	HLA-B*40:02	Toxicity
1887	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-B	HLA-B*15:01	Toxicity
1888	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-DRB1	HLA-DRB1*04:03	Toxicity
1889	pharmgkb	Drug Class	Antibiotics			Hypersensitivity	LGALS3	rs11125	Toxicity
1890	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid,Psoriasis	CD84	rs6427528	Efficacy
1891	pharmgkb	Drug	ustekinumab			Psoriasis	IL12B	rs3213094	Efficacy
1892	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	CUX2	rs7958375	Toxicity
1893	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	RIPOR2	rs10946739	Toxicity
1894	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs320003	Toxicity
1895	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs319952	Toxicity
1896	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs393994	Toxicity
1897	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	CYP3A4	rs35599367	Metabolism/PK
1898	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	NR1I2	rs1523130	Metabolism/PK
1899	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	NR1I2	rs2276707	Metabolism/PK
1900	pharmgkb	Drug Class	hmg coa reductase inhibitors					rs247616	Efficacy
1901	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A4	rs2242480	Metabolism/PK
1902	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A5	rs776746	Dosage,Metabolism/PK
1903	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A5	rs15524	Metabolism/PK
1904	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	rs10517	Dosage
1905	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	STX1B	rs72800847	Dosage
1906	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	CYP1A1	rs3826041	Dosage
1907	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	DNMT3A	rs2304429	Dosage
1908	pharmgkb	Drug	rituximab			Vasculitis		rs3759467	Efficacy
1909	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	SLCO1B1	rs4149056	Efficacy
1910	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	TGFB1	rs1800469	Toxicity
1911	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	TGFBR2	rs3087465	Toxicity
1912	pharmgkb	Drug	zileuton	60490.0	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	Asthma	PRORP	rs12436663	Efficacy
1913	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL23R	rs11209026	Toxicity
1914	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CTLA4	rs3087243	Toxicity
1915	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	SLC12A8	rs651630	Toxicity
1916	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	FBXL19	rs10782001	Toxicity
1917	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs5993883	Efficacy
1918	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs6269	Efficacy
1919	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs4818	Efficacy
1920	pharmgkb	Drug	furosemide	3440.0	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	Heart Failure	ABCC4	rs17268282	Efficacy
1921	pharmgkb	Drug	granisetron	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
1922	pharmgkb	Drug	granisetron	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C		CYP1A1	CYP1A1*1, CYP1A1*2A	Metabolism/PK
1923	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	HLA-DRB1	HLA-DRB1*04:01	Efficacy
1924	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	HLA-B	HLA-B*15:01	Efficacy
1925	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	ABCB1	rs1128503	Toxicity
1926	pharmgkb	Drug	bevacizumab			Breast Neoplasms	EDN1	rs5370	Efficacy
1927	pharmgkb	Drug	bevacizumab			Breast Neoplasms	VEGFA	rs3025039	Efficacy
1928	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		ABCB1	rs1045642	Toxicity
1929	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		GSTM1	GSTM1 non-null, GSTM1 null	Toxicity
1930	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		GSTT1	GSTT1 non-null, GSTT1 null	Toxicity
1931	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	NTRK2	rs1439050	Toxicity
1932	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	GRIK3	rs1334802	Toxicity
1933	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	SLC18A2	rs363341	Toxicity
1934	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	DRD2	rs1124491	Toxicity
1935	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	HTR2A	rs9567733	Toxicity
1936	pharmgkb	Drug	bevacizumab			Colorectal Neoplasms	CXCR4	rs2228014	Efficacy
1937	pharmgkb	Drug	exemestane	60198.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
1938	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	PGLYRP4	rs2916205	Efficacy
1939	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CTNNA2	rs11126740	Efficacy
1940	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	MAP3K1	rs96844	Efficacy
1941	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL12B	rs2546890	Efficacy
1942	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CDKAL1	rs6908425	Efficacy
1943	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	HLA-C	rs12191877	Efficacy
1944	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	ZNF816	rs9304742	Efficacy
1945	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL17RA	rs4819554	Efficacy
1946	pharmgkb	Drug, Biological Intermediate	levodopa	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	DRD2	rs1799732	Toxicity
1947	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:01	Toxicity
1948	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,Epidermal Necrolysis, Toxic,erythema exudativum multiforme,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-A	HLA-A*11:01	Toxicity
1949	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01	Toxicity
1950	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01	Toxicity
1951	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs12083537	Efficacy
1952	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs11265618	Efficacy
1953	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	FOXP3	rs3761548	Toxicity
1954	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Colorectal Neoplasms	ABCC1	rs6498588	Metabolism/PK
1955	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms,Neutropenia	ABCC1	rs17501331	Toxicity
1956	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Colorectal Neoplasms	ABCC1	rs35621	Metabolism/PK
1957	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	ABCC1	rs3743527	Toxicity
1958	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs12041331	Efficacy
1959	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs4661012	Efficacy
1960	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	rs7438135	Metabolism/PK
1961	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Neutropenia		rs149104283	Toxicity
1962	pharmgkb	Drug	dabigatran				ABCB1	rs1045642	Metabolism/PK
1963	pharmgkb	Drug	rivaroxaban	9875401.0			ABCB1	rs1045642	Metabolism/PK
1964	pharmgkb	Drug	dabigatran				ABCB1	rs2032582	Metabolism/PK
1965	pharmgkb	Drug	rivaroxaban	9875401.0			ABCB1	rs2032582	Metabolism/PK
1966	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	POR	rs1057868	Metabolism/PK
1967	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	IL10	rs1800896	Metabolism/PK
1968	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	VASP	rs10995	Efficacy
1969	pharmgkb	Drug	cetuximab			Head and Neck Neoplasms	EGFR	rs2227983	Efficacy
1970	pharmgkb	Drug Class	Platinum compounds			Neoplasms	GSTP1	rs1695	Efficacy
1971	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	ENOSF1	rs2612091	Toxicity
1972	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX1B	rs4889606	Efficacy
1973	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2B6	rs3745274	Metabolism/PK
1974	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	CYP3A5	rs776746	Efficacy
1975	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	ABCB1	rs1128503	Efficacy
1976	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative,Kidney Transplantation	ABCB1	rs2032582	Efficacy
1977	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	ABCB1	rs1045642	Efficacy
1978	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC22A1	rs2282143	Metabolism/PK
1979	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	SLC26A9	rs7512462	Efficacy
1980	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease	P2RY12	rs3732759	Efficacy
1981	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	SLC6A2	rs2242446	Efficacy
1982	pharmgkb	Metabolite	cotinine	854019.0	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	UGT2B10	rs2942857	Metabolism/PK
1983	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR1B	rs9361233	Efficacy
1984	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hyperglycemia,Hypertension	DPYS	rs2669429	Toxicity
1985	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs3217164	Toxicity
1986	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs2244614	Toxicity
1987	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1P1	rs11861118	Toxicity
1988	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1P1	rs7187684	Toxicity
1989	pharmgkb	Drug Class	opioids				FAAH	rs2295632	Toxicity
1990	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs2295632	Toxicity
1991	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs4141964	Toxicity
1992	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs3766246	Toxicity
1993	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,lung transplantation	IL18	rs1946518	Metabolism/PK
1994	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	IL18	rs5744247	Metabolism/PK
1995	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Metabolic Syndrome	C3	rs2277984	Toxicity
1996	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs79663003	Efficacy
1997	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs75222709	Efficacy
1998	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy,Seizures	UGT1A10,UGT1A7,UGT1A8,UGT1A9	rs2741049	Efficacy
1999	pharmgkb	Drug Class	Antihypertensives			Hypertension	CLNK	rs13144136	Efficacy
2000	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	ADRA2A	rs1800544	Efficacy
2001	pharmgkb	Drug	sulfasalazine	5359476.0	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O		ABCG2	rs2231142	Metabolism/PK
2002	pharmgkb	Drug	amisulpride	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Schizophrenia	ANKS1B	rs7968606	Efficacy
2003	pharmgkb	Drug	sulindac	5352.0	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O		FMO3	rs2266782	Metabolism/PK
2004	pharmgkb	Drug	sulindac	5352.0	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O		FMO3	rs2266780	Metabolism/PK
2005	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CTLA4	rs4553808	Metabolism/PK
2006	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	IL3	rs181781	Metabolism/PK
2007	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		PEAR1	rs41273215	Efficacy
2008	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		PEAR1	rs57731889	Efficacy
2009	pharmgkb	Drug	rocuronium	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1A2	rs3834939	Metabolism/PK
2010	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Arthralgia,Breast Neoplasms	ABCB1	rs1045642	Toxicity
2011	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	ABCB1	rs2032582	Metabolism/PK
2012	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CYP19A1	rs727479	Efficacy
2013	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C19	rs4986893	Toxicity
2014	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01	Toxicity
2015	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Ototoxicity	TPMT	TPMT*1, TPMT*3A	Toxicity
2016	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	TPMT	rs1800460	Toxicity
2017	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Carcinoma, Non-Small-Cell Lung	SLC31A1	rs10981694	Toxicity
2018	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	FOXP3	rs3761548	Efficacy
2019	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Asthenia,Neoplasms	UMPS	rs4678145	Toxicity
2020	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity,Neoplasms	SLC22A7	rs2270860	Toxicity
2021	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Diarrhea,Neoplasms	SLC22A7	rs4149178	Toxicity
2022	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Diarrhea,Neoplasms	TYMS	rs2853741	Toxicity
2023	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Hyperbilirubinemia,Neoplasms	CDA	rs1048977	Toxicity
2024	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Hyperbilirubinemia,Neoplasms	DPYD	rs12119882	Toxicity
2025	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Nausea,Vomiting	UMPS	rs2279199	Toxicity
2026	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	ABCB1	rs2032582	Toxicity
2027	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Diabetes Mellitus, Type 2	TBXA2R	rs1131882	Efficacy,Toxicity
2028	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC		CYP3A,CYP3A4	rs2740574	Metabolism/PK
2029	pharmgkb	Drug	gemtuzumab ozogamicin			Leukemia, Myeloid, Acute	CD33	rs35112940	Efficacy
2030	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	rs2189784	Dosage
2031	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F11	rs1060467	Dosage
2032	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	COMT	rs4646316	Toxicity
2033	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	COMT	rs9332377	Toxicity
2034	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms,nephrotoxicity	COMT	rs4646316	Toxicity
2035	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms,nephrotoxicity	COMT	rs9332377	Toxicity
2036	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	ABCB1	rs2032582	Toxicity
2037	pharmgkb	Drug Class	Beta Blocking Agents			major adverse cardiac events (mace)	ADRB1	rs1801252	Toxicity
2038	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT1A6	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	Dosage
2039	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	rs766023281	Dosage,Toxicity
2040	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	rs746071566	Dosage,Toxicity
2041	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Epidermal Necrolysis, Toxic,HIV Infections,Stevens-Johnson Syndrome	GSTM1	GSTM1 non-null, GSTM1 null	Toxicity
2042	pharmgkb	Drug	heparin	772.0	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	heparin-induced thrombocytopenia	HLA-DRB3	HLA-DRB3*01:01	Toxicity
2043	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Lymphopenia	ABCB1	rs2032582	Toxicity
2044	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,mucositis	ABCB1	rs1045642	Toxicity
2045	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	discontinuation	FGFR4	rs351855	Efficacy
2046	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Hyperglycemia,Leukopenia	PIK3R1	rs10515074	Toxicity
2047	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders,Depressive Disorder	COMT	rs4680	Efficacy
2048	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	TPMT	TPMT*1, TPMT*3B, TPMT*3C	Efficacy
2049	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	C6	rs9200	Metabolism/PK
2050	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	C6	rs10052999	Metabolism/PK
2051	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCG2	rs2231142	Metabolism/PK
2052	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs28399504	Metabolism/PK
2053	pharmgkb	Drug	dolutegravir	54726191.0	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	HIV Infections	ABCG2	rs2231142	Metabolism/PK
2054	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Bipolar Disorder,Psychotic Disorders	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Dosage,Metabolism/PK
2055	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs35303484	Metabolism/PK
2056	pharmgkb	Drug Class	hormonal contraceptives for systemic use			Stroke,Venous Thrombosis	F2	rs1799963	Toxicity
2057	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease,Diabetes Mellitus,Hypercholesterolemia	SLCO1B1	rs2306283	Toxicity
2058	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	NAT2	rs1799929	Toxicity
2059	pharmgkb	Drug	oseltamivir	65028.0	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC		CES1	rs200707504	Metabolism/PK
2060	pharmgkb	Drug Class	hormonal contraceptives for systemic use				F11	rs2289252	Toxicity
2061	pharmgkb	Drug Class	hormonal contraceptives for systemic use				KNG1	rs710446	Toxicity
2062	pharmgkb	Drug	glatiramer acetate	3081884.0	C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N			rs12459996	Toxicity
2063	pharmgkb	Drug	glatiramer acetate	3081884.0	C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N			rs1056854	Toxicity
2064	pharmgkb	Drug	glatiramer acetate	3081884.0	C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N			rs75041078	Toxicity
2065	pharmgkb	Drug Class	hormonal contraceptives for systemic use				SUGCT	rs4379368	Toxicity
2066	pharmgkb	Drug Class	hormonal contraceptives for systemic use				ABO	rs56392308	Toxicity
2067	pharmgkb	Drug Class	hormonal contraceptives for systemic use				ABO	rs8176719	Toxicity
2068	pharmgkb	Drug Class	hormonal contraceptives for systemic use				CYP2C9	rs1799853	Toxicity
2069	pharmgkb	Drug	ethanol	702.0	CCO		SLC6A3	rs6350	Toxicity
2070	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CDH2	rs8094439	Efficacy
2071	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CDH2	rs17446819	Efficacy
2072	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid	STAT4	rs7574865	Efficacy
2073	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid	PSORS1C1	rs2233945	Efficacy
2074	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2			rs12459249	Metabolism/PK
2075	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	FOXF2	rs199564443	Toxicity
2076	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	rs1071816	Toxicity
2077	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	EHMT2	rs652888	Toxicity
2078	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	HLA-B*08:01	Toxicity
2079	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	HLA-B*27:05	Toxicity
2080	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		ABCB1	rs1128503	Efficacy
2081	pharmgkb	Drug	isoniazid	3767.0	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	BACH1	rs2070401	Toxicity
2082	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O		ADRB2	rs1800888	Other
2083	pharmgkb	Drug	isoniazid	3767.0	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	XPO1	rs11125883	Toxicity
2084	pharmgkb	Drug	isoniazid	3767.0	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	MAFK	rs4720833	Toxicity
2085	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Myocardial Infarction	ABCB1	rs1045642	Efficacy,Toxicity,Metabolism/PK
2086	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome	CES1	rs2307240	Efficacy
2087	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9	rs28898617	Metabolism/PK
2088	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	UGT2B7	rs7439366	Efficacy
2089	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs2838958	Efficacy
2090	pharmgkb	Drug	lumefantrine	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A5	rs10264272	Metabolism/PK
2091	pharmgkb	Drug	lumefantrine	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A,CYP3A5,ZSCAN25	rs776746	Metabolism/PK
2092	pharmgkb	Drug	lumefantrine	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A4	rs2740574	Efficacy,Metabolism/PK
2093	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1L1	rs4072879	Dosage
2094	pharmgkb	Drug	midazolam	4192.0	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
2095	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	rs2279343	Efficacy
2096	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCB1	rs1045642	Efficacy
2097	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCB1	rs1128503	Efficacy
2098	pharmgkb	Drug Class	Thiazides, plain			Hypernatremia,Hypertension	SLCO2A1	rs34550074	Toxicity
2099	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs324899	Efficacy
2100	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs6942227	Efficacy
2101	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs1611259	Efficacy
2102	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	EPHX2	rs59724122	Efficacy
2103	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	GRAMD1B	rs61123830	Efficacy
2104	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	MYO1H	rs7959663	Efficacy
2105	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs66486766	Efficacy
2106	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs7405404	Efficacy
2107	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	FAM178B	rs6728642	Efficacy
2108	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	ZNF804A	rs62200793	Efficacy
2109	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs7588746	Efficacy
2110	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs3919583	Efficacy
2111	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs1611255	Efficacy
2112	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs209474	Efficacy
2113	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	ADCY1	rs1521470	Efficacy
2114	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	FAM177A1	rs79403677	Efficacy
2115	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,gastrointestinal toxicity,Hematologic Diseases,Leukopenia	XPC	rs2228000	Toxicity
2116	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Toxicity
2117	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	SLC47A1	rs2252281	Efficacy
2118	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC47A2	rs12943590	Metabolism/PK
2119	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	SLC47A1	rs2289669	Efficacy
2120	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC47A2	rs12943590	Efficacy
2121	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC		CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	Metabolism/PK
2122	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Asthenia,Nausea,Neoplasms,Vomiting	TYMS	rs699517	Toxicity
2123	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Gastrointestinal Stromal Tumors	POR	rs1057868	Efficacy
2124	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Gastrointestinal Stromal Tumors	SLCO1B3	rs4149117	Efficacy
2125	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	BCHE	rs1803274	Other
2126	pharmgkb	Drug	ustekinumab			Psoriasis	TIRAP	rs8177374	Efficacy
2127	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases,Psoriasis	TLR2	rs11938228	Efficacy
2128	pharmgkb	Drug	ustekinumab			Psoriasis	TLR5	rs5744174	Efficacy
2129	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	TLR9	rs352139	Efficacy
2130	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	TLR2	rs4696480	Efficacy
2131	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	LY96	rs11465996	Efficacy
2132	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
2133	pharmgkb	Drug	ritodrine	33572.0	C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O	adverse events,Premature Birth	CACNA1C	rs10774053	Toxicity
2134	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Exanthema	HLA-B	HLA-B*35:05	Toxicity
2135	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:10	Toxicity
2136	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*51:01	Toxicity
2137	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*51:02	Toxicity
2138	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*54:01	Toxicity
2139	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*55:01	Toxicity
2140	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*55:02	Toxicity
2141	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:01	Toxicity
2142	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:06	Toxicity
2143	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2236196	Other
2144	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs55781567	Toxicity
2145	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*78:01	Toxicity
2146	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:02	Toxicity
2147	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:01	Toxicity
2148	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:05	Toxicity
2149	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:06	Toxicity
2150	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:09	Toxicity
2151	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:12	Toxicity
2152	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:24	Toxicity
2153	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:25	Toxicity
2154	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:27	Toxicity
2155	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:32	Toxicity
2156	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:35	Toxicity
2157	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*52:01	Toxicity
2158	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*35:10	Toxicity
2159	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:03	Toxicity
2160	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*01:02	Toxicity
2161	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*10:01	Toxicity
2162	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*08:01	Toxicity
2163	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*04:04	Toxicity
2164	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*01:03	Toxicity
2165	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:06	Toxicity
2166	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:07	Toxicity
2167	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*05:01	Toxicity
2168	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*05:09	Toxicity
2169	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*18:01	Toxicity
2170	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	rs1128503	Toxicity
2171	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCG2	rs13120400	Efficacy,Metabolism/PK
2172	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs145489027	Toxicity
2173	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs1495509	Toxicity
2174	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell,Neutropenia	ABCB1	rs2032582	Toxicity
2175	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	rs2032582	Efficacy
2176	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	Acquired Immunodeficiency Syndrome,HIV Infections,nephrolithiasis	NR1I2	rs2472677	Metabolism/PK
2177	pharmgkb	Drug	bevacizumab			Breast Neoplasms,Colorectal Neoplasms	VEGFA	rs3025039	Efficacy
2178	pharmgkb	Drug	pazopanib	11525740.0		Kidney Neoplasms	KDR	rs34231037	Efficacy,Metabolism/PK
2179	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs78015114	Efficacy
2180	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder		rs74795342	Efficacy
2181	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A3	rs3806596	Efficacy,Metabolism/PK
2182	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DBH	rs1611131	Toxicity
2183	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs4646	Other
2184	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	liver transplantation	CYP3A5	rs776746	Dosage,Metabolism/PK
2185	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XRCC3	rs861539	Efficacy
2186	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs529520	Efficacy
2187	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5		CYP2C9	rs1799853	Efficacy
2188	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism,Death	DRD2	rs1800497	Toxicity
2189	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	NOTCH4	rs367398	Toxicity
2190	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	FMO3	rs2266780	Metabolism/PK
2191	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs927650	Metabolism/PK
2192	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs2585428	Metabolism/PK
2193	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs2248359	Metabolism/PK
2194	pharmgkb	Drug	aripiprazole	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Schizophrenia	DRD2	rs6277	Efficacy
2195	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				IL10	rs1800896	Toxicity
2196	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				CTLA4	rs231775	Toxicity
2197	pharmgkb	Drug	ketorolac	3826.0	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O			rs2562456	Efficacy
2198	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	rs1128503	Metabolism/PK
2199	pharmgkb	Drug Class	corticosteroids			Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCL2L11	rs724710	Toxicity
2200	pharmgkb	Drug Class	corticosteroids			Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCL2L11	rs2241843	Toxicity
2201	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		CYP1A2	rs2069514	Metabolism/PK
2202	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		CYP1A2	rs762551	Metabolism/PK
2203	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GATA4	rs2645400	Dosage
2204	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GATA4	rs4841588	Dosage
2205	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs11168292	Dosage
2206	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs11168293	Dosage
2207	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs4760658	Dosage
2208	pharmgkb	Drug	sildenafil	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Heart Failure	CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
2209	pharmgkb	Drug	somatropin recombinant			Turner Syndrome	CDK4	rs2069502	Other
2210	pharmgkb	Drug	somatropin recombinant				CDK4	rs2270777	Other
2211	pharmgkb	Drug	idarubicin	42890.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	NCF4	rs1883112	Efficacy
2212	pharmgkb	Drug	idarubicin	42890.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	RAC2	rs13058338	Efficacy
2213	pharmgkb	Drug Class	Drugs Used In Diabetes			Diabetes Mellitus, Type 2	IRS1	rs1801278	Efficacy
2214	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A1	rs683369	Toxicity
2215	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs274558	Toxicity
2216	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	EGFR	rs10258429	Toxicity
2217	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCB1	rs2235040	Toxicity
2218	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs2242446	Other
2219	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs36029	Other
2220	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs1861647	Other
2221	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCG2	rs2231142	Toxicity
2222	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N		SLC22A1	rs12208357	Metabolism/PK
2223	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	POR	rs1057868	Metabolism/PK
2224	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Organ Transplantation	CYP3A4	rs35599367	Other
2225	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	SUMO4	rs237025	Metabolism/PK
2226	pharmgkb	Drug	omeprazole	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux	ABCB1	rs1045642	Efficacy,Metabolism/PK
2227	pharmgkb	Drug	dapoxetine	71353.0	CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
2228	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	TLR4	rs1927907	Other
2229	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	PSORS1C1	rs3131003	Toxicity
2230	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs408626	Efficacy,Toxicity
2231	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs442767	Toxicity
2232	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs4803381	Metabolism/PK
2233	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	rs56113850	Metabolism/PK
2234	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SP1	rs784888	Efficacy,Metabolism/PK
2235	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	AMHR2	rs784892	Efficacy,Metabolism/PK
2236	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRL1,RGS19	rs6090041	Toxicity
2237	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	LKAAEAR1,OPRL1	rs6090043	Toxicity
2238	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	CDA	rs2072671	Toxicity
2239	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PEBP4	rs17685420	Efficacy
2240	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZDHHC7	rs3210967	Efficacy
2241	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF134	rs10413455	Efficacy
2242	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARSA	rs2071421	Efficacy
2243	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SPSB2	rs12302749	Efficacy
2244	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF211	rs10420097	Efficacy
2245	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CORO7	rs3810818	Efficacy
2246	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	FXR2	rs9901675	Efficacy
2247	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF565	rs4805162	Efficacy
2248	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ELP5	rs4562	Efficacy
2249	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CDH23	rs17712523	Efficacy
2250	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARHGAP12	rs2799018	Efficacy
2251	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PIGM	rs12409352	Efficacy
2252	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CHURC1	rs4902333	Efficacy
2253	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	TRIB3	rs2295490	Efficacy
2254	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CMTM8	rs4627790	Efficacy
2255	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PDIA2	rs1048786	Efficacy
2256	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	OPCML	rs751655	Efficacy
2257	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ETFDH	rs11559290	Efficacy
2258	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	NFIB	rs7858	Efficacy
2259	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARHGEF28	rs929740	Efficacy
2260	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SENP3	rs11552708	Efficacy
2261	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ESYT2	rs1061735	Efficacy
2262	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	RRP7A	rs11553441	Efficacy
2263	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	HTT	rs362272	Efficacy
2264	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	FARP2	rs757978	Efficacy
2265	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	GGH	rs17279558	Efficacy
2266	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity		rs3761372	Efficacy
2267	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PURA	rs2013169	Efficacy
2268	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs6700741	Efficacy
2269	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	NRXN1	rs4971678	Efficacy
2270	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9873889	Efficacy
2271	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9879065	Efficacy
2272	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs4437856	Efficacy
2273	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs2419128	Efficacy
2274	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs12094644	Efficacy
2275	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9310658	Efficacy
2276	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs7616119	Efficacy
2277	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs7653345	Efficacy
2278	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9819548	Efficacy
2279	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs13093500	Efficacy
2280	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs12630569	Efficacy
2281	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9824595	Efficacy
2282	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs4334661	Efficacy
2283	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs7625956	Efficacy
2284	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs4858478	Efficacy
2285	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs12502866	Efficacy
2286	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs61692318	Efficacy
2287	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs10007051	Efficacy
2288	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs11933890	Efficacy
2289	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs62319299	Efficacy
2290	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs56229625	Efficacy
2291	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs55881666	Efficacy
2292	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TTC37	rs12657120	Efficacy
2293	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TTC37	rs4639250	Efficacy
2294	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TREML4	rs13204353	Efficacy
2295	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	INVS	rs10123866	Efficacy
2296	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs7472	Efficacy
2297	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs10124893	Efficacy
2298	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs6479008	Efficacy
2299	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs10989064	Efficacy
2300	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	FCN2	rs3124955	Efficacy
2301	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	FCN2	rs3128624	Efficacy
2302	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908402	Efficacy
2303	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908403	Efficacy
2304	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908404	Efficacy
2305	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908405	Efficacy
2306	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724452	Efficacy
2307	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724464	Efficacy
2308	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786394	Efficacy
2309	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786400	Efficacy
2310	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908406	Efficacy
2311	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786412	Efficacy
2312	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908407	Efficacy
2313	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908408	Efficacy
2314	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908409	Efficacy
2315	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908410	Efficacy
2316	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs78482393	Efficacy
2317	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs78615940	Efficacy
2318	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724494	Efficacy
2319	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908411	Efficacy
2320	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs7316769	Efficacy
2321	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs7306991	Efficacy
2322	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs10771997	Efficacy
2323	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs10771998	Efficacy
2324	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs10771999	Efficacy
2325	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ATP10A	rs12595802	Efficacy
2326	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	rs3889402	Efficacy
2327	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	rs12603700	Efficacy
2328	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	rs56355515	Efficacy
2329	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs58042962	Efficacy
2330	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major		rs2933304	Efficacy
2331	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9310657	Efficacy
2332	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TREML4	rs9369266	Efficacy
2333	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs7035619	Efficacy
2334	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	rs7668258	Metabolism/PK
2335	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	rs12233719	Metabolism/PK
2336	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Hemorrhage,Myocardial Infarction	CYP2C19	rs11568732	Toxicity
2337	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		AGTR1	rs5186	Metabolism/PK
2338	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		BDKRB2	rs1799722	Metabolism/PK
2339	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Colonic Neoplasms	UGT1A6	rs1105879	Efficacy
2340	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Colonic Neoplasms	UGT1A6	rs2070959	Efficacy
2341	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	ABCC2	rs717620	Efficacy
2342	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:07	Toxicity
2343	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema	HLA-A	HLA-A*33:03	Toxicity
2344	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	drug reaction with eosinophilia and systemic symptoms,Stevens-Johnson Syndrome	PSORS1C1	rs9263726	Toxicity
2345	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	drug reaction with eosinophilia and systemic symptoms,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	CYCSP5	rs3099844	Toxicity
2346	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	drug reaction with eosinophilia and systemic symptoms,Stevens-Johnson Syndrome		rs2734583	Toxicity
2347	pharmgkb	Drug	granisetron	3510.0	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C	Neoplasms	ABCB1	rs1045642	Efficacy
2348	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	rs8192709	Metabolism/PK
2349	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	rs3211371	Metabolism/PK
2350	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	SOD2	rs5746136	Toxicity
2351	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP3A7	CYP3A7*1A, CYP3A7*1C	Metabolism/PK
2352	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2J2	rs890293	Toxicity
2353	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCC2	rs3740066	Metabolism/PK
2354	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C8	CYP2C8*1, CYP2C8*3	Metabolism/PK
2355	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C8	CYP2C8*1, CYP2C8*3	Toxicity
2356	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	PPARA	rs4253728	Toxicity
2357	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CALU	rs1043550	Dosage
2358	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7294	Other
2359	pharmgkb	Drug Class	antineoplastic agents			Neoplasms	ABCB1	rs1045642	Toxicity
2360	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms,Neutropenia	ABCB1	rs12720066	Toxicity
2361	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508453	Efficacy
2362	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	rs9282564	Metabolism/PK
2363	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	UGT2B7	rs7439366	Efficacy
2364	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease,Hemorrhage	ABCB1	rs1045642	Toxicity
2365	pharmgkb	Drug	apixaban	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	Atrial Fibrillation	ABCG2	rs2231142	Metabolism/PK
2366	pharmgkb	Drug	apixaban	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	Atrial Fibrillation	CYP3A5	rs776746	Metabolism/PK
2367	pharmgkb	Drug Class	Vitamin K				CYP4F2	rs2108622	Metabolism/PK
2368	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	KLB	rs11940694	Dosage
2369	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Anemia, Sickle Cell	UGT2B7	rs7668282	Metabolism/PK
2370	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	insomnia	CYP1A2	rs762551	Toxicity
2371	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	CPA6	rs2162145	Efficacy
2372	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	NBEA	rs57081354	Efficacy
2373	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	PRPF31	rs254271	Efficacy
2374	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
2375	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Leukopenia,Neoplasms		rs12046844	Toxicity
2376	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	rs1142345	Dosage,Toxicity
2377	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	rs4149056	Efficacy
2378	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs3734704	Toxicity
2379	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs6929249	Toxicity
2380	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs834576	Toxicity
2381	pharmgkb	Drug	bevacizumab			Hypertension	PRKCA	rs9381299	Toxicity
2382	pharmgkb	Drug	donepezil	3152.0	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease,cognitive dysfunction	BCHE	rs1803274	Efficacy
2383	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	ABCG2	rs2231142	Efficacy,Toxicity
2384	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	POLR2A	rs2228130	Toxicity
2385	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Psoriasis	ABCC1	rs35592	Efficacy
2386	pharmgkb	Drug	oxazepam	4616.0	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O			rs1976391	Metabolism/PK
2387	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia		rs887829	Metabolism/PK
2388	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	UGT1A1	rs887829	Dosage
2389	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Drug Toxicity	CYP2C9	rs544027339	Toxicity
2390	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Drug Toxicity	CYP2C9	rs1029359343	Toxicity
2391	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-A	HLA-A*24:02	Toxicity
2392	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension		rs11065987	Efficacy
2393	pharmgkb	Drug Class	Platinum compounds			overall survival,Thrombocytopenia	SLC31A1	rs4979223	Efficacy,Toxicity
2394	pharmgkb	Drug Class	Platinum compounds			Thrombocytopenia	SLC31A1	rs4978536	Toxicity
2395	pharmgkb	Drug Class	Platinum compounds			Drug Toxicity,overall survival	SLC31A1	rs2233914	Efficacy,Toxicity
2396	pharmgkb	Drug Class	Platinum compounds			Anemia,Leukopenia,Nausea,Neutropenia,Thrombocytopenia,Vomiting	SLC31A1	rs10817464	Toxicity
2397	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs188052243	Other
2398	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1335150891	Other
2399	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs748620513	Other
2400	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1184321568	Other
2401	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs143879757	Other
2402	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1212037891	Other
2403	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	MTHFR	rs1801133	Efficacy
2404	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	UGT1A3	rs7604115	Metabolism/PK
2405	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	UGT1A3	UGT1A3*1, UGT1A3*2	Metabolism/PK
2406	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ABCC9	rs704212	Metabolism/PK
2407	pharmgkb	Drug	montelukast	5281040.0	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4	Metabolism/PK
2408	pharmgkb	Drug Class	HMG CoA reductase inhibitors, other combinations			Cardiovascular Diseases,Rhabdomyolysis	EYS	rs9342288	Toxicity
2409	pharmgkb	Drug Class	hmg coa reductase inhibitors			Rhabdomyolysis	EYS	rs1337512	Toxicity
2410	pharmgkb	Drug Class	hmg coa reductase inhibitors			Rhabdomyolysis	EYS	rs3857532	Toxicity
2411	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs767263838	Metabolism/PK
2412	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs767263838	Metabolism/PK
2413	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs767263838	Metabolism/PK
2414	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3,SULT1A4	rs757573592	Metabolism/PK
2415	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3,SULT1A4	rs757573592	Metabolism/PK
2416	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs757573592	Metabolism/PK
2417	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs776817009	Metabolism/PK
2418	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs776817009	Metabolism/PK
2419	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs762151655	Metabolism/PK
2420	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs762151655	Metabolism/PK
2421	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs762151655	Metabolism/PK
2422	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs750575779	Metabolism/PK
2423	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs750575779	Metabolism/PK
2424	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs553050853	Metabolism/PK
2425	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs553050853	Metabolism/PK
2426	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs553050853	Metabolism/PK
2427	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs751527244	Metabolism/PK
2428	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs751527244	Metabolism/PK
2429	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs751527244	Metabolism/PK
2430	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs1293732453	Metabolism/PK
2431	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs1293732453	Metabolism/PK
2432	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs1293732453	Metabolism/PK
2433	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	rs1328799050	Metabolism/PK
2434	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	rs1328799050	Metabolism/PK
2435	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	rs1328799050	Metabolism/PK
2436	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	ABCB1	rs1045642	Efficacy,Metabolism/PK
2437	pharmgkb	Drug	levetiracetam	441341.0	CC[C@H](C(=O)N)N1CCCC1=O	adverse events,Epilepsy	HLA-A	HLA-A*11:01	Toxicity
2438	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	ANKK1	rs1800497	Efficacy
2439	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Hypertension	ABCB1	rs1045642	Efficacy
2440	pharmgkb	Drug	pioglitazone	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3		CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3	Other
2441	pharmgkb	Drug	etanercept			Spondylitis, Ankylosing	TNFRSF1B	rs1061622	Efficacy
2442	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	rs4587017	Efficacy
2443	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	rs10028494	Efficacy
2444	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	rs1045642	Toxicity
2445	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	rs2032582	Toxicity
2446	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	rs1128503	Toxicity
2447	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ATF2	rs7583431	Efficacy
2448	pharmgkb	Drug Class	opioids			Pain, Postoperative	IL17A	rs2275913	Dosage
2449	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative		rs13093031	Efficacy
2450	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative		rs6961071	Efficacy
2451	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Neoplasms,Pain	ABCB1	rs2032582	Toxicity
2452	pharmgkb	Drug	acetylcysteine	12035.0	CC(=O)N[C@@H](CS)C(=O)O	Pulmonary Fibrosis	TOLLIP	rs3750920	Efficacy
2453	pharmgkb	Drug	cangrelor	9854012.0	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F		P2RY12	rs6787801	Efficacy
2454	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema	HLA-B	HLA-B*44:03	Toxicity
2455	pharmgkb	Drug	stavudine	18283.0	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	HIV Infections,Peripheral Nervous System Diseases	SAMHD1	rs8124728	Toxicity
2456	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A5	rs15524	Metabolism/PK
2457	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A5,ZSCAN25	rs4646450	Metabolism/PK
2458	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Toxicity
2459	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	KIF6	rs20455	Efficacy
2460	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia	KIF6	rs20455	Efficacy
2461	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,lung transplantation	ABCB1	rs9282564	Metabolism/PK
2462	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	rs2229109	Efficacy
2463	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	NR1I2	rs2276707	Metabolism/PK
2464	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC		NR1I2	rs3814055	Metabolism/PK
2465	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma		rs10511905	Efficacy
2466	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	RASSF1	rs2236947	Efficacy
2467	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs4261893	Efficacy
2468	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	KMT2E	rs117986340	Efficacy
2469	pharmgkb	Drug	duloxetine	60835.0	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	NCAM1	rs2303377	Efficacy
2470	pharmgkb	Drug	phenazepam	40113.0	C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl	Alcoholism	CYP2C19	rs12248560	Efficacy
2471	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	CYP3A5	rs17161788	Efficacy
2472	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		ABCB1	rs1045642	Toxicity
2473	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL6	rs1800795	Efficacy
2474	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs2372536	Efficacy
2475	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ITPA	rs1127354	Efficacy,Toxicity
2476	pharmgkb	Drug	cetuximab			Colorectal Neoplasms,Head and Neck Neoplasms	FCGR2A	rs1801274	Efficacy
2477	pharmgkb	Drug	cetuximab			Neoplasms	FCGR3A	rs396991	Efficacy
2478	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	MDM2	rs1690924	Efficacy
2479	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XRCC1	rs1799782	Efficacy
2480	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	SLC19A1	rs1051266	Efficacy
2481	pharmgkb	Drug	oxaliplatin	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	PIN1	rs2233678	Efficacy
2482	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	PIN1	rs2233678	Efficacy
2483	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	rs701829	Toxicity
2484	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	rs201929247	Toxicity
2485	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	rs17211071	Toxicity
2486	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*15:01, HLA-DRB1*16:02	Toxicity
2487	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-A	HLA-A*24:02	Toxicity
2488	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs10929302	Toxicity
2489	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs1976391	Toxicity
2490	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs887829	Toxicity
2491	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	NEDD4L	rs4149601	Efficacy
2492	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms,Colorectal Neoplasms,Neoplasms,Rectal Neoplasms,Uterine Cervical Neoplasms	XRCC1	rs25487	Efficacy
2493	pharmgkb	Drug	clonidine	2803.0	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	Liver Cirrhosis	ADRA2C	rs11269124	Efficacy
2494	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs144854329	Efficacy
2495	pharmgkb	Drug	thioridazine	5452.0	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC		CYP2D6	rs1080985	Other
2496	pharmgkb	Drug Class	antipsychotics			Dystonia	CYP2D6	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14	Toxicity
2497	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	MMP3	rs35068180	Efficacy
2498	pharmgkb	Drug	ceftriaxone	5479530.0	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	Central Nervous System Infections	ABCG2	rs13120400	Metabolism/PK
2499	pharmgkb	Drug	ceftriaxone	5479530.0	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	Central Nervous System Infections	ABCC2	rs2273697	Metabolism/PK
2500	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9	rs4148324	Metabolism/PK
2501	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs12505410	Metabolism/PK
2502	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs13120400	Metabolism/PK
2503	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs13137622	Metabolism/PK
2504	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism,Substance-Related Disorders	DRD2	rs1800497	Toxicity
2505	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Acquired Immunodeficiency Syndrome	CYCSP5	rs3099844	Toxicity
2506	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C		CYP3A5	rs776746	Other
2507	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	ABCB1	rs2032582	Efficacy
2508	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	ABCB1	rs1128503	Efficacy
2509	pharmgkb	Drug	acamprosate	71158.0	CC(=O)NCCCS(=O)(=O)O	Alcoholism	GRIN2B	rs2058878	Efficacy
2510	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	FCGR3A	rs396991	Efficacy
2511	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	FCGR2A	rs1801274	Efficacy
2512	pharmgkb	Drug	maraviroc	3002977.0	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	HIV Infections	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	Efficacy,Metabolism/PK
2513	pharmgkb	Drug, Biological Intermediate	levodopa	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	SLC6A3	rs3836790	Efficacy
2514	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRM1	rs3192723	Efficacy
2515	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	IL1B	rs1143634	Dosage,Efficacy
2516	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	IL1B	rs1143634	Dosage,Efficacy
2517	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	UGT2A1	rs11249454	Toxicity
2518	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCB4	rs1202283	Efficacy
2519	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCC2	rs2273697	Efficacy
2520	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CHST1	rs9787901	Toxicity
2521	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	NQO1	rs10517	Efficacy
2522	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CYP2F1	rs305968	Toxicity
2523	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC19A1	rs12659	Toxicity
2524	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC19A1	rs1051266	Toxicity
2525	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	CDA	rs471760	Toxicity
2526	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	SLC28A1	rs3825876	Toxicity
2527	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	SLC28A1	rs12148896	Toxicity
2528	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	KCNJ6	rs6517442	Efficacy
2529	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Pain	TRPV1	rs224534	Efficacy
2530	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Pain	UGT2B15	rs1902023	Efficacy
2531	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ABCB1	rs2032582	Toxicity
2532	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	TH	rs2070762	Efficacy
2533	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	DRD2	rs2283265	Toxicity
2534	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	rs1045642	Metabolism/PK
2535	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	rs2032582	Metabolism/PK
2536	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		NTNG1	rs61816456	Efficacy
2537	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		GREM2	rs77567654	Efficacy
2538	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		GREM2	rs10802887	Efficacy
2539	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		GREM2	rs1934341	Efficacy
2540	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		GREM2	rs4659982	Efficacy
2541	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		MYT1L	rs79663562	Efficacy
2542	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		TRIB2	rs10193126	Efficacy
2543	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		TBL1XR1	rs57449396	Efficacy
2544	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		PKD2	rs2725215	Efficacy
2545	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs4148157	Efficacy
2546	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs76979899	Efficacy
2547	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs4148155	Efficacy
2548	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		HLA-C	rs9366772	Efficacy
2549	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TAOK3	rs795484	Dosage,Efficacy
2550	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TAOK3	rs1277441	Dosage,Efficacy
2551	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Diabetes Mellitus, Type 2	KCNJ11	rs5219	Toxicity
2552	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Maculopapular Exanthema	CFHR4	rs78239784	Toxicity
2553	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs28386840	Efficacy
2554	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	TCF7L2	rs290487	Toxicity
2555	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*57:01	Toxicity
2556	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	ABCC8,KCNJ11	rs757110	Efficacy
2557	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs2075572	Toxicity
2558	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	rs4680	Toxicity
2559	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs9479757	Dosage
2560	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD2	rs1800497	Toxicity
2561	pharmgkb	Drug	sibutramine	5210.0	CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C	Obesity	GNB3	rs5443	Efficacy
2562	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	OPRM1	rs2075572	Toxicity
2563	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs511435	Toxicity
2564	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs524731	Toxicity
2565	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs524731	Toxicity
2566	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs3823010	Toxicity
2567	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs3823010	Toxicity
2568	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs3778156	Toxicity
2569	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs3778156	Toxicity
2570	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs609148	Toxicity
2571	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs495491	Toxicity
2572	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs548646	Toxicity
2573	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs648893	Toxicity
2574	pharmgkb	Drug	disopyramide	3114.0	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C	short qt syndrome 1	KCNH2	rs104894021	Efficacy
2575	pharmgkb	Drug	quinidine	441074.0	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	short qt syndrome 1	KCNH2	rs104894021	Efficacy
2576	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CYP2E1	rs2031920	Toxicity
2577	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CHRNA4	rs1044394	Toxicity
2578	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	rs1799971	Efficacy
2579	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	CYP2B6*1, CYP2B6*6	Efficacy
2580	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRK1	rs1051660	Toxicity
2581	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2B6	rs2279343	Metabolism/PK
2582	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs553202	Efficacy
2583	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs524731	Efficacy
2584	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs548646	Efficacy
2585	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs648007	Efficacy
2586	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs3778148	Efficacy
2587	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs1461773	Efficacy
2588	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs2075572	Efficacy
2589	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs681243	Efficacy
2590	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GAL	rs694066	Toxicity
2591	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	HTR3B	rs3758987	Toxicity
2592	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRK1	rs6473797	Toxicity
2593	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	CSNK1E	rs1534891	Toxicity
2594	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		DRD2	rs6277	Efficacy
2595	pharmgkb	Drug	nimodipine	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
2596	pharmgkb	Drug	nimodipine	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CACNA1C	rs2239128	Efficacy
2597	pharmgkb	Drug	dextropropoxyphene	441275.0			CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
2598	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA7	rs2337980	Efficacy
2599	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CRHBP	rs10055255	Toxicity
2600	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
2601	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ANKK1,DRD2	rs1800497	Toxicity
2602	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A13	rs1709083	Toxicity
2603	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A13	rs72552266	Toxicity
2604	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	rs28399433	Toxicity
2605	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2B6	CYP2B6*1, CYP2B6*4	Toxicity
2606	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HTR3B	rs3758987	Toxicity
2607	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HTR3B	rs11606194	Toxicity
2608	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	rs8109525	Efficacy
2609	pharmgkb	Drug	varenicline	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	HYKK	rs7164594	Efficacy
2610	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	BDNF	rs6265	Toxicity
2611	pharmgkb	Drug	modafinil	4236.0	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	methamphetamine dependence	COMT	rs4680	Efficacy
2612	pharmgkb	Drug Class	highly active antiretroviral therapy (haart)			HIV Infections	OPRM1	rs671531	Efficacy
2613	pharmgkb	Drug	ethanol	702.0	CCO		DRD2	rs1800497	Dosage
2614	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs2236256	Toxicity
2615	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	GABRA2	rs11503014	Toxicity
2616	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	ACE	rs8075924	Efficacy
2617	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	HTR2A	rs2770296	Efficacy
2618	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	DBH	rs2873804	Efficacy
2619	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SLC18A2	rs363225	Efficacy
2620	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SLC18A2	rs363226	Efficacy
2621	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	FKBP5	rs17614642	Efficacy
2622	pharmgkb	Drug	pitavastatin	5282452.0			ABCC2	rs717620	Metabolism/PK
2623	pharmgkb	Drug	pioglitazone	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus, Type 2	PPARG	rs1801282	Efficacy
2624	pharmgkb	Drug	pioglitazone	4829.0	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus, Type 2	PTPRD	rs17584499	Efficacy
2625	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	PPA2	rs2636697	Efficacy
2626	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs813676	Efficacy
2627	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	ATP1A2	rs6688363	Efficacy
2628	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia		rs8050896	Efficacy
2629	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	SPOPL	rs10170310	Efficacy
2630	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TNFRSF11A	rs2980976	Efficacy
2631	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	PDE4D	rs17382202	Efficacy
2632	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	MIR582,PDE4D	rs17742120	Efficacy
2633	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs711355	Efficacy
2634	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs785423	Efficacy
2635	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia		rs7395555	Efficacy
2636	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	PPA2	rs2636719	Efficacy
2637	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	pneumonitis,progression-free survival	RPTOR	rs9906827	Efficacy,Toxicity
2638	pharmgkb	Drug	prochlorperazine	4917.0	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	Nausea	ANKK1,DRD2	rs1800497	Efficacy
2639	pharmgkb	Drug	prochlorperazine	4917.0	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	Nausea	DRD2	rs1079597	Efficacy
2640	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs6090378	Toxicity
2641	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs3787138	Toxicity
2642	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs3787140	Toxicity
2643	pharmgkb	Drug	spironolactone	5833.0	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	Hypertension	CYP4A11	rs3890011	Efficacy
2644	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs9479757	Toxicity
2645	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colorectal Neoplasms	TYMS	rs11280056	Efficacy
2646	pharmgkb	Drug	pemetrexed	60843.0	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Mesothelioma	TYMS	rs11280056	Efficacy
2647	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs1799971	Toxicity
2648	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2298897	Toxicity
2649	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236855	Toxicity
2650	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRD1	rs678849	Toxicity
2651	pharmgkb	Drug	rifampin	5381226.0	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	drug-induced liver injury	SLCO1B1	SLCO1B1*1, SLCO1B1*15	Toxicity
2652	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ABCB1	rs1045642	Other
2653	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ANKK1,DRD2	rs1800497	Toxicity
2654	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	cessation,Tobacco Use Disorder	HINT1	rs3852209	Other
2655	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HINT1	rs3852209	Efficacy
2656	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs3778150	Toxicity
2657	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence		rs9384169	Toxicity
2658	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs562859	Toxicity
2659	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence		rs9478495	Toxicity
2660	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	rs10485057	Toxicity
2661	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs10485057	Dosage
2662	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		OPRM1	rs10485057	Dosage
2663	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs10485057	Toxicity
2664	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA3,CHRNA5	rs16969968	Dosage,Efficacy
2665	pharmgkb	Drug	aripiprazole	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Psychomotor Agitation	DRD2	rs2514218	Toxicity
2666	pharmgkb	Drug Class	cannabinoids			Marijuana Abuse	OPRM1	rs1799971	Toxicity
2667	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		ANKK1,DRD2	rs1800497	Toxicity
2668	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		DRD2	rs1800497	Toxicity
2669	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	rs1799971	Toxicity
2670	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs3778150	Efficacy
2671	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs3778150	Dosage
2672	pharmgkb	Drug	oxazepam	4616.0	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O		UGT2B15	rs1902023	Metabolism/PK
2673	pharmgkb	Drug	lorazepam	3958.0	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl		UGT2B15	rs1902023	Metabolism/PK
2674	pharmgkb	Drug	ethanol	702.0	CCO		SLC6A3	rs28363170	Other
2675	pharmgkb	Drug	ethanol	702.0	CCO		SLC6A3	rs28363170	Other
2676	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	ABCB1	rs1128503	Dosage,Efficacy
2677	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ACSS2	rs6088638	Toxicity
2678	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTT,MSANTD1	rs362306	Efficacy
2679	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH3	rs3787429	Efficacy
2680	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP1B1	rs1056827	Efficacy
2681	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9	rs6706232	Efficacy
2682	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP1B1	rs10012	Efficacy
2683	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTT,MSANTD1	rs362267	Efficacy
2684	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP2E1	rs2515641	Efficacy
2685	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs4818	Efficacy
2686	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	AKT1	rs3803300	Efficacy
2687	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH4	rs4483927	Efficacy
2688	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	DRD3	rs6280	Efficacy
2689	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	AKT1	rs2494732	Efficacy
2690	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs1799971	Dosage
2691	pharmgkb	Drug	varenicline	5310966.0	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	CHRNA5	rs2036527	Efficacy
2692	pharmgkb	Drug	bupropion	444.0	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CHRNA5	rs2036527	Efficacy
2693	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs2036527	Efficacy
2694	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs1277441	Efficacy
2695	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs1277441	Dosage
2696	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs795484	Efficacy
2697	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs795484	Dosage
2698	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Pregnancy	CHRNA3	rs1051730	Other
2699	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA3	rs1051730	Toxicity
2700	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	ABCB1	rs1045642	Dosage
2701	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	ABCB1	rs1045642	Dosage
2702	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs508448	Other
2703	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs3778151	Toxicity
2704	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	BDNF,BDNF-AS	rs16917234	Other
2705	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs4654327	Toxicity
2706	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	XIRP2	rs7606603	Efficacy
2707	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension		rs16872401	Efficacy
2708	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TXNDC11	rs3784921	Efficacy
2709	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension		rs7184292	Efficacy
2710	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension		rs7184292	Dosage
2711	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs3743075	Toxicity
2712	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs7178270	Toxicity
2713	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs1948	Toxicity
2714	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs2074957	Toxicity
2715	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs4807493	Toxicity
2716	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs10432303	Toxicity
2717	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs8109485	Toxicity
2718	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs4432372	Toxicity
2719	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs10405681	Toxicity
2720	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs1476592	Toxicity
2721	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PIP5K1C	rs10419980	Toxicity
2722	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PNPLA3	rs738409	Toxicity
2723	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		ADRB2	rs1042718	Other
2724	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Neoplasms,Pain	CYP3A5	CYP3A5*1, CYP3A5*3	Toxicity
2725	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major	GNB3,P3H3	rs5441	Efficacy
2726	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	rs2242480	Efficacy
2727	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs10516440	Toxicity
2728	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP27B1	rs10877012	Efficacy
2729	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A1	rs887829	Efficacy
2730	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	GC	rs7041	Efficacy
2731	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A3	rs1983023	Efficacy
2732	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	VDR	rs731236	Efficacy
2733	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	VDR	rs1544410	Efficacy
2734	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Psoriasis	TNFAIP3	rs610604	Efficacy
2735	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Psoriasis	SH3BP2,TNFAIP3	rs6920220	Efficacy
2736	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism,Attention Deficit Disorder with Hyperactivity	MAP2K4	rs2159140	Toxicity
2737	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ADGRL3	rs2271339	Toxicity
2738	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ADGRL3	rs1456862	Toxicity
2739	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Neoplasms	SLC22A1	rs628031	Efficacy,Toxicity,Metabolism/PK
2740	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CYP1A2	rs762551	Dosage
2741	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Drug Toxicity,Gastrointestinal Stromal Tumors	ABCG2	rs2231137	Dosage
2742	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Drug Toxicity,Gastrointestinal Stromal Tumors	ABCB1,RUNDC3B	rs28656907	Dosage
2743	pharmgkb	Drug	mexiletine	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	rs1567817380	Efficacy
2744	pharmgkb	Drug	mexiletine	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	rs121908560	Efficacy
2745	pharmgkb	Drug	flecainide	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Myotonic Disorders	SCN4A	rs1567817380	Efficacy
2746	pharmgkb	Drug	mexiletine	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	rs886043595	Efficacy
2747	pharmgkb	Drug	mexiletine	4178.0	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	rs121908547	Efficacy
2748	pharmgkb	Drug	flecainide	3356.0	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Myotonic Disorders	SCN4A	rs121908547	Efficacy
2749	pharmgkb	Drug	rocuronium	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		ABCB1	rs1128503	Efficacy
2750	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA,HNRNPH2	rs869312136	Efficacy
2751	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs28935195	Efficacy
2752	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs1569304898	Efficacy
2753	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs398123212	Efficacy
2754	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs104894827	Efficacy
2755	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs372966991	Efficacy
2756	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs869312146	Efficacy
2757	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs397515870	Efficacy
2758	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs398123223	Efficacy
2759	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs28935490	Efficacy
2760	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA,HNRNPH2	rs869312138	Efficacy
2761	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs398123217	Efficacy
2762	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs397515874	Efficacy
2763	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs727505292	Efficacy
2764	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs869312399	Efficacy
2765	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs104894828	Efficacy
2766	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs398123226	Efficacy
2767	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs727504348	Efficacy
2768	pharmgkb	Drug	migalastat	176077.0		Fabry Disease	GLA	rs190347120	Efficacy
2769	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	P2RX7	rs1718125	Dosage
2770	pharmgkb	Drug	tianeptine	68870.0		Depressive Disorder, Major,suicidal ideation	OPRM1	rs1799971	Toxicity
2771	pharmgkb	Drug	ibuprofen	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C8	CYP2C8*1, CYP2C8*3	Dosage
2772	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26	Metabolism/PK
2773	pharmgkb	Drug	tolbutamide	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	rs762081829	Metabolism/PK
2774	pharmgkb	Drug	tolbutamide	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	rs761895497	Metabolism/PK
2775	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs61311738	Metabolism/PK
2776	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs145119820	Metabolism/PK
2777	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs1187513719	Metabolism/PK
2778	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs144928727	Metabolism/PK
2779	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Drug Toxicity,Tuberculosis	XPO1	rs4430924	Toxicity
2780	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs765399160	Metabolism/PK
2781	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs765399160	Metabolism/PK
2782	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		NPIPB8,SULT1A1	rs28374453	Metabolism/PK
2783	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		NPIPB8,SULT1A1	rs28374453	Metabolism/PK
2784	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		NPIPB8,SULT1A1	rs28374453	Metabolism/PK
2785	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs1042028	Metabolism/PK
2786	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs1042028	Metabolism/PK
2787	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs1042028	Metabolism/PK
2788	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs72547527	Metabolism/PK
2789	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs72547527	Metabolism/PK
2790	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs72547527	Metabolism/PK
2791	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs1042008	Metabolism/PK
2792	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs1042008	Metabolism/PK
2793	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs1042008	Metabolism/PK
2794	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs767487725	Metabolism/PK
2795	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs767487725	Metabolism/PK
2796	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs767487725	Metabolism/PK
2797	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs758145522	Metabolism/PK
2798	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs758145522	Metabolism/PK
2799	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs758145522	Metabolism/PK
2800	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs544820732	Metabolism/PK
2801	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs544820732	Metabolism/PK
2802	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs544820732	Metabolism/PK
2803	pharmgkb	Drug	tapentadol	9838022.0	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	rs552524124	Metabolism/PK
2804	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	rs552524124	Metabolism/PK
2805	pharmgkb	Metabolite	desmethylnaproxen	162920.0	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	rs552524124	Metabolism/PK
2806	pharmgkb	Drug, Biological Intermediate	conjugated estrogens	23667301.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]	Endometrial Neoplasms	SULT1A1	rs1042028	Toxicity
2807	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	Pain	SULT1A1	rs1042028	Efficacy
2808	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Mesothelioma,Thrombocytopenia	AQP1	rs1049305	Toxicity
2809	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Thrombocytopenia	AQP1	rs28362731	Toxicity
2810	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Alopecia,Mesothelioma	AQP1	rs1049305	Toxicity
2811	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Anemia,Mesothelioma	AQP1	rs1049305	Toxicity
2812	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Leukopenia,Mesothelioma	AQP1	rs1049305	Toxicity
2813	pharmgkb	Drug	ethanol	702.0	CCO		SRPRB	rs17376019	Metabolism/PK
2814	pharmgkb	Metabolite	acetaldehyde	177.0			ADH1A	rs1229976	Metabolism/PK
2815	pharmgkb	Drug	ABT-751			Neoplasms	UGT1A8	rs6431558	Other
2816	pharmgkb	Drug Class	Beta Blocking Agents				KL	rs36217263	Efficacy
2817	pharmgkb	Drug Class	calcium channel blockers			Hypertension	CACNA1C	rs2238032	Efficacy
2818	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	hematopoietic stem cell transplantation,Neurotoxicity Syndromes	ABCB1	rs1128503	Toxicity
2819	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	ADRB1	rs1801252	Efficacy
2820	pharmgkb	Drug Class	glucocorticoids			Asthma	HSD3B1	rs1047303	Efficacy
2821	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Anxiety Disorders	ADORA2A	rs3761422	Toxicity
2822	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	SLC15A2	rs2257212	Efficacy
2823	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Cardiovascular Diseases	HMGCR	rs3846662	Other
2824	pharmgkb	Drug Class	calcium channel blockers			Hypertension	CACNA1C	rs2239128	Efficacy
2825	pharmgkb	Drug Class	calcium channel blockers				CACNA1C	rs2239050	Efficacy
2826	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2,Weight gain	PLIN1	rs894160	Toxicity
2827	pharmgkb	Metabolite	acetaldehyde	177.0			ADH1B	rs1229984	Metabolism/PK
2828	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis		rs111618861	Toxicity
2829	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	CCL11	rs1129844	Toxicity
2830	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRD1	rs678849	Efficacy
2831	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		MYD88	rs6853	Toxicity
2832	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ALDH1L1	rs2886059	Efficacy
2833	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	DRD2	rs1799732	Toxicity
2834	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CACNA1E	rs3845446	Dosage
2835	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	PDE4D	rs2164660	Efficacy
2836	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	SLC22A2	rs316019	Toxicity
2837	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs5030843	Metabolism/PK
2838	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs75193786	Metabolism/PK
2839	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs5030843	Metabolism/PK
2840	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs76394784	Metabolism/PK
2841	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs138809906	Metabolism/PK
2842	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs138809906	Metabolism/PK
2843	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs5030849	Metabolism/PK
2844	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs5030849	Metabolism/PK
2845	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs62516101	Metabolism/PK
2846	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs62516101	Metabolism/PK
2847	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs5030858	Metabolism/PK
2848	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs5030858	Metabolism/PK
2849	pharmgkb	Drug	carbocisteine	193653.0			PAH	rs5030860	Metabolism/PK
2850	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs5030860	Metabolism/PK
2851	pharmgkb	Drug	l-phenylalanine	6140.0	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	rs76394784	Metabolism/PK
2852	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,pneumonitis	ERCC2	rs1799793	Toxicity
2853	pharmgkb	Drug Class	Platinum compounds			adverse events,Carcinoma, Non-Small-Cell Lung	ERCC2	rs1799793	Toxicity
2854	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRG1	rs13250975	Efficacy
2855	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ZMAT4	rs1367094	Efficacy
2856	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs6551665	Efficacy
2857	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia		rs6924995	Efficacy
2858	pharmgkb	Drug	adalimumab			Inflammatory Bowel Diseases	ATG5	rs9373839	Efficacy
2859	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	SLC22A2	rs316019	Toxicity
2860	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Constriction, Pathologic,Ischemic Attack, Transient,Stroke	CES1	rs8192950	Efficacy
2861	pharmgkb	Drug	ticagrelor	9871419.0	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs12566888	Efficacy
2862	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17	Toxicity
2863	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615.0	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17	Metabolism/PK
2864	pharmgkb	Drug	tolterodine	60774.0	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98	Metabolism/PK
2865	pharmgkb	Drug Class	hmg coa reductase inhibitors			Alzheimer Disease	APOE	rs429358	Efficacy
2866	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		APOE	rs7412	Efficacy
2867	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		APOE	rs7412	Efficacy
2868	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOE	rs7412	Efficacy
2869	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		APOE	rs7412	Efficacy
2870	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		APOE	rs429358	Efficacy
2871	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Myocardial Infarction	APOE	rs429358	Efficacy
2872	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease	ABCB1	rs1045642	Efficacy
2873	pharmgkb	Drug	propranolol	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	Liver Cirrhosis	ADRB2	rs1042713	Efficacy
2874	pharmgkb	Drug Class	Antihypertensives			Hypertension	PTPRD	rs324498	Efficacy
2875	pharmgkb	Drug Class	Antihypertensives			Hypertension		rs11749255	Efficacy
2876	pharmgkb	Drug Class	Antihypertensives			Hypertension		rs6487504	Efficacy
2877	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*9, CYP2D6*29	Metabolism/PK
2878	pharmgkb	Metabolite	acetaldehyde	177.0			PGM1	rs4643	Metabolism/PK
2879	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,overall survival	SLCO1B3	rs4149117	Efficacy
2880	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	chronic lung allograft dysfunction,lung transplantation	SLCO1B3	rs4149117	Efficacy
2881	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,overall survival	SLCO1B3	rs7311358	Efficacy
2882	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,transplant rejection	SLCO1B3	rs4149117	Efficacy
2883	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,transplant rejection	SLCO1B3	rs7311358	Efficacy
2884	pharmgkb	Drug	mycophenolic acid	446541.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	chronic lung allograft dysfunction,lung transplantation	SLCO1B3	rs7311358	Efficacy
2885	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRK1	rs6473797	Toxicity
2886	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs495491	Toxicity
2887	pharmgkb	Drug	botulinum toxin type a			Migraine NOS	TRPV1	rs222749	Efficacy
2888	pharmgkb	Drug	botulinum toxin type a			Migraine NOS	CALCA	rs3781719	Efficacy
2889	pharmgkb	Drug	letermovir	45138674.0			SLCO1B1	rs4149032	Metabolism/PK
2890	pharmgkb	Drug	letermovir	45138674.0			SLCO1B1	rs4149056	Metabolism/PK
2891	pharmgkb	Drug	letermovir	45138674.0			UGT1A1	rs4148323	Metabolism/PK
2892	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	DRD2	rs12364283	Toxicity
2893	pharmgkb	Drug Class	opioids			Heroin Dependence,Opioid-Related Disorders	DRD2	rs1076560	Other
2894	pharmgkb	Drug	adalimumab			Crohn Disease		rs9828223	Efficacy
2895	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	SYT1	rs2251214	Toxicity
2896	pharmgkb	Drug	disulfiram	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	SLC6A3	rs28363170	Efficacy
2897	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	RABGAP1L	rs61826952	Toxicity
2898	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	adverse events,Arthritis, Rheumatoid	SLC19A1	rs2838956	Toxicity
2899	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	SORCS2	rs73208473	Metabolism/PK
2900	pharmgkb	Drug	Vitamin K1	5284607.0			CYP4F2	CYP4F2*1, CYP4F2*3	Metabolism/PK
2901	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement,Hemorrhage	APOB	rs679899	Toxicity
2902	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement,Hemorrhage	APOB	rs1367117	Toxicity
2903	pharmgkb	Drug	lopinavir	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	CYP3A,CYP3A5,ZSCAN25	rs776746	Metabolism/PK
2904	pharmgkb	Drug	amprenavir	65016.0	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	HIV Infections	SLCO1B1	rs4149056	Metabolism/PK
2905	pharmgkb	Drug	lopinavir	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
2906	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	NUCB2	rs757081	Efficacy
2907	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension		rs1446468	Efficacy
2908	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	RRP1B	rs9306160	Efficacy
2909	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	SH2B3	rs3184504	Efficacy
2910	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	C5orf56	rs12521868	Efficacy
2911	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	KCNK3	rs1275988	Efficacy
2912	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	CSK	rs1378942	Efficacy
2913	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PDE3A	rs12579720	Efficacy
2914	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	SULT1C3	rs6722745	Efficacy
2915	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	STN1	rs4387287	Efficacy
2916	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	TBX2	rs8068318	Efficacy
2917	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PLCE1	rs932764	Efficacy
2918	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	ADO	rs10995311	Efficacy
2919	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKAG2	rs10224002	Efficacy
2920	pharmgkb	Drug	candesartan	2541.0	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	DOT1L,PLEKHJ1	rs740406	Efficacy
2921	pharmgkb	Drug	remifentanil	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		ABCB1	rs1045642	Dosage
2922	pharmgkb	Drug	remifentanil	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		ABCB1	rs1045642	Efficacy
2923	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs114077267	Toxicity
2924	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs115208233	Toxicity
2925	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs116181528	Toxicity
2926	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA3,CHRNA5	rs578776	Toxicity
2927	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA4	rs1044396	Toxicity
2928	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CHRNA4	rs2229959	Toxicity
2929	pharmgkb	Drug Class	antipsychotics			Weight gain		rs7720513	Toxicity
2930	pharmgkb	Drug Class	Beta blocking agents, selective			Hypertension	BST1	rs28404156	Efficacy
2931	pharmgkb	Drug Class	antipsychotics			Weight gain	DGKB	rs1525085	Toxicity
2932	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ANKS1B	rs2133896	Toxicity
2933	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	ANKS1B	rs2133896	Toxicity
2934	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	ANKS1B	rs2133896	Toxicity
2935	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		OPRD1	rs581111	Efficacy
2936	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O			rs6848893	Efficacy
2937	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity	ERCC1	rs11615	Toxicity
2938	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs910080	Toxicity
2939	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs1997794	Toxicity
2940	pharmgkb	Drug	artemether	9796294.0	C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC)C		CYP2B6	CYP2B6*1, CYP2B6*6	Metabolism/PK
2941	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs1022563	Toxicity
2942	pharmgkb	Drug	budesonide	63006.0	CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C	Asthma		rs2392165	Efficacy
2943	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	rs778068631	Metabolism/PK
2944	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
2945	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC6A4	rs2066713	Toxicity
2946	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC6A4	rs25531	Toxicity
2947	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC6A4	rs4251417	Toxicity
2948	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	UGT2B7	rs7439366	Efficacy
2949	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	rs7439366	Metabolism/PK
2950	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hepatitis C,Liver Neoplasms	GALNT14	rs9679162	Efficacy
2951	pharmgkb	Drug	thioguanine	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N	Crohn Disease	TPMT	TPMT*1, TPMT*3A, TPMT*3C	Metabolism/PK
2952	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764.0		HIV Infections,nephrotoxicity	SLC28A2	rs11854484	Toxicity
2953	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764.0		HIV Infections,nephrotoxicity	CYP24A1	rs2248359	Toxicity
2954	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764.0		HIV Infections,nephrotoxicity	CYP27B1	rs4646536	Toxicity
2955	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs717620	Toxicity
2956	pharmgkb	Drug	temozolomide	5394.0	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	Glioma	ABCB1	rs2229109	Efficacy
2957	pharmgkb	Drug	creatine	586.0	CN(CC(=O)O)C(=N)N	Amyotrophic Lateral Sclerosis	MOBP	rs616147	Efficacy
2958	pharmgkb	Drug	desloratadine	124087.0	C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4	sedation,Urticaria	HRH1	rs901865	Toxicity
2959	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	OTOS	rs2291767	Toxicity
2960	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	TPMT	rs12201199	Toxicity
2961	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Ototoxicity	SLC22A2	rs316019	Toxicity
2962	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	ABCC3	rs1051640	Toxicity
2963	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms,Ototoxicity,Testicular Neoplasms	SLC16A5	rs4788863	Toxicity
2964	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs3842	Other
2965	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs1045642	Other
2966	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	rs28399433	Other
2967	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism,Bipolar Disorder	CACNA1C	rs1034936	Toxicity
2968	pharmgkb	Drug	lurasidone	213046.0	C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O	Schizophrenia	HTR1A	rs6295	Efficacy
2969	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Toxic liver disease,Tuberculosis	ABCC2	rs3740065	Toxicity
2970	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	RORA	rs4774388	Efficacy
2971	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Toxic liver disease	RELA	rs11227247	Toxicity
2972	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKB	rs2272733	Efficacy
2973	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	IKBKE	rs2151222	Toxicity
2974	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKE	rs12142086	Toxicity
2975	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NFKBIA	rs2233406	Toxicity
2976	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Toxic liver disease	NFKBIA	rs2233407	Toxicity
2977	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKB	rs9694958	Toxicity
2978	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKE	rs3748022	Toxicity
2979	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NFKBIA	rs2233409	Toxicity
2980	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Toxic liver disease	NFKBIB,SIRT2	rs2053071	Toxicity
2981	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NR1H2	rs2695121	Toxicity
2982	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Diarrhea	TAB2	rs577001	Toxicity
2983	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	NFKBIA	rs8904	Toxicity
2984	pharmgkb	Drug	progesterone	5994.0	CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17	Metabolism/PK
2985	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ANKK1,DRD2	rs1800497	Toxicity
2986	pharmgkb	Drug Class	opioids			Dizziness	COMT	rs4633	Toxicity
2987	pharmgkb	Drug Class	opioids			Sexual Dysfunctions, Psychological	COMT	rs4633	Toxicity
2988	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
2989	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
2990	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		ABCB1	rs1128503	Dosage
2991	pharmgkb	Drug	methamphetamine	10836.0	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	FAAH	rs324420	Other
2992	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ADGRV1	rs2366929	Toxicity
2993	pharmgkb	Drug	diclofenac	3033.0	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl		CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4	Metabolism/PK
2994	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs10457090	Toxicity
2995	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs589046	Toxicity
2996	pharmgkb	Drug	hydralazine / isosorbide dinitrate	9954530.0		Heart Failure	GNB3	rs5443	Efficacy
2997	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3749034	Dosage
2998	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3762556	Dosage
2999	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs769404	Dosage
3000	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs204047	Dosage
3001	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs797397	Metabolism/PK
3002	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs204047	Metabolism/PK
3003	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs3802279	Dosage
3004	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs3802281	Dosage
3005	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs963549	Dosage
3006	pharmgkb	Drug	dipyrone	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		CYP2C19	CYP2C19*1, CYP2C19*2	Metabolism/PK
3007	pharmgkb	Drug	dipyrone	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		CYP2C9	CYP2C9*1, CYP2C9*3	Metabolism/PK
3008	pharmgkb	Drug	dipyrone	522325.0	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14	Metabolism/PK
3009	pharmgkb	Drug Class	opioids			Nausea,Vomiting	CRYBG2	rs36024412	Toxicity
3010	pharmgkb	Drug Class	opioids			Nausea,Vomiting	CLCC1	rs168107	Toxicity
3011	pharmgkb	Drug Class	opioids			Nausea,Vomiting	POM121L2	rs41269255	Toxicity
3012	pharmgkb	Drug Class	opioids			Nausea,Vomiting	ZNF165	rs9393888	Toxicity
3013	pharmgkb	Drug Class	opioids			Nausea,Vomiting	MUC16	rs11882256	Toxicity
3014	pharmgkb	Drug Class	opioids			Nausea,Vomiting	PDE3A	rs12305038	Toxicity
3015	pharmgkb	Drug Class	opioids			Nausea,Vomiting	ZNF568	rs10405238	Toxicity
3016	pharmgkb	Drug	cytarabine	6253.0	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute	ABCB1	rs1045642	Efficacy
3017	pharmgkb	Drug	hydralazine	3637.0	C1=CC=C2C(=C1)C=NN=C2NN	Hypertension	NAT2	NAT2*5, NAT2*6, NAT2*7, NAT2*14	Toxicity
3018	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCC3	rs4793665	Other
3019	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	ERCC1	rs3212986	Toxicity
3020	pharmgkb	Drug	alprazolam	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4		CYP3A,CYP3A4	rs35599367	Metabolism/PK
3021	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA5	rs588765	Toxicity
3022	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA3,CHRNA5	rs16969968	Toxicity
3023	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs2070762	Toxicity
3024	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs10770141	Toxicity
3025	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs10770140	Toxicity
3026	pharmgkb	Drug	dexmedetomidine	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	rs1800035	Efficacy
3027	pharmgkb	Drug	dexmedetomidine	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	rs201376588	Efficacy
3028	pharmgkb	Drug	dexmedetomidine	68602.0	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	rs775887911	Efficacy
3029	pharmgkb	Drug	imatinib	5291.0	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	Metabolism/PK
3030	pharmgkb	Drug	amlodipine	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN		CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	Metabolism/PK
3031	pharmgkb	Drug	fesoterodine	6918558.0	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	Metabolism/PK
3032	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	rs7439366	Efficacy
3033	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	COMT,TXNRD2	rs933271	Efficacy
3034	pharmgkb	Drug Class	opioids			Hyperalgesia	COMT	rs4680	Toxicity
3035	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	rs780801862	Metabolism/PK
3036	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs780801862	Metabolism/PK
3037	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*29	Metabolism/PK
3038	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	SLC6A4	rs1042173	Dosage
3039	pharmgkb	Drug	vancomycin	14969.0	C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O	drug reaction with eosinophilia and systemic symptoms	HLA-A	HLA-A*32:01	Toxicity
3040	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	PDE4B	rs6421482	Toxicity
3041	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs61767420	Toxicity
3042	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	GCKR	rs1260326	Toxicity
3043	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs494904	Toxicity
3044	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs1402398	Toxicity
3045	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs9679319	Toxicity
3046	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	THSD7B	rs13382553	Toxicity
3047	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs2673136	Toxicity
3048	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	CADM2	rs62250713	Toxicity
3049	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ADH1B	rs75967634	Toxicity
3050	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ADH1B	rs1229984	Toxicity
3051	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs13129401	Toxicity
3052	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ADH1C	rs13125415	Toxicity
3053	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC39A8	rs13135092	Toxicity
3054	pharmgkb	Drug Class	antineoplastic agents			Drug Toxicity	TP53	rs1042522	Toxicity
3055	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	DPP6	rs2533200	Toxicity
3056	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs2582405	Toxicity
3057	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs7900002	Toxicity
3058	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs56722963	Toxicity
3059	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	MED19,TMX2	rs576859	Toxicity
3060	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs1783835	Toxicity
3061	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	SLC4A8	rs12296477	Toxicity
3062	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs6589386	Toxicity
3063	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	ARID4A	rs61974485	Toxicity
3064	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism		rs8008020	Toxicity
3065	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	TNRC6A	rs72768626	Toxicity
3066	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	FTO	rs9937709	Toxicity
3067	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	FUT2	rs492602	Toxicity
3068	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	ABCB1	rs1045642	Efficacy
3069	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTR2A	rs6313	Efficacy
3070	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	HTR2A	rs6313	Efficacy
3071	pharmgkb	Drug	ethylmorphine	5359271.0			CYP2D6	CYP2D6*1, CYP2D6*4	Metabolism/PK
3072	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Toxicity
3073	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Toxicity
3074	pharmgkb	Drug, Metabolite	dihydrocodeine	5284543.0			CYP2D6	CYP2D6*1, CYP2D6*4	Metabolism/PK
3075	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Drug Toxicity	CYP2D6	CYP2D6*1, CYP2D6*2xN	Toxicity
3076	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		GSTM3	rs36120609	Metabolism/PK
3077	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	HLA-G	rs371194629	Efficacy
3078	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs1799971	Toxicity
3079	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		UGT1A1	UGT1A1*1, UGT1A1*28	Metabolism/PK
3080	pharmgkb	Drug	raloxifene	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	bone density	UGT1A1	UGT1A1*1, UGT1A1*28	Efficacy
3081	pharmgkb	Drug	raloxifene	5035.0	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Osteoporosis	UGT1A1	UGT1A1*1, UGT1A1*28	Metabolism/PK
3082	pharmgkb	Drug	metronidazole	4173.0	CC1=NC=C(N1CCO)[N+](=O)[O-]		CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	Metabolism/PK
3083	pharmgkb	Drug	tranilast	5282230.0		Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*28	Toxicity
3084	pharmgkb	Drug	nilotinib	644241.0	CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5	Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	Toxicity
3085	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	drug reaction with eosinophilia and systemic symptoms	HLA-A	HLA-A*31:01	Toxicity
3086	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		ABCB1	rs1128503	Metabolism/PK
3087	pharmgkb	Drug	dabigatran				CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
3088	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*10	Dosage
3089	pharmgkb	Drug Class	opioids			Death,Opioid-Related Disorders	ABCB1	rs9282564	Toxicity
3090	pharmgkb	Drug Class	opioids			Death,Opioid-Related Disorders	COMT	rs4680	Toxicity
3091	pharmgkb	Drug	tafenoquine	115358.0	CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC	Malaria		rs62103056	Efficacy
3092	pharmgkb	Drug	indinavir	5362440.0	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	UGT1A1	UGT1A1*1, UGT1A1*28	Toxicity
3093	pharmgkb	Drug	peginterferon alfa-2a			Hepatitis B, Chronic	IFNL3,IFNL4	rs12979860	Efficacy
3094	pharmgkb	Drug	sofosbuvir	45375808.0	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	Hepatitis C, Chronic	IFNL3,IFNL4	rs12979860	Efficacy
3095	pharmgkb	Drug Class	interferons			Hepatitis C	IFNL3,IFNL4	rs12979860	Efficacy
3096	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	CYP2B6	rs2279343	Toxicity
3097	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	PNOC	rs351776	Toxicity
3098	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	PNOC	rs351776	Toxicity
3099	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	CYP2A7P1,CYP2B6	rs3745274	Toxicity
3100	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	rs4680	Toxicity
3101	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	PNOC	rs4732636	Toxicity
3102	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	PNOC	rs4732636	Toxicity
3103	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	rs740603	Toxicity
3104	pharmgkb	Drug Class	Platinum compounds			overall survival,Thrombocytopenia	SLC31A1	rs10759637	Efficacy
3105	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC28A2	rs11854484	Efficacy
3106	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs28399499	Metabolism/PK
3107	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	CYP2B6*1, CYP2B6*6	Toxicity
3108	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	CYP2B6*1, CYP2B6*6	Efficacy
3109	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62	Metabolism/PK
3110	pharmgkb	Drug	atazanavir	148192.0	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	UGT1A1	rs887829	Other
3111	pharmgkb	Drug Class	antidepressants			Depression	HTR7,RPP30	rs7905446	Efficacy
3112	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	HTR7	rs7905446	Efficacy
3113	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Bipolar Disorder	HTR7,RPP30	rs7905446	Efficacy
3114	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	HTR7,RPP30	rs7905446	Efficacy
3115	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs495491	Toxicity
3116	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs495491	Toxicity
3117	pharmgkb	Drug Class	Platinum compounds			overall survival	TP53	rs1042522	Efficacy
3118	pharmgkb	Drug Class	corticosteroids			Asthma	CRHR1	rs1876828	Efficacy
3119	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	hand-foot syndrome,Neoplasms	CDA	rs3215400	Toxicity
3120	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms,Osteosarcoma,Ototoxicity,Testicular Neoplasms	XPC	rs2228001	Toxicity
3121	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neutropenia,Urinary Bladder Neoplasms	TMEM43,XPC	rs2228001	Toxicity
3122	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity,Urinary Bladder Neoplasms	TMEM43,XPC	rs2228001	Toxicity
3123	pharmgkb	Drug	dapsone	2955.0	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02	Toxicity
3124	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Neoplasms	ABCG2	rs2231142	Toxicity
3125	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*28	Toxicity
3126	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC3	rs9895420	Efficacy
3127	pharmgkb	Drug	omeprazole	4594.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC		CYP2C19	CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33	Metabolism/PK
3128	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	VKORC1	rs9923231	Toxicity
3129	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17244841	Efficacy
3130	pharmgkb	Metabolite	lovastatin acid	64727.0	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C		SLCO1B1	rs4149056	Metabolism/PK
3131	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia,Schizophrenia	ANKK1,DRD2	rs1800497	Toxicity
3132	pharmgkb	Drug	clobazam	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
3133	pharmgkb	Drug	clobazam	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
3134	pharmgkb	Drug	clobazam	2789.0	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Dosage
3135	pharmgkb	Drug Class	corticosteroids			Asthma	ADRB2	rs1042713	Efficacy
3136	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		LPA	rs10455872	Efficacy
3137	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	rs4680	Efficacy
3138	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	rs4680	Toxicity
3139	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Arteriosclerosis,Coronary Disease,Essential hypertension,glomerular disease,Glomerulonephritis, IGA,Kidney Diseases	ACE	rs1799752	Efficacy
3140	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung,Mesothelioma,Pancreatic Neoplasms	CDA	rs2072671	Toxicity
3141	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Anxiety Disorders	ADORA2A	rs5751876	Toxicity
3142	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	rs11568315	Efficacy
3143	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depression	CYP2C19	CYP2C19*2	Metabolism/PK
3144	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	rs1051740	Metabolism/PK
3145	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	rs1051740	Dosage
3146	pharmgkb	Drug	lapatinib	208908.0	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	Toxic liver disease	HLA-DRB1	HLA-DRB1*07:01	Toxicity
3147	pharmgkb	Prodrug	tegafur	5386.0		Drug Toxicity	UMPS	rs1801019	Toxicity
3148	pharmgkb	Drug	lopinavir	92727.0	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	SLCO1B1	rs4149056	Metabolism/PK
3149	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Gout	ABCG2	rs2231142	Efficacy
3150	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis		rs1495741	Toxicity
3151	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ANKK1	rs1800497	Efficacy
3152	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
3153	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN1A	rs3812718	Efficacy
3154	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CALU	rs339097	Dosage
3155	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	rs2108622	Dosage
3156	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	rs2234922	Dosage
3157	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56	Metabolism/PK
3158	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	rs746647	Toxicity
3159	pharmgkb	Drug Class	antipsychotics			Schizophrenia,tardive dyskinesia		rs6977820	Toxicity
3160	pharmgkb	Drug Class	hmg coa reductase inhibitors			Hyperlipidemias	CETP	rs1532624	Efficacy
3161	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072661	Efficacy,Toxicity
3162	pharmgkb	Drug	digoxin	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	rs1045642	Metabolism/PK
3163	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		UGT2B10	rs61750900	Metabolism/PK
3164	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms	SOD2	rs4880	Efficacy
3165	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	POR	rs1057868	Metabolism/PK
3166	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3	Metabolism/PK
3167	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3	Toxicity
3168	pharmgkb	Drug	sunitinib	5329102.0	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Leukopenia,Myelosuppression,Neutropenia,Thrombocytopenia	FLT3	rs1933437	Toxicity
3169	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	MTRR	rs1801394	Efficacy
3170	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7196161	Dosage
3171	pharmgkb	Drug Class	Bisphosphonates			Osteoporosis,Osteoporosis, Postmenopausal	FDPS	rs2297480	Efficacy
3172	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	CRHR2	rs7793837	Efficacy
3173	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ACE	rs1799752	Efficacy
3174	pharmgkb	Drug	nortriptyline	4543.0	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	GNB3	rs5443	Efficacy
3175	pharmgkb	Drug	mirtazapine	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
3176	pharmgkb	Drug	fluindione			Thromboembolism	VKORC1	rs9934438	Efficacy
3177	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	EPHA7	rs78132896	Toxicity
3178	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CYP19A1	rs1008805	Toxicity
3179	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs10497203	Toxicity
3180	pharmgkb	Drug Class	anthracyclines and related substances			Heart Failure,Neoplasms	CBR3	rs1056892	Toxicity
3181	pharmgkb	Drug Class	anthracyclines and related substances			Cardiomyopathies,Neoplasms	CBR1	rs9024	Toxicity
3182	pharmgkb	Drug	esomeprazole	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	eosinophilic esophagitis	STAT6	rs1059513	Efficacy
3183	pharmgkb	Drug Class	antipsychotics			Mental Disorders	HTR2C	rs3813929	Toxicity
3184	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders,Schizophrenia	HTR2C	rs3813929	Toxicity
3185	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Mental Disorders,Schizophrenia	HTR2C	rs3813929	Toxicity
3186	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Mental Disorders,Schizophrenia	HTR2C	rs3813929	Toxicity
3187	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Metabolic Syndrome,Schizophrenia	HTR2C	rs1414334	Toxicity
3188	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Metabolic Syndrome	HTR2C	rs1414334	Toxicity
3189	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	HTR2C	rs518147	Toxicity
3190	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia,Weight gain	HTR2C	rs6318	Toxicity
3191	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	neuropathic pain	HTR2C	rs6318	Efficacy
3192	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Weight gain	HTR2C	rs2497538	Toxicity
3193	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms,Menopause	CYP19A1	rs4646	Efficacy
3194	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP19A1	rs4646	Efficacy
3195	pharmgkb	Drug	amitriptyline	2160.0	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
3196	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2C19	CYP2C19*1, CYP2C19*14, CYP2C19*23	Metabolism/PK
3197	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs1051730	Toxicity
3198	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs1051730	Dosage
3199	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	NT5C2	rs11598702	Metabolism/PK
3200	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs7582141	Toxicity
3201	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs6432512	Toxicity
3202	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264631	Toxicity
3203	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264588	Toxicity
3204	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKCA	rs16960228	Efficacy
3205	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	COL22A1	rs6988229	Efficacy
3206	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264651	Toxicity
3207	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Brain Neoplasms,Deafness,Ototoxicity	ACYP2	rs1872328	Toxicity
3208	pharmgkb	Drug	caffeine	2519.0	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		ADORA2A	rs2298383	Toxicity
3209	pharmgkb	Drug	cerivastatin	446156.0	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	Rhabdomyolysis	SLCO1B1	rs4149056	Toxicity
3210	pharmgkb	Drug	clodronate	25419.0	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl		VDR	rs1544410	Efficacy
3211	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
3212	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC		CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
3213	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		ADRB1	rs1801253	Efficacy
3214	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Arthritis, Rheumatoid	SLCO1C1	rs3794271	Efficacy
3215	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	CYP2D6	CYP2D6*1, CYP2D6*4	Dosage
3216	pharmgkb	Drug Class	sulfonamides, urea derivatives				TCF7L2	rs7903146	Efficacy
3217	pharmgkb	Drug	trastuzumab			Breast Neoplasms	FCGR3A	rs396991	Efficacy
3218	pharmgkb	Drug Class	anthracyclines and related substances			Cardiomyopathies	HAS3	rs2232228	Toxicity
3219	pharmgkb	Drug	trastuzumab			Breast Neoplasms	FCGR2A	rs1801274	Efficacy
3220	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	COMT	rs13306278	Efficacy
3221	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs7089580	Dosage
3222	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	rs4149015	Metabolism/PK
3223	pharmgkb	Drug Class	hmg coa reductase inhibitors					rs1719247	Toxicity
3224	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C			rs1346268	Toxicity
3225	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	Dosage
3226	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	rs2032582	Efficacy
3227	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs885004	Toxicity
3228	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs7853758	Toxicity
3229	pharmgkb	Drug	ibuprofen	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C8	CYP2C8*1, CYP2C8*3	Metabolism/PK
3230	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	SEMA3C	rs7779029	Toxicity
3231	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	SCN1A	rs3812718	Dosage
3232	pharmgkb	Drug	sildenafil	5212.0	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	GNB3	rs5443	Efficacy
3233	pharmgkb	Drug	rituximab				FCGR3A	rs396991	Efficacy
3234	pharmgkb	Drug	naloxone	5284596.0	C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O		OPRM1	rs1799971	Efficacy
3235	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	C8orf34	rs1517114	Toxicity
3236	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	severe cutaneous adverse reactions	HLA-B	HLA-B*58:01	Toxicity
3237	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C19	rs3814637	Dosage
3238	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C19	rs3814637	Toxicity
3239	pharmgkb	Drug	gliclazide	3475.0	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	Diabetes Mellitus	KCNJ11	rs5219	Efficacy
3240	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	KCNJ11	rs5219	Efficacy
3241	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs5443	Efficacy
3242	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	CETP	rs708272	Efficacy
3243	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs4803419	Metabolism/PK
3244	pharmgkb	Drug	alfentanil	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	rs1799971	Efficacy
3245	pharmgkb	Drug	alfentanil	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC		OPRM1	rs1799971	Toxicity
3246	pharmgkb	Drug	alfentanil	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	rs1799971	Metabolism/PK
3247	pharmgkb	Drug	alfentanil	51263.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	rs1799971	Dosage
3248	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	somnolence	OPRM1	rs1799971	Toxicity
3249	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Vomiting	OPRM1	rs540825	Toxicity
3250	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Nausea,Pain, Postoperative,Vomiting	OPRM1	rs9397685	Toxicity
3251	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	OPRM1	rs1799971	Efficacy
3252	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	OPRM1	rs1799971	Dosage
3253	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Constipation,dry mouth,Respiratory Insufficiency	OPRM1	rs1799971	Toxicity
3254	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neonatal Abstinence Syndrome	OPRM1	rs1799971	Toxicity
3255	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		OPRM1	rs1799971	Dosage
3256	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		OPRM1	rs1323040	Dosage
3257	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	rs4680	Toxicity
3258	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	rs4680	Toxicity
3259	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	rs740603	Toxicity
3260	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	COMT	rs4680	Efficacy
3261	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	somnolence	COMT	rs4680	Toxicity
3262	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	COMT	rs4680	Dosage
3263	pharmgkb	Drug	remifentanil	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	Pain	COMT	rs4680	Efficacy
3264	pharmgkb	Drug Class	opioids			Pain	COMT	rs4680	Efficacy
3265	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		COMT	rs4680	Efficacy
3266	pharmgkb	Drug Class	opioids			adverse events,Nausea,Vomiting	OPRM1	rs1799971	Toxicity
3267	pharmgkb	Drug Class	opioids			Pain, Postoperative	OPRM1	rs1799971	Efficacy
3268	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		OPRM1	rs1799971	Efficacy
3269	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRM1	rs2075572	Toxicity
3270	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders,Sleep Disorders	OPRM1	rs1799971	Toxicity
3271	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	OPRM1	rs558025	Dosage
3272	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	OPRM1	rs1799971	Toxicity
3273	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	rs4680	Toxicity
3274	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	Efficacy
3275	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	Metabolism/PK
3276	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	Dosage
3277	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4917639	Dosage
3278	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Drug Toxicity	TYMS	rs45445694	Toxicity
3279	pharmgkb	Metabolite	acetaldehyde	177.0			ALDH2	rs671	Metabolism/PK
3280	pharmgkb	Drug	ethanol	702.0	CCO		ALDH2	rs671	Metabolism/PK
3281	pharmgkb	Drug	ivacaftor / lumacaftor	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	Toxicity
3282	pharmgkb	Drug	ivacaftor / lumacaftor	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs74551128	Efficacy
3283	pharmgkb	Drug	ivacaftor / lumacaftor	71494926.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909011	Efficacy
3284	pharmgkb	Drug	esomeprazole	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
3285	pharmgkb	Drug Class	Platinum compounds			Neoplasms	NQO1	rs1800566	Efficacy
3286	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Dosage
3287	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
3288	pharmgkb	Drug Class	antidepressants			Depressive Disorder	GRIK4	rs1954787	Efficacy
3289	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O		GP1BA	rs6065	Efficacy
3290	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	LPA	rs10455872	Efficacy
3291	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	LPA	rs10455872	Toxicity
3292	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors				TNF	rs1800629	Efficacy
3293	pharmgkb	Drug	lapatinib	208908.0	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	Toxic liver disease	HLA-DQA1	HLA-DQA1*02:01	Toxicity
3294	pharmgkb	Drug	cetuximab			Colorectal Neoplasms,Rectal Neoplasms	EGF	rs4444903	Efficacy
3295	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Medulloblastoma,Neoplasms,Ototoxicity,Testicular Neoplasms	GSTP1	rs1695	Toxicity
3296	pharmgkb	Drug Class	antipsychotics			Weight gain	MC4R	rs17782313	Toxicity
3297	pharmgkb	Drug Class	antipsychotics			Weight gain	MC4R	rs489693	Toxicity
3298	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Urticaria	LTC4S	rs730012	Toxicity
3299	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease,Myocardial Infarction	PTGS1	rs10306114	Efficacy
3300	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs1076560	Toxicity
3301	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Neoplasms	GSTP1	rs1695	Efficacy
3302	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		UGT1A1	UGT1A1*1, UGT1A1*6	Dosage
3303	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	ABCB1	rs1045642	Dosage
3304	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236857	Toxicity
3305	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Drug Hypersensitivity	HLA-B	HLA-B*35:01	Toxicity
3306	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs510769	Toxicity
3307	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs3766951	Toxicity
3308	pharmgkb	Drug	tolterodine	60774.0	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	Metabolism/PK
3309	pharmgkb	Metabolite	SN-38	104842.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Carcinoma, Non-Small-Cell Lung	UGT1A9	rs3832043	Metabolism/PK
3310	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Postoperative Nausea and Vomiting,Vomiting	ABCB1	rs1045642	Efficacy
3311	pharmgkb	Drug	ondansetron	4595.0	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Postoperative Nausea and Vomiting,Vomiting	ABCB1	rs2032582	Efficacy
3312	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	OPRM1	rs1799971	Dosage
3313	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs578776	Efficacy,Toxicity
3314	pharmgkb	Drug	hydrochlorothiazide	3639.0	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension,Hypertension	YEATS4	rs7297610	Efficacy
3315	pharmgkb	Drug	latanoprost	5282380.0	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGFR	rs3753380	Efficacy
3316	pharmgkb	Drug	propafenone	4932.0	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O	Arrhythmias, Cardiac	CYP2D6	CYP2D6*1, CYP2D6*10	Efficacy
3317	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT1A4	rs2011425	Metabolism/PK
3318	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Panic Disorder	HTR1A	rs6295	Efficacy
3319	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections,Toxic liver disease	ABCB1	rs1045642	Toxicity
3320	pharmgkb	Drug	hydralazine	3637.0	C1=CC=C2C(=C1)C=NN=C2NN		NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7	Metabolism/PK
3321	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		SLC22A1	rs34059508	Metabolism/PK
3322	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		ABCB1	rs3842	Metabolism/PK
3323	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	somnolence	ABCB1	rs10248420	Toxicity
3324	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	somnolence	CYP3A5	CYP3A5*1, CYP3A5*3	Toxicity
3325	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		APOC3	rs5128	Metabolism/PK
3326	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Asthenia	ABCB1	rs4728709	Toxicity
3327	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Arrhythmias, Cardiac	ABCB1	rs3842	Toxicity
3328	pharmgkb	Drug	tamoxifen	2733526.0	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98	Metabolism/PK
3329	pharmgkb	Drug	atomoxetine	54841.0	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
3330	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Efficacy
3331	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,Carcinoma, Renal Cell	KDR	rs2071559	Efficacy
3332	pharmgkb	Drug Class	Platinum compounds			Neoplasms	GSTP1	rs1695	Toxicity
3333	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	ABCB1	rs2032582	Efficacy
3334	pharmgkb	Drug	alendronate	2088.0	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	Osteoporosis	VDR	rs1544410	Efficacy
3335	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms,Peripheral Nervous System Diseases	EPHA5	rs7349683	Toxicity
3336	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	HSPA5	rs430397	Efficacy
3337	pharmgkb	Drug Class	direct acting antivirals			sustained virological response (svr)	IFNL4	rs11322783	Efficacy
3338	pharmgkb	Drug	telmisartan	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C		UGT1A3	UGT1A3*1, UGT1A3*2, UGT1A3*3	Metabolism/PK
3339	pharmgkb	Drug	telmisartan	65999.0	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C		SLCO1B3	rs60140950	Metabolism/PK
3340	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections,Tuberculosis	CYP2B6	rs2279345	Metabolism/PK
3341	pharmgkb	Drug	cysteamine	6058.0	C(CS)N	Cystic Fibrosis	CFTR	rs113993960	Efficacy
3342	pharmgkb	Drug	lumacaftor	16678941.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	Cystic Fibrosis	CFTR	rs113993960	Efficacy
3343	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2		CES1	rs71647871	Metabolism/PK
3344	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CES1	rs71647871	Dosage
3345	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	C18orf56,TYMS	rs45445694	Efficacy
3346	pharmgkb	Drug Class	taxanes			Peripheral Nervous System Diseases		rs74497159	Toxicity
3347	pharmgkb	Drug	indomethacin	3715.0	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O		CYP2C9	CYP2C9*1, CYP2C9*3	Toxicity
3348	pharmgkb	Drug	naproxen	1302.0	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O		CYP2C9	rs780801862	Metabolism/PK
3349	pharmgkb	Drug	cavosonstat	56960912.0	C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O	Cystic Fibrosis	CFTR	rs113993960	Efficacy
3350	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	ALDH2	rs671	Other
3351	pharmgkb	Drug	lumacaftor	16678941.0	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	Cystic Fibrosis	CFTR	rs121909047	Efficacy
3352	pharmgkb	Drug	enalapril	5362032.0	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O		CES1	rs71647871	Metabolism/PK
3353	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909011	Efficacy
3354	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs77010898	Efficacy
3355	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508602	Efficacy
3356	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C		CES1	rs71647871	Metabolism/PK
3357	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs1800100	Efficacy
3358	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs1800111	Efficacy
3359	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508328	Efficacy
3360	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909019	Efficacy
3361	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508510	Efficacy
3362	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121908751	Efficacy
3363	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508139	Efficacy
3364	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs34911792	Efficacy
3365	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs77409459	Efficacy
3366	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508435	Efficacy
3367	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs121909047	Efficacy
3368	pharmgkb	Drug Class	hmg coa reductase inhibitors			Muscular Diseases	RYR1	rs118192172	Toxicity
3369	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Sleep Apnea Syndromes	OPRM1	rs1799971	Toxicity
3370	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	COMT	rs4680	Dosage
3371	pharmgkb	Drug Class	opioids			Sleep Disorders	OPRM1	rs1799971	Toxicity
3372	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		OPRM1	rs79910351	Efficacy
3373	pharmgkb	Drug	remifentanil	60815.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		OPRM1	rs79910351	Efficacy
3374	pharmgkb	Drug	sofosbuvir	45375808.0	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	Hepatitis C, Chronic	IFNL4	rs11322783	Efficacy
3375	pharmgkb	Drug Class	opioids			Low Back Pain	KCNJ6	rs6517442	Dosage
3376	pharmgkb	Drug Class	opioids			Low Back Pain	ABCB1	rs1045642	Toxicity
3377	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain,Pain, Postoperative	OPRM1	rs1799971	Dosage
3378	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain, Postoperative	ABCB1	rs2032582	Dosage
3379	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs72547529	Dosage,Efficacy
3380	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CNR1	rs806368	Dosage
3381	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	TPH2	rs1386493	Dosage
3382	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRL1	rs2229205	Dosage
3383	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP2B6	rs16974799	Dosage
3384	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NFIB	rs28379954	Metabolism/PK
3385	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders,Pruritus	NECTIN4	rs11265549	Toxicity
3386	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	NECTIN4	rs11265549	Dosage
3387	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	NECTIN4	rs11265549	Metabolism/PK
3388	pharmgkb	Drug	ethanol	702.0	CCO		OPRM1	rs1799971	Toxicity
3389	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		SLCO1B1	rs4149056	Efficacy
3390	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain, Postoperative	NFKBIA	rs696	Dosage
3391	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CSMD1	rs6990851	Efficacy
3392	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	DLG2	rs2449598	Efficacy
3393	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CSMD1	rs6981827	Efficacy
3394	pharmgkb	Drug	anastrozole	2187.0	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms		rs1437153	Efficacy
3395	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence,Memory Disorders	DBH	rs1611114	Toxicity
3396	pharmgkb	Drug	propranolol	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	Temporomandibular joint-pain-dysfunction syndrome	COMT	rs4680	Efficacy
3397	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms,Drug Toxicity	ABCC4	rs9561778	Toxicity
3398	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs2301339	Efficacy
3399	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs11064426	Efficacy
3400	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Coronary Artery Disease,Hemorrhage,Myocardial Infarction	CYP2C19	CYP2C19*1, CYP2C19*17	Toxicity
3401	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	HTR2C	rs3813928	Efficacy
3402	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	STRBP	rs9032	Efficacy
3403	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PYROXD2	rs1061115	Efficacy
3404	pharmgkb	Drug	deferasirox	5493381.0	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	Drug Toxicity,Thalassemia	UGT1A1	rs4124874	Toxicity
3405	pharmgkb	Drug	pregabalin	5486971.0	CC(C)C[C@@H](CC(=O)O)CN	adverse events,neuropathic pain	SLC7A5	rs4240803	Toxicity
3406	pharmgkb	Drug	gabapentin	3446.0	C1CCC(CC1)(CC(=O)O)CN	adverse events,neuropathic pain	SLC7A5	rs4240803	Toxicity
3407	pharmgkb	Drug	gabapentin	3446.0	C1CCC(CC1)(CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	Efficacy
3408	pharmgkb	Drug	gabapentin	3446.0	C1CCC(CC1)(CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	Dosage
3409	pharmgkb	Drug	pregabalin	5486971.0	CC(C)C[C@@H](CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	Efficacy
3410	pharmgkb	Drug	propylthiouracil	657298.0	CCCC1=CC(=O)NC(=S)N1	Agranulocytosis,Graves Disease	HLA-B	HLA-B*38:02	Toxicity
3411	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O		ADRB1	rs1801252	Efficacy
3412	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	ADRB1	rs1801253	Dosage
3413	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Mood Disorders	FKBP5	rs4713916	Efficacy
3414	pharmgkb	Drug	mirtazapine	4205.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Mood Disorders	FKBP5	rs4713916	Efficacy
3415	pharmgkb	Drug	bucindolol	51045.0	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	Heart Failure	ADRB1	rs1801253	Efficacy
3416	pharmgkb	Drug, Metabolite	paliperidone	115237.0	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs489693	Efficacy
3417	pharmgkb	Drug, Metabolite	paliperidone	115237.0	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs17782313	Toxicity
3418	pharmgkb	Drug	haloperidol	3559.0	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	MC4R	rs489693	Toxicity
3419	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	MC4R	rs489693	Toxicity
3420	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Weight gain	MC4R	rs17782313	Toxicity
3421	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs489693	Toxicity
3422	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs17782313	Toxicity
3423	pharmgkb	Drug	amisulpride	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Hypertriglyceridemia,Weight gain	MC4R	rs489693	Toxicity
3424	pharmgkb	Drug	amisulpride	2159.0	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Weight gain	MC4R	rs17782313	Toxicity
3425	pharmgkb	Drug	aripiprazole	60795.0	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Weight gain	MC4R	rs489693	Toxicity
3426	pharmgkb	Drug	ataluren	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	rs77010898	Other
3427	pharmgkb	Drug	ataluren	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	rs75039782	Other
3428	pharmgkb	Drug	ataluren	11219835.0	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	rs113993959	Other
3429	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	KRAS	rs112445441	Efficacy
3430	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA5	rs3135506	Efficacy
3431	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149081	Toxicity
3432	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	rs1045642	Metabolism/PK
3433	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	BDNF-AS	rs11030096	Toxicity
3434	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	GABRB3	rs4906902	Toxicity
3435	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD2	rs1079596	Toxicity
3436	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs2654754	Toxicity
3437	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD2	rs1125394	Toxicity
3438	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs9288993	Toxicity
3439	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TACR1	rs735668	Toxicity
3440	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ZNF804A	rs7597593	Toxicity
3441	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNR1	rs2023239	Toxicity
3442	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs510769	Toxicity
3443	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNR1	rs6928499	Toxicity
3444	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CYP2A7P1,CYP2B6	rs3745274	Toxicity
3445	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs6280	Toxicity
3446	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CYP2D6	rs1065852	Toxicity
3447	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs324029	Toxicity
3448	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	EXOC4	rs718656	Toxicity
3449	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TACR3	rs1384401	Toxicity
3450	pharmgkb	Drug Class	opioids			Opioid-Related Disorders		rs4530637	Toxicity
3451	pharmgkb	Drug	rocuronium	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1A2	rs7967354	Dosage
3452	pharmgkb	Drug	rocuronium	441290.0	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		IAPP,SLCO1A2	rs11045995	Dosage
3453	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Fractures, Bone,Pain,Pain, Postoperative	ABCB1	rs1045642	Efficacy
3454	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain, Postoperative	OPRM1	rs1799971	Efficacy
3455	pharmgkb	Drug	ibuprofen	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		PTGS2	rs20417	Efficacy
3456	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Fractures, Bone,Pain,Pain, Postoperative	ABCB1	rs2032582	Efficacy
3457	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	FTO	rs16952570	Toxicity
3458	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	FTO	rs16952570	Toxicity
3459	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neoplasms,Pain	OPRK1	rs1051660	Dosage
3460	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	COMT	rs4680	Efficacy
3461	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	OPRM1	rs1799971	Efficacy
3462	pharmgkb	Drug	butorphanol	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		OPRK1	rs702764	Efficacy
3463	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		COMT	rs6269	Efficacy
3464	pharmgkb	Drug	butorphanol	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		COMT	rs4633	Efficacy
3465	pharmgkb	Drug	butorphanol	5361092.0	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		COMT	rs6269	Efficacy
3466	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCA1	rs2230806	Efficacy
3467	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCA1	rs2230806	Efficacy
3468	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCA1	rs2230806	Efficacy
3469	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Efficacy
3470	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Efficacy
3471	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Efficacy
3472	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4	Efficacy
3473	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CETP	rs708272	Efficacy
3474	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CETP	rs5882	Efficacy
3475	pharmgkb	Metabolite	cotinine glucuronide	178540.0			UGT1A9	rs12471326	Metabolism/PK
3476	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs145014075	Metabolism/PK
3477	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,heart transplantation,Kidney Neoplasms,Kidney Transplantation,lung transplantation,Neuroendocrine Tumors	CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
3478	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Kidney Neoplasms,Neuroendocrine Tumors	MTOR	rs2024627	Efficacy
3479	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-B	HLA-B*08:01, HLA-B*39:01	Toxicity
3480	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-C	HLA-C*12:03	Toxicity
3481	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DQB1	HLA-DQB1*02:01	Toxicity
3482	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DPB1	HLA-DPB1*10:01	Toxicity
3483	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DRB1	HLA-DRB1*03:01, HLA-DRB1*04:04	Toxicity
3484	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MICA	rs1051792	Efficacy
3485	pharmgkb	Drug Class	Ace Inhibitors, Plain			Angioedema	KCNMA1	rs2253201	Toxicity
3486	pharmgkb	Drug	voriconazole	71616.0	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		SLCO2B1	rs3781727	Metabolism/PK
3487	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	adverse events,Arthritis, Rheumatoid	ADORA2A	rs2236624	Toxicity
3488	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs2298383	Toxicity
3489	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A-AS1	rs17004921	Efficacy
3490	pharmgkb	Drug	glyburide	3488.0	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	Toxicity
3491	pharmgkb	Drug	glimepiride	3476.0	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	Toxicity
3492	pharmgkb	Drug	glipizide	3478.0	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	Toxicity
3493	pharmgkb	Drug	oseltamivir	65028.0	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC		ABCB1	rs1045642	Toxicity
3494	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	ABCG2	rs3114020	Metabolism/PK
3495	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	ABCG2	rs2231142	Metabolism/PK
3496	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	SLC22A1	rs628031	Metabolism/PK
3497	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT1A4	UGT1A4*1a, UGT1A4*1b, UGT1A4*2	Metabolism/PK
3498	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	rs7668258	Dosage
3499	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DRB1	HLA-DRB1*08:03	Toxicity
3500	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-B	HLA-B*39:01	Toxicity
3501	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DQB1	HLA-DQB1*06:01	Toxicity
3502	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DQA1	HLA-DQA1*01:03	Toxicity
3503	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs745364489	Toxicity
3504	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	postanesthesia apnea	BCHE	rs1799807	Toxicity
3505	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	postanesthesia apnea	BCHE	rs1803274	Toxicity
3506	pharmgkb	Drug Class	antidepressants			adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6313	Toxicity
3507	pharmgkb	Drug Class	antidepressants			adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6311	Toxicity
3508	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs7997012	Efficacy
3509	pharmgkb	Drug	FOLFIRINOX			Pancreatic Neoplasms,Thrombocytopenia	UGT1A1	UGT1A1*1, UGT1A1*28	Toxicity
3510	pharmgkb	Drug	temozolomide	5394.0	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	Glioma	ABCB1	rs1128503	Metabolism/PK
3511	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Diseases	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	Metabolism/PK
3512	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10	Dosage
3513	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10	Metabolism/PK
3514	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	Efficacy
3515	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4	Dosage
3516	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	Metabolism/PK
3517	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Exanthema,Toxic liver disease	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	Toxicity
3518	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*2, CYP2D6*10	Toxicity
3519	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Toxicity
3520	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4	Toxicity
3521	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depression	CYP2D6	CYP2D6*1, CYP2D6*4	Dosage
3522	pharmgkb	Drug	metoprolol	4171.0	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	CYP2D6	CYP2D6*1, CYP2D6*45, CYP2D6*46	Metabolism/PK
3523	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
3524	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
3525	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:02	Toxicity
3526	pharmgkb	Drug	isepamicin	3037209.0		Ototoxicity	MT-ND1,MT-RNR1	rs267606617	Toxicity
3527	pharmgkb	Drug	micronomicin	3037206.0		Ototoxicity	MT-ND1,MT-RNR1	rs267606619	Toxicity
3528	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs1556422499	Toxicity
3529	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-ND1,MT-RNR1	rs1603218569	Toxicity
3530	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity		rs28358572	Toxicity
3531	pharmgkb	Drug	dihydrostreptomycin	439369.0		Ototoxicity	MT-RNR1	rs1556422499	Toxicity
3532	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	rs2740574	Metabolism/PK
3533	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs28358569	Toxicity
3534	pharmgkb	Drug	gentamicin	3467.0	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs28358569	Toxicity
3535	pharmgkb	Drug	neomycin	8378.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N	Ototoxicity	MT-ND1,MT-RNR1	rs267606617	Toxicity
3536	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs1556422499	Toxicity
3537	pharmgkb	Drug	streptomycin	19649.0	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity		rs28358571	Toxicity
3538	pharmgkb	Drug	kanamycin	6032.0	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity		rs28358571	Toxicity
3539	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	CYP3A4	rs2740574	Dosage
3540	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A,CYP3A4	rs2740574	Metabolism/PK
3541	pharmgkb	Drug	tolbutamide	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62	Metabolism/PK
3542	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		COMT	rs4680	Dosage
3543	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO2B1	rs12422149	Efficacy
3544	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	PACSIN2	rs2413739	Toxicity
3545	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Irritable Bowel Syndrome	PACSIN2	rs2413739	Efficacy
3546	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Leukopenia	NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6	Toxicity
3547	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2		NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6	Dosage
3548	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Neutropenia	NUDT15	NUDT15*1, NUDT15*6	Toxicity
3549	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	rs4149056	Efficacy
3550	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	CETP	rs708272	Efficacy
3551	pharmgkb	Drug Class	hmg coa reductase inhibitors				ABCB1	rs1128503	Other
3552	pharmgkb	Drug Class	hmg coa reductase inhibitors			Hypercholesterolemia,Myocardial Infarction	GNB3	rs5443	Efficacy
3553	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs4948496	Metabolism/PK
3554	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs4948496	Toxicity
3555	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms	SLCO1B1	rs11045879	Metabolism/PK
3556	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukopenia,Osteosarcoma	ABCC2	rs17222723	Toxicity
3557	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Leukopenia,Osteosarcoma	GSTP1	rs1695	Toxicity
3558	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O		SOD2	rs4880	Other
3559	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236861	Toxicity
3560	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGT	rs4762	Efficacy
3561	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGT	rs699	Efficacy
3562	pharmgkb	Drug	atenolol	2249.0	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension,Hypertrophy, Left Ventricular	AGT	rs699	Efficacy
3563	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGTR1	rs5186	Efficacy
3564	pharmgkb	Drug	irbesartan	3749.0	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	ACE	rs1799752	Efficacy
3565	pharmgkb	Drug	diazepam	3016.0	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
3566	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	SOD2	rs2758339	Toxicity
3567	pharmgkb	Drug	sulfamethoxazole	5329.0	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like	Toxicity
3568	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs774072493	Toxicity
3569	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs568724445	Toxicity
3570	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs764841347	Toxicity
3571	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs1560022535	Toxicity
3572	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs531738678	Toxicity
3573	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs201820739	Toxicity
3574	pharmgkb	Drug	succinylcholine	5314.0	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C		BCHE	rs28933390	Toxicity
3575	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Mesothelioma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFD1	rs2236225	Efficacy
3576	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TYMS	rs45445694	Efficacy
3577	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149056	Efficacy
3578	pharmgkb	Drug Class	Beta Blocking Agents					rs139945292	Efficacy
3579	pharmgkb	Drug Class	Beta Blocking Agents					rs139945292	Toxicity
3580	pharmgkb	Drug	rivaroxaban	9875401.0			ABCB1	rs1045642	Toxicity
3581	pharmgkb	Drug	apixaban	10182969.0	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N		ABCB1	rs4148738	Toxicity
3582	pharmgkb	Drug	pegaspargase				ARHGAP28	rs9958628	Toxicity
3583	pharmgkb	Drug	pegaspargase				HLA-DQB1	HLA-DQB1*02:02	Toxicity
3584	pharmgkb	Drug	pegaspargase				HLA-DRB1	HLA-DRB1*07:01	Toxicity
3585	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs3758149	Metabolism/PK
3586	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs1051296	Metabolism/PK
3587	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Dosage
3588	pharmgkb	Drug	phenprocoumon	9908.0	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
3589	pharmgkb	Drug, Biological Intermediate	conjugated estrogens	23667301.0	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]		SLCO1B1	SLCO1B1*1, SLCO1B1*12, SLCO1B1*13	Metabolism/PK
3590	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	SLCO1B1	SLCO1B1*1, SLCO1B1*14	Efficacy
3591	pharmgkb	Drug	olmesartan	130881.0	CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O		SLCO1B1	SLCO1B1*15, SLCO1B1*37	Metabolism/PK
3592	pharmgkb	Drug	repaglinide	65981.0	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	Metabolism/PK
3593	pharmgkb	Drug	atrasentan				SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	Metabolism/PK
3594	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNIH3	rs10799590	Toxicity
3595	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	FPGS	rs1544105	Efficacy
3596	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	drug-induced liver injury,Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	DHFR	rs70991108	Toxicity
3597	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	gastrointestinal toxicity,mucositis,Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ENOSF1,TYMS	rs11280056	Toxicity
3598	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ENOSF1,TYMS	rs11280056	Efficacy
3599	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TLR2	rs3804100	Dosage
3600	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	ERCC1	rs11615	Efficacy
3601	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Pancreatic Neoplasms	ERCC1	rs11615	Efficacy
3602	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Ovarian Neoplasms	ERCC1	rs2336219	Efficacy
3603	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs3758149	Efficacy
3604	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs11545077	Efficacy
3605	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs11545076	Efficacy
3606	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		CYP2A7P1,CYP2B6	rs3745274	Metabolism/PK
3607	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma, Non-Hodgkin,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TYMS	rs45445694	Toxicity
3608	pharmgkb	Drug	salbutamol	2083.0	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	ADRB2	rs1042713	Efficacy
3609	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7668258	Efficacy
3610	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	rs7668258	Metabolism/PK
3611	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	rs2032582	Metabolism/PK
3612	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ASTN2	rs7858836	Dosage
3613	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ASTN2	rs958804	Dosage
3614	pharmgkb	Drug Class	antiepileptics			Epilepsy	SCN2A	rs2304016	Efficacy
3615	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN2A	rs2304016	Efficacy
3616	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	SCN2A	rs2304016	Efficacy
3617	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	SCN2A	rs2304016	Efficacy
3618	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	SCN2A	rs2304016	Efficacy
3619	pharmgkb	Drug	topiramate	5284627.0	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	Epilepsy	SCN2A	rs2304016	Efficacy
3620	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*67:01	Toxicity
3621	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	VDR	rs11574077	Metabolism/PK
3622	pharmgkb	Drug Class	interferons			Hepatitis C	IFNL3,IFNL4	rs12979860	Efficacy
3623	pharmgkb	Drug	flurbiprofen	3394.0	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O		CYP2C9	rs780801862	Metabolism/PK
3624	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3762555	Dosage
3625	pharmgkb	Drug	rosiglitazone	77999.0	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3	Efficacy
3626	pharmgkb	Drug	talinolol				ABCC2	rs2273697	Metabolism/PK
3627	pharmgkb	Drug	thiotepa			Neoplasms	GSTP1	rs1138272	Metabolism/PK
3628	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs9606186	Efficacy
3629	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs11150606	Dosage
3630	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	CCND1	rs9344	Efficacy
3631	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Acute coronary syndrome,Hyperlipoproteinemia Type II	ABCB1	rs2032582	Efficacy
3632	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	rs12208357	Metabolism/PK
3633	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	MC4R	rs11872992	Toxicity
3634	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	MC4R	rs11872992	Toxicity
3635	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia,Weight gain	GLP1R	rs2268639	Toxicity
3636	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	GLP1R	rs2268639	Toxicity
3637	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Thrombosis	NQO1	rs1800566	Efficacy
3638	pharmgkb	Drug Class	Dipeptidyl peptidase 4 (DPP-4) inhibitors			Diabetes Mellitus	CDKAL1	rs7754840	Efficacy
3639	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs1381376	Toxicity
3640	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs3778156	Toxicity
3641	pharmgkb	Drug	tolbutamide	5505.0	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	rs771237265	Metabolism/PK
3642	pharmgkb	Drug Class	antipsychotics			Weight gain		rs62097526	Toxicity
3643	pharmgkb	Drug	mephenytoin	4060.0	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs183701923	Metabolism/PK
3644	pharmgkb	Drug	doxorubicin	31703.0	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	AKR1C3	rs1937840	Other
3645	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		OPRM1	rs1799971	Other
3646	pharmgkb	Drug, Biological Intermediate	levodopa	6047.0	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	gastrointestinal toxicity,Hallucinations,Parkinson Disease	DRD3	rs6280	Toxicity
3647	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD2	rs6275	Dosage
3648	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1045642	Metabolism/PK
3649	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Leukemia, B-Cell, Acute	ABCC2	rs3740065	Toxicity
3650	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149056	Metabolism/PK
3651	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149081	Metabolism/PK
3652	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs2306283	Metabolism/PK
3653	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1A2	rs4149009	Metabolism/PK
3654	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	FPGS	rs1544105	Metabolism/PK
3655	pharmgkb	Drug Class	Bisphosphonates			osteonecrosis of jaw caused by drug		rs2736308	Toxicity
3656	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCB1	rs1045642	Efficacy,Toxicity
3657	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity	SLC19A1	rs1051266	Toxicity
3658	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs1801131	Toxicity
3659	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1128503	Toxicity
3660	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1045642	Toxicity
3661	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTR	rs1805087	Efficacy
3662	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTR	rs1805087	Toxicity
3663	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs717620	Toxicity
3664	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	CCND1	rs9344	Toxicity
3665	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	CCND1	rs9344	Efficacy
3666	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Anemia,Leukopenia,Lymphoma, Non-Hodgkin,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia,Toxic liver disease	MTHFD1	rs2236225	Toxicity
3667	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTRR	rs1801394	Toxicity
3668	pharmgkb	Drug	disulfiram	3117.0	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	OPRD1	rs678849	Efficacy
3669	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	gastrointestinal toxicity,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045879	Toxicity
3670	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	adverse events		rs115346678	Toxicity
3671	pharmgkb	Drug	cephalexin	27447.0	CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O	adverse events		rs34545984	Toxicity
3672	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	adverse events	WBP2NL	rs9620007	Toxicity
3673	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	adverse events	OPRM1	rs62436463	Toxicity
3674	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events	OPRM1	rs62436463	Toxicity
3675	pharmgkb	Drug	meperidine	4058.0	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	adverse events	FIP1L1	rs113100019	Toxicity
3676	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	adverse events	OPRM1	rs62436463	Toxicity
3677	pharmgkb	Prodrug	codeine	5284371.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	adverse events	SEPTIN3,WBP2NL	rs739296	Toxicity
3678	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events	SEPTIN3,WBP2NL	rs739296	Toxicity
3679	pharmgkb	Drug	hydrocodone	5284569.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	adverse events	SEPTIN3,WBP2NL	rs739296	Toxicity
3680	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	adverse events	SEPTIN3,WBP2NL	rs739296	Toxicity
3681	pharmgkb	Drug	meperidine	4058.0	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	adverse events	SERINC5	rs185462714	Toxicity
3682	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	adverse events		rs76103438	Toxicity
3683	pharmgkb	Drug	ketorolac	3826.0	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O	Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Efficacy
3684	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Peripheral Nervous System Diseases	ABCB1	rs1128503	Toxicity
3685	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism		rs12749274	Efficacy
3686	pharmgkb	Drug	acamprosate	71158.0	CC(=O)NCCCS(=O)(=O)O	Alcoholism		rs77583603	Efficacy
3687	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*46:01	Toxicity
3688	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:21	Toxicity
3689	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*24:02	Toxicity
3690	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP2B6	rs2279343	Dosage
3691	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Pain	ABCB1	rs1045642	Dosage
3692	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD1	rs5326	Dosage
3693	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		CYP3A4	CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34	Metabolism/PK
3694	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders		rs62368105	Efficacy
3695	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders		rs6973474	Efficacy
3696	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders		rs13169373	Efficacy
3697	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders		rs7205113	Efficacy
3698	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	ADAMTSL2	rs756770	Efficacy
3699	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ADH1C	rs698	Efficacy
3700	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ADH1B	rs2066702	Efficacy
3701	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ALDH2	rs671	Efficacy
3702	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	OPRM1	rs1799971	Dosage
3703	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O		AKR1C4	rs17134592	Metabolism/PK
3704	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O		AKR1C4	rs3829125	Metabolism/PK
3705	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRK1	rs997917	Toxicity
3706	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRK1	rs997917	Toxicity
3707	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Peptic Ulcer	EYA1	rs12678747	Toxicity
3708	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	Toxicity
3709	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs72549435	Metabolism/PK
3710	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs199515342	Metabolism/PK
3711	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs571335587	Metabolism/PK
3712	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs61605570	Metabolism/PK
3713	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs768416963	Metabolism/PK
3714	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs1302192284	Metabolism/PK
3715	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs111869995	Metabolism/PK
3716	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs137904044	Metabolism/PK
3717	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs114558780	Metabolism/PK
3718	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs200554095	Metabolism/PK
3719	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs772964366	Metabolism/PK
3720	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs758479488	Metabolism/PK
3721	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs145157460	Metabolism/PK
3722	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs148693084	Metabolism/PK
3723	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs1303839356	Metabolism/PK
3724	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs778019189	Metabolism/PK
3725	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs374515279	Metabolism/PK
3726	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs777098658	Metabolism/PK
3727	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs145308399	Metabolism/PK
3728	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs5031016	Metabolism/PK
3729	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs678849	Efficacy
3730	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Constipation,Delirium,Lung Neoplasms,Nausea,Pain,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention	FAAH	rs324420	Toxicity
3731	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	adverse events,Constipation,Delirium,Dizziness,Nausea,Pain, Postoperative,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention,Vomiting	OPRM1	rs1799971	Toxicity
3732	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain,Pain, Postoperative	OPRM1	rs1799971	Dosage
3733	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6	Metabolism/PK
3734	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2B6	rs3745274	Dosage
3735	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRM1	rs10485058	Efficacy
3736	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DAO	rs55944529	Metabolism/PK
3737	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DAO	rs55944529	Dosage
3738	pharmgkb	Drug	abiraterone	132971.0	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O	Prostatic Neoplasms	SRD5A2	rs523349	Efficacy
3739	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCG2	rs2231142	Other
3740	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCG2	rs2231142	Metabolism/PK
3741	pharmgkb	Drug	fluvastatin	1548972.0	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		ABCG2	rs2231142	Metabolism/PK
3742	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Leukemia,Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801133	Metabolism/PK
3743	pharmgkb	Drug	folic acid	6037.0	C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N		MTHFR	rs1801133	Metabolism/PK
3744	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801133	Efficacy
3745	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Graft vs Host Disease,Leukemia,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MTHFR	rs1801133	Efficacy
3746	pharmgkb	Prodrug	sacubitril				CES1	rs71647871	Metabolism/PK
3747	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Respiratory Insufficiency	HLA-B	HLA-B*07:02	Toxicity
3748	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Respiratory Insufficiency	HLA-C	HLA-C*07:02	Toxicity
3749	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Acquired Immunodeficiency Syndrome	GSTM1	GSTM1 non-null, GSTM1 null	Toxicity
3750	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		adverse events,Hypersensitivity	NAT2	rs1799931	Toxicity
3751	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		adverse events,Hypersensitivity	NAT2	rs1799930	Toxicity
3752	pharmgkb	Drug Class	hmg coa reductase inhibitors			Neoplasms		rs13210472	Toxicity
3753	pharmgkb	Drug	Glucarpidase			nephrotoxicity	INSRR,NTRK1	rs10908521	Toxicity
3754	pharmgkb	Drug	Glucarpidase			nephrotoxicity		rs1353327	Toxicity
3755	pharmgkb	Drug	Glucarpidase			nephrotoxicity		rs9345389	Toxicity
3756	pharmgkb	Drug	Glucarpidase			nephrotoxicity	GATA3	rs3824662	Toxicity
3757	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Confusion,Drug Toxicity,Headache,Muscle Rigidity,Schizophrenia,sedation,Seizures,Tachycardia	CYP1A2	CYP1A2*1A, CYP1A2*1C, CYP1A2*1F	Toxicity
3758	pharmgkb	Drug	quetiapine	5002.0	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A4	CYP3A4*1, CYP3A4*3	Metabolism/PK
3759	pharmgkb	Drug	alprazolam	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	adverse events,Alcoholism,Anxiety Disorders	CYP3A4	CYP3A4*1, CYP3A4*22	Toxicity
3760	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Neoplasms,Neurotoxicity Syndromes	CYP3A5	CYP3A5*1, CYP3A5*3	Toxicity
3761	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms	CYP3A4	CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22	Toxicity
3762	pharmgkb	Drug	diclofenac	3033.0	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62	Metabolism/PK
3763	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease,Hypercholesterolemia,Myocardial Infarction	KIF6	rs20455	Efficacy
3764	pharmgkb	Drug	acetaminophen	1983.0	CC(=O)NC1=CC=C(C=C1)O	severe cutaneous adverse reactions	HLA-DQB1	HLA-DQB1*02:02	Toxicity
3765	pharmgkb	Drug Class	opioids			Pain, Postoperative		rs2952768	Efficacy
3766	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative		rs2952768	Dosage
3767	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34	Toxicity
3768	pharmgkb	Drug	thioguanine	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N	Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34	Toxicity
3769	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34	Dosage
3770	pharmgkb	Drug	thioguanine	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34	Dosage
3771	pharmgkb	Drug	thioguanine	2723601.0	C1=NC2=C(N1)C(=S)N=C(N2)N		TPMT	TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34	Metabolism/PK
3772	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Lupus Erythematosus, Systemic,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37	Metabolism/PK
3773	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	schizoaffective disorder,Schizophrenia	CYP1A2	CYP1A2*1A, CYP1A2*1F	Metabolism/PK
3774	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	rs3742106	Metabolism/PK
3775	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	rs1751034	Metabolism/PK
3776	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764.0		HIV Infections,nephrotoxicity	ABCC10	rs9349256	Toxicity
3777	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764.0		HIV Infections,nephrotoxicity	ABCC4	rs3742106	Toxicity
3778	pharmgkb	Drug	digoxin	30322.0	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	Shortened QT interval	NOS1AP	rs10494366	Toxicity
3779	pharmgkb	Drug Class	highly active antiretroviral therapy (haart)			HIV Infections	ABCB1	rs1045642	Efficacy
3780	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		adverse events,Hypersensitivity,severe cutaneous adverse reactions	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B	Toxicity
3781	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	AHRR	rs2292596	Efficacy
3782	pharmgkb	Drug	phenytoin	1775.0	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Stevens-Johnson Syndrome	CYP2C9	CYP2C9*1, CYP2C9*3	Toxicity
3783	pharmgkb	Drug	ketoprofen	3825.0	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	Dyspepsia,Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*2	Toxicity
3784	pharmgkb	Drug	ketoprofen	3825.0	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*3	Efficacy
3785	pharmgkb	Drug	methoxsalen	4114.0	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2		CYP2A6	CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22	Metabolism/PK
3786	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46	Dosage
3787	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	Toxicity
3788	pharmgkb	Drug	hydralazine	3637.0	C1=CC=C2C(=C1)C=NN=C2NN	Hypertension	NAT2	NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A	Efficacy
3789	pharmgkb	Prodrug	tegafur	5386.0		Neoplasms	CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46	Metabolism/PK
3790	pharmgkb	Drug	letrozole	3902.0	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46	Metabolism/PK
3791	pharmgkb	Drug	coumarin				CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20	Metabolism/PK
3792	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2	Toxicity
3793	pharmgkb	Drug	buprenorphine / naloxone			Opioid-Related Disorders	UGT2B7	rs7662029	Metabolism/PK
3794	pharmgkb	Drug	buprenorphine / naloxone			Opioid-Related Disorders	UGT2B7	rs7439366	Metabolism/PK
3795	pharmgkb	Drug	tramadol	33741.0	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Opioid-Related Disorders	ABCB1	rs1045642	Toxicity
3796	pharmgkb	Drug	nifedipine	4485.0	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC		CYP3A4	CYP3A4*1, CYP3A4*17	Metabolism/PK
3797	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	N6AMT1	rs2254638	Efficacy
3798	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	P2RY12	rs2046934	Efficacy
3799	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	PTGS1	rs1330344	Efficacy
3800	pharmgkb	Drug	nimodipine	4497.0	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CACNA1C	rs2239050	Efficacy
3801	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Death	ADRA2C	rs61767072	Efficacy
3802	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs10787959	Efficacy
3803	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs3740563	Efficacy
3804	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs11198893	Efficacy
3805	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs4752292	Efficacy
3806	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	TNF	rs1800629	Toxicity
3807	pharmgkb	Drug	Glucarpidase			nephrotoxicity	SLCO1B1	rs4149056	Toxicity
3808	pharmgkb	Drug	Glucarpidase			nephrotoxicity	ABCC4	rs7317112	Toxicity
3809	pharmgkb	Drug	alprazolam	2118.0	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	Alcoholism,Anxiety Disorders	CYP3A4	CYP3A4*1, CYP3A4*22	Efficacy
3810	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Pain	CYP3A4	rs2740574	Efficacy
3811	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	rs1934969	Other
3812	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
3813	pharmgkb	Drug	clozapine	2818.0	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Agranulocytosis	HLA-DRB1	HLA-DRB1*04:02	Toxicity
3814	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Maculopapular Exanthema	HLA-DRB1	HLA-DRB1*03:01	Toxicity
3815	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	PIK3R5	rs444904	Toxicity
3816	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	EGFR	rs917881	Toxicity
3817	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	VEGFB	rs12366035	Toxicity
3818	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs4035887	Toxicity
3819	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	KDR	rs4864950	Toxicity
3820	pharmgkb	Drug	regorafenib			Drug Toxicity	KDR	rs4864950	Toxicity
3821	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity		rs10958704	Toxicity
3822	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs1868089	Toxicity
3823	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	PRKCE	rs11125039	Toxicity
3824	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	ADAMTS18	rs1346563	Toxicity
3825	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	EGFR	rs2330951	Toxicity
3826	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	MAP2K6	rs11651488	Toxicity
3827	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	CDH13	rs17682789	Toxicity
3828	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	WWOX	rs9927200	Toxicity
3829	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	EGFR	rs917881	Toxicity
3830	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	MAP2K6	rs12948059	Toxicity
3831	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity		rs315498	Toxicity
3832	pharmgkb	Drug	sorafenib	216239.0	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs9973653	Toxicity
3833	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Essential hypertension	CAMK1D	rs10737062	Efficacy
3834	pharmgkb	Drug	losartan	3961.0	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Essential hypertension	CAMK1D	rs10752271	Efficacy
3835	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	IL10	rs1800871	Metabolism/PK
3836	pharmgkb	Drug	rivaroxaban	9875401.0			ABCB1	rs1045642	Metabolism/PK
3837	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Respiratory Insufficiency	CYP3A4	rs2242480	Toxicity
3838	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain	CYP3A4	rs2242480	Dosage
3839	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A4	rs2242480	Efficacy
3840	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A4	rs2242480	Metabolism/PK
3841	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A4	rs2242480	Toxicity
3842	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hyperlipidemias	CYP3A4	rs2242480	Efficacy
3843	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A4	rs2242480	Metabolism/PK
3844	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	Metabolism/PK
3845	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	sedation	FASTKD3,MTRR	rs1801394	Efficacy
3846	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3,MTRR	rs1801394	Other
3847	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		GABRA2	rs279858	Other
3848	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3,MTRR	rs2307116	Other
3849	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		KCNK3	rs1275988	Other
3850	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		CYP2E1,DUX1	rs2031920	Other
3851	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		CYP2E1	rs3813867	Other
3852	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F	sedation	KCNK2	rs6686529	Efficacy
3853	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		GRIN2B	rs1806201	Other
3854	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3,MTRR	rs3733784	Efficacy
3855	pharmgkb	Drug	sevoflurane	5206.0	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3,MTRR	rs2307116	Efficacy
3856	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:01	Toxicity
3857	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:18, HLA-B*40:01	Toxicity
3858	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	HLA-C	HLA-C*06:02	Efficacy
3859	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Drug Hypersensitivity	HLA-DQB1	HLA-DQB1*05:01	Toxicity
3860	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:01	Toxicity
3861	pharmgkb	Drug	minocycline	5281021.0	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C	drug-induced liver injury	HLA-B	HLA-B*35:02	Toxicity
3862	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	liver transplantation,transplant rejection	ITPA	rs1127354	Efficacy
3863	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs2244613	Toxicity
3864	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Psoriasis	CALM1	rs12885713	Efficacy
3865	pharmgkb	Drug	cyclosporine	6435893.0	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C			rs2874116	Efficacy
3866	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	TPMT	rs1142345	Toxicity
3867	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,Depressive Disorder	HTR2A	rs7997012	Efficacy
3868	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders	HTR2A	rs7997012	Efficacy
3869	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Nausea,Vomiting	HTR2A	rs6311	Toxicity
3870	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders,Depressive Disorder, Major	HTR2A	rs6311	Toxicity
3871	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression,Depressive Disorder, Major	HTR2A	rs6311	Toxicity
3872	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6313	Toxicity
3873	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	HTR2A	rs6313	Toxicity
3874	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	HTR2A	rs9316233	Efficacy
3875	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			ability to concentrate,Depressive Disorder, Major,Diarrhea,Dizziness,Tremor	HTR2A	rs6311	Toxicity
3876	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
3877	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	SLC6A4	rs57098334	Efficacy
3878	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major,Mood Disorders,Panic Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
3879	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
3880	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depression,Depressive Disorder, Major	SLC6A4	rs57098334	Efficacy
3881	pharmgkb	Drug Class	antidepressants			Depression	SLC6A4	rs57098334	Toxicity
3882	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors				SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
3883	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP2D6	rs1065852	Efficacy
3884	pharmgkb	Drug	vincristine	5978.0	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Peripheral Nervous System Diseases	CEP72	rs924607	Toxicity
3885	pharmgkb	Drug	mianserin	4184.0	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	Depression	CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10	Metabolism/PK
3886	pharmgkb	Drug	rabeprazole	5029.0	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC	Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
3887	pharmgkb	Drug	esomeprazole	9568614.0	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux,Helicobacter Infections	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Efficacy
3888	pharmgkb	Drug	prasugrel	6918456.0	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	Acute coronary syndrome	CYP2C19	CYP2C19*1, CYP2C19*17	Toxicity
3889	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCG2	rs2231142	Toxicity
3890	pharmgkb	Drug	Glucarpidase			nephrotoxicity	ARID5B	rs10821936	Toxicity
3891	pharmgkb	Metabolite	n-desmethyltamoxifen	3032890.0	CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114	Metabolism/PK
3892	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP3A5	rs776746	Other
3893	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801133	Toxicity
3894	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	rs2032582	Efficacy
3895	pharmgkb	Prodrug	cyclophosphamide	2907.0	C1CNP(=O)(OC1)N(CCCl)CCCl	Neoplasms,Ovarian Neoplasms	XRCC1	rs25487	Efficacy,Toxicity
3896	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	rs11572103	Dosage
3897	pharmgkb	Drug	leflunomide	3899.0	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	CYP1A2	rs762551	Toxicity
3898	pharmgkb	Drug Class	antipsychotics			Schizophrenia	CYP1A2	rs2069514	Toxicity
3899	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	rs1131873	Dosage
3900	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	CLOCK	rs1801260	Toxicity
3901	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs17868320	Efficacy
3902	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	GNB3	rs5443	Efficacy
3903	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SCAP	rs12487736	Other
3904	pharmgkb	Drug	pravastatin	54687.0	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	rs2306283	Efficacy
3905	pharmgkb	Drug	amlodipine	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	Hypertension	CYP3A4	rs2740574	Efficacy
3906	pharmgkb	Drug	fenofibrate	3339.0	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	FABP1	rs2241883	Efficacy
3907	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	BDNF	rs6265	Toxicity
3908	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Breast Neoplasms	RRM1	rs1042858	Efficacy
3909	pharmgkb	Drug	benazepril	5362124.0	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Essential hypertension	ADRB2	rs1042713	Efficacy
3910	pharmgkb	Drug	ranibizumab			Macular Degeneration	VEGFA	rs833069	Efficacy
3911	pharmgkb	Drug	propranolol	4946.0	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O		CYP2D6	CYP2D6*1, CYP2D6*10	Other
3912	pharmgkb	Drug	mefloquine	4046.0	C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O	Malaria	G6PD	G6PD A- 202A_376G, G6PD B (reference)	Toxicity
3913	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	UGT1A9	rs3832043	Toxicity
3914	pharmgkb	Drug	chloroquine	2719.0	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl	Anemia, Hemolytic	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
3915	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCC2	rs3740066	Efficacy
3916	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Mental Disorders	HTR3B	rs1176744	Toxicity
3917	pharmgkb	Drug	ranibizumab			Macular Degeneration	VEGFA	rs699947	Efficacy
3918	pharmgkb	Prodrug	capecitabine	60953.0	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ADCY2	rs4702484	Efficacy
3919	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Hypertension	CYP3A5	rs776746	Toxicity
3920	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Muscular Diseases	SLCO1B1	rs4363657	Toxicity
3921	pharmgkb	Drug	carisoprodol	2576.0	CCCC(C)(COC(=O)N)COC(=O)NC(C)C		CYP2C19	CYP2C19*1, CYP2C19*2	Metabolism/PK
3922	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Angina Pectoris,Coronary Artery Disease,Myocardial Infarction,Myocardial Ischemia,Thrombosis	PON1	rs662	Efficacy,Toxicity
3923	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		P2RY12	rs6785930	Efficacy,Toxicity
3924	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs1045642	Efficacy
3925	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Deafness,Neoplasms,Ototoxicity	GSTT1	GSTT1 non-null, GSTT1 null	Toxicity
3926	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections,Kidney Diseases	ABCC2	rs2273697	Toxicity
3927	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs699947	Efficacy
3928	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	UGT2B7	rs7439366	Other
3929	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Neurotoxicity Syndromes	CYP3A5	rs776746	Toxicity
3930	pharmgkb	Drug	atorvastatin	60823.0	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CETP	rs708272	Efficacy,Toxicity
3931	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Hyperlipoproteinemia Type II	CETP	rs708272	Efficacy
3932	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	rs8192726	Other
3933	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	rs28399454	Other
3934	pharmgkb	Drug Class	Photodynamic therapy			Macular Degeneration	CFH	rs1061170	Efficacy
3935	pharmgkb	Drug	gefitinib	123631.0	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Lung Neoplasms	ABCG2	rs2231142	Toxicity
3936	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	rs1128503	Efficacy
3937	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	UGT2B7	rs28365062	Metabolism/PK
3938	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	CYP3A5	rs776746	Other
3939	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Substance-Related Disorders	DRD2	rs6277	Efficacy
3940	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC		IMPDH1	rs2278293	Toxicity
3941	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs2032582	Efficacy
3942	pharmgkb	Drug	mycophenolate mofetil	5281078.0	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs6714486	Efficacy
3943	pharmgkb	Drug	lithium	28486.0	[Li+]	Bipolar Disorder	NTRK2	rs1387923	Efficacy
3944	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP3A5	rs776746	Other
3945	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	FMO3	rs1736557	Toxicity
3946	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	HNMT	rs17583889	Toxicity
3947	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms		rs17645700	Toxicity
3948	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	UGT1A6	rs4261716	Toxicity
3949	pharmgkb	Drug Class	anthracyclines and related substances				UGT1A6	rs6759892	Toxicity
3950	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	UGT1A6	rs17863783	Toxicity
3951	pharmgkb	Drug Class	anthracyclines and related substances				ADH7	rs729147	Toxicity
3952	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC22A2	rs316019	Toxicity
3953	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB4	rs1149222	Toxicity
3954	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB4	rs4148808	Toxicity
3955	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB1	rs2235047	Toxicity
3956	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs4877847	Toxicity
3957	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC10A2	rs9514091	Toxicity
3958	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC10A2	rs7319981	Toxicity
3959	pharmgkb	Drug Class	anthracyclines and related substances				SLC28A1	rs2290271	Toxicity
3960	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCC1	rs4148350	Toxicity
3961	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A1	rs2305364	Toxicity
3962	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SPG7	rs2019604	Toxicity
3963	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	CYP4F2	rs2108623	Toxicity
3964	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SULT2B1	rs10426377	Toxicity
3965	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	HNF4A	rs2071197	Efficacy,Metabolism/PK
3966	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	CYP2C8	rs1934951	Toxicity
3967	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC2	rs13181	Toxicity
3968	pharmgkb	Drug	ustekinumab			Psoriasis	TNFAIP3	rs610604	Efficacy
3969	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs1128503	Metabolism/PK
3970	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs1045642	Dosage,Metabolism/PK
3971	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCC2	rs717620	Efficacy
3972	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	SLCO1B1	rs2306283	Toxicity
3973	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Colorectal Neoplasms	ABCB1	rs1045642	Toxicity
3974	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs4329505	Efficacy
3975	pharmgkb	Drug	sirolimus	6436030.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC		CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
3976	pharmgkb	Drug	propofol	4943.0	CC(C)C1=C(C(=CC=C1)C(C)C)O		CYP2B6	rs2279343	Metabolism/PK
3977	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Angina Pectoris	P2RY12	rs2046934	Efficacy
3978	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	IL10	rs1800896	Metabolism/PK
3979	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Chronic Disease	CYP3A4	rs35599367	Efficacy
3980	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	HNF4A	rs2071197	Metabolism/PK
3981	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs10841753	Metabolism/PK
3982	pharmgkb	Drug	lumefantrine	6437380.0	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A5	rs41303343	Metabolism/PK
3983	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:02	Toxicity
3984	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs16870989	Toxicity
3985	pharmgkb	Drug	nevirapine	4463.0	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,HIV Infections,Stevens-Johnson Syndrome,Toxic liver disease	CYP2B6	rs3745274	Toxicity
3986	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs7661530	Toxicity
3987	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs7675300	Toxicity
3988	pharmgkb	Drug	buprenorphine	40400.0	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs581111	Efficacy
3989	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	PSORS1C1	rs3815087	Toxicity
3990	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NR1I3	rs2501873	Dosage
3991	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	ABCB1	rs2032582	Dosage,Metabolism/PK
3992	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	ABCB1	rs1128503	Dosage,Metabolism/PK
3993	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	platelet reactivity	ABCB1	rs1045642	Efficacy
3994	pharmgkb	Drug	acenocoumarol	9052.0	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	Dosage
3995	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs12714145	Dosage
3996	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs699664	Dosage
3997	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BDNF	rs7103411	Efficacy
3998	pharmgkb	Prodrug	gemcitabine	60750.0	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC29A3	rs780668	Efficacy
3999	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs7624766	Efficacy
4000	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs1901633	Efficacy
4001	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs4982133	Efficacy
4002	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs1703794	Efficacy
4003	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	PTPRM	rs6506569	Efficacy
4004	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs2650972	Efficacy
4005	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid		rs6064463	Efficacy
4006	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		ABCB1	rs1045642	Dosage
4007	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	transplant rejection	CYP3A5	rs776746	Efficacy
4008	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	rs1045642	Toxicity
4009	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	AMPD1	rs17602729	Efficacy,Toxicity
4010	pharmgkb	Drug Class	Platinum compounds			Neoplasms	ERCC2	rs1799793	Efficacy,Toxicity
4011	pharmgkb	Prodrug	adefovir dipivoxil	60871.0	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C		SLC22A6	rs11568634	Other
4012	pharmgkb	Drug	lisinopril	5362119.0	C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O	Diabetes Mellitus, Type 1,Heart Failure	ACE	rs1799752	Efficacy
4013	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Psychotic Disorders,Schizophrenia,Substance-Related Disorders	ABCB1	rs1045642	Metabolism/PK
4014	pharmgkb	Drug	allopurinol	2094.0	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs10011796	Efficacy
4015	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs5569	Efficacy
4016	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs1799972	Toxicity
4017	pharmgkb	Drug	cocaine	5760.0	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs1799971	Toxicity
4018	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	rs1799971	Toxicity
4019	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	CYP3A4	rs2242480	Efficacy
4020	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs4633	Efficacy
4021	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs4680	Efficacy
4022	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ANKK1,DRD2	rs1800497	Efficacy
4023	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	ABCB1	rs1045642	Efficacy
4024	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	ABCB1	rs1045642	Dosage
4025	pharmgkb	Drug	heroin	5462328.0	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs1799971	Toxicity
4026	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	CYP2E1	rs2031920	Toxicity
4027	pharmgkb	Drug	amlodipine	2162.0	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	Hypertension	CYP3A4	rs2246709	Efficacy
4028	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	ABCB1	rs1045642	Dosage,Metabolism/PK
4029	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP4F2	rs2108622	Other
4030	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Toxicity
4031	pharmgkb	Drug	simvastatin	54454.0	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCB1	rs1045642	Efficacy
4032	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	rs7439366	Dosage
4033	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Neoplasms	LRP2	rs2075252	Toxicity
4034	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs1128503	Metabolism/PK
4035	pharmgkb	Drug	efavirenz	64139.0	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	rs3211371	Metabolism/PK
4036	pharmgkb	Drug	carvedilol	2585.0	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O		UGT1A1	UGT1A1*1, UGT1A1*28	Metabolism/PK
4037	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	CYP2B6	CYP2B6*1, CYP2B6*6	Dosage
4038	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
4039	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Metabolism/PK
4040	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3	Metabolism/PK
4041	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	hematopoietic stem cell transplantation,Kidney Transplantation,transplant rejection	CYP3A5	CYP3A5*1, CYP3A5*3	Efficacy
4042	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O		CYP2C19	CYP2C19*1, CYP2C19*2	Efficacy
4043	pharmgkb	Drug	oxaliplatin	6857599.0	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]		GSTP1	rs1695	Efficacy
4044	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADRA2A	rs1800544	Efficacy
4045	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	POR	rs1057868	Toxicity
4046	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,Ovarian Neoplasms	ERCC1	rs3212986	Efficacy
4047	pharmgkb	Prodrug	clopidogrel	60606.0	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Coronary Artery Disease	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Efficacy
4048	pharmgkb	Drug	azathioprine	2265.0	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	ITPA	rs7270101	Toxicity
4049	pharmgkb	Drug	aspirin	2244.0	CC(=O)OC1=CC=CC=C1C(=O)O	Acute coronary syndrome,Coronary Artery Disease	ITGB3	rs5918	Efficacy
4050	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid,Crohn Disease,Psoriasis,Spondylitis, Ankylosing	TNF	rs1799724	Efficacy
4051	pharmgkb	Drug, Metabolite	mercaptopurine	667490.0	C1=NC2=C(N1)C(=S)N=CN2	Myelosuppression,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ITPA	rs1127354	Toxicity
4052	pharmgkb	Drug	metformin	4091.0	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	ATM,C11orf65	rs11212617	Efficacy
4053	pharmgkb	Drug	tacrolimus	445643.0	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	nephrotoxicity	CYP3A5	CYP3A5*1, CYP3A5*3	Toxicity
4054	pharmgkb	Drug	risperidone	5073.0	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	DRD2	rs1799978	Efficacy
4055	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98	Metabolism/PK
4056	pharmgkb	Drug	olanzapine	4585.0	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		CYP3A5	CYP3A5*1, CYP3A5*3	Metabolism/PK
4057	pharmgkb	Drug Class	antiepileptics			Epilepsies, Partial,Epilepsy,Epilepsy, Generalized	ABCB1	rs1045642	Efficacy
4058	pharmgkb	Drug	naproxen	1302.0	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29	Metabolism/PK
4059	pharmgkb	Drug	fluorouracil	3385.0	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs3918290	Efficacy
4060	pharmgkb	Drug	ivacaftor	16220172.0	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	Efficacy
4061	pharmgkb	Prodrug	tenofovir	464205.0	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	Fanconi Syndrome,HIV Infections	ABCC2	rs8187710	Toxicity
4062	pharmgkb	Drug	ethanol	702.0	CCO	Alcoholism	OPRM1	rs1799971	Toxicity
4063	pharmgkb	Drug	sufentanil	41693.0	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	adverse events,Pain, Postoperative	OPRM1	rs1799971	Toxicity
4064	pharmgkb	Drug	naltrexone	5360515.0	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism,hypersexuality state,Tobacco Use Disorder	OPRM1	rs1799971	Efficacy
4065	pharmgkb	Drug	rosuvastatin	6439133.0	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO1B1	rs4149056	Efficacy
4066	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs1799971	Toxicity
4067	pharmgkb	Drug	ibuprofen	3672.0	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	Pain, Postoperative	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4	Efficacy
4068	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neoplasms,Pain,Pain, Postoperative	COMT	rs6269	Dosage
4069	pharmgkb	Drug	everolimus	6442177.0	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Kidney Neoplasms,Kidney Transplantation,Neuroendocrine Tumors	CYP3A4	CYP3A4*1, CYP3A4*22	Metabolism/PK
4070	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		OPRM1	rs1799971	Metabolism/PK
4071	pharmgkb	Drug	pantoprazole	4679.0	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	Helicobacter Infections	ABCB1	rs1045642	Efficacy
4072	pharmgkb	Drug	lamotrigine	3878.0	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	rs28365063	Metabolism/PK
4073	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	cns depression,Drug Toxicity	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	Toxicity
4074	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	Toxicity
4075	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Efficacy
4076	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3	Efficacy
4077	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801131	Dosage
4078	pharmgkb	Prodrug	irinotecan	60838.0	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Lymphoma,Neoplasms	UGT1A1	rs4124874	Toxicity
4079	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641.0		Anemia, Hemolytic,Hemolysis	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like	Toxicity
4080	pharmgkb	Drug	sulfametopyrazine	9047.0	COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	Toxicity
4081	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs1051266	Efficacy
4082	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801131	Efficacy
4083	pharmgkb	Drug	cisplatin	441203.0	N.N.Cl[Pt+2]Cl	Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	ERCC1	rs3212986	Efficacy
4084	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C18orf56,TYMS	rs45445694	Metabolism/PK
4085	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1045642	Efficacy
4086	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms	SLC19A1	rs1051266	Toxicity
4087	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17708472	Dosage
4088	pharmgkb	Drug	oxcarbazepine	34312.0	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:02	Toxicity
4089	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity,hematopoietic stem cell transplantation,Psoriasis,Toxic liver disease	TYMS	rs11280056	Toxicity
4090	pharmgkb	Drug	warfarin	54678486.0	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	rs1800566	Dosage
4091	pharmgkb	Drug	nicotine	942.0	CN1CCCC1C2=CN=CC=C2		OPRM1	rs1799971	Dosage
4092	pharmgkb	Drug	valproic acid	3121.0	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	rs7439366	Metabolism/PK
4093	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCG2	rs2231142	Metabolism/PK
4094	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, Lymphoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs717620	Metabolism/PK
4095	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, B-Cell, Acute,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs3740065	Metabolism/PK
4096	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Leukemia,Lymphoma, T-Cell,Neoplasms,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs1051266	Metabolism/PK
4097	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC2	rs2273697	Toxicity
4098	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCB1	rs1128503	Toxicity
4099	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	ABCB1	rs1045642	Efficacy
4100	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Brain Diseases,Drug Toxicity,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTR	rs1805087	Toxicity
4101	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	FASTKD3,MTRR	rs1801394	Toxicity
4102	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCG2	rs2231142	Toxicity
4103	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045879	Toxicity
4104	pharmgkb	Drug	methotrexate	126941.0	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, Non-Hodgkin,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	rs1801131	Toxicity
4105	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01	Toxicity
4106	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ABCB1	rs1128503	Dosage
4107	pharmgkb	Drug	methadone	4095.0	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ABCB1	rs1045642	Dosage
4108	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	Efficacy
4109	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	OPRM1	rs1799971	Toxicity
4110	pharmgkb	Drug, Metabolite	morphine	5288826.0	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	COMT	rs4680	Toxicity
4111	pharmgkb	Drug	oxycodone	5284603.0	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	COMT	rs4680	Toxicity
4112	pharmgkb	Drug	methylphenidate	4158.0	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	COMT	rs4680	Efficacy
4113	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Obsessive-Compulsive Disorder	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	Efficacy
4114	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Neoplasms	ABCB1	rs1045642	Efficacy
4115	pharmgkb	Drug	docetaxel	148124.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms,Neoplasms	ABCB1	rs1045642	Efficacy
4116	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neoplasms,Neutropenia,Peripheral Nervous System Diseases	ABCB1	rs1045642	Toxicity
4117	pharmgkb	Drug	paclitaxel	36314.0	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neutropenia,Peripheral Nervous System Diseases,Toxic liver disease	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4	Toxicity
4118	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Heart Failure	ADRB1	rs1801253	Efficacy
4119	pharmgkb	Drug Class	Beta Blocking Agents			Heart Failure	GRK5	rs2230345	Efficacy
4120	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Heart Failure	ADRB2	rs1042713	Efficacy
4121	pharmgkb	Drug	carbamazepine	2554.0	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:01	Toxicity
4122	pharmgkb	Drug	fentanyl	3345.0	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	CYP3A4*1, CYP3A4*18	Dosage
4123	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F		HTR2A	rs6313	Efficacy
4124	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F		HTR2A	rs6311	Efficacy
4125	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4126	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4127	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depression	HTR2A	rs6313	Efficacy
4128	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4129	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4130	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4131	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4132	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major,Obsessive-Compulsive Disorder	HTR2A	rs6311	Efficacy
4133	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4134	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4135	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4136	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6313	Efficacy
4137	pharmgkb	Drug	venlafaxine	5656.0	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders,Depression	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
4138	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs7997012	Efficacy
4139	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs7997012	Efficacy
4140	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	Toxicity
4141	pharmgkb	Drug	fluvoxamine	3404.0	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4142	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	Toxicity
4143	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6311	Toxicity
4144	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major	HTR2A	rs6311	Efficacy
4145	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6313	Toxicity
4146	pharmgkb	Drug	paroxetine	43815.0	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	HTR2A	rs7997012	Efficacy
4147	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depression	HTR2A	rs7997012	Efficacy
4148	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
4149	pharmgkb	Drug	citalopram	2771.0	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		SLC6A4	rs25531	Efficacy
4150	pharmgkb	Drug	escitalopram	146570.0	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,Depressive Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
4151	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Panic Disorder	SLC6A4	rs57098334	Efficacy
4152	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Panic Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
4153	pharmgkb	Drug	sertraline	68617.0	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Toxicity
4154	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	SLC6A4	rs25531	Efficacy
4155	pharmgkb	Drug	fluoxetine	3386.0	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major,Obsessive-Compulsive Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	Efficacy
4156	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough	BDKRB2	rs1799722	Toxicity
